0001753926-23-001015.txt : 20230808 0001753926-23-001015.hdr.sgml : 20230808 20230808162054 ACCESSION NUMBER: 0001753926-23-001015 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 52 CONFORMED PERIOD OF REPORT: 20230630 FILED AS OF DATE: 20230808 DATE AS OF CHANGE: 20230808 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INTER PARFUMS INC CENTRAL INDEX KEY: 0000822663 STANDARD INDUSTRIAL CLASSIFICATION: PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844] IRS NUMBER: 133275609 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-16469 FILM NUMBER: 231151692 BUSINESS ADDRESS: STREET 1: 551 FIFTH AVE STREET 2: STE 1500 CITY: NEW YORK STATE: NY ZIP: 10176 BUSINESS PHONE: 2129832640 MAIL ADDRESS: STREET 1: 551 FIFTH AVENUE STREET 2: STE 1500 CITY: NEW YORK STATE: NY ZIP: 10176 FORMER COMPANY: FORMER CONFORMED NAME: JEAN PHILIPPE FRAGRANCES INC DATE OF NAME CHANGE: 19920703 10-Q 1 g083669_10q.htm 10-Q
0000822663 false 2023 Q2 --12-31 2023-06-30 NY P7Y P50Y P10Y 120000000 80000000 P4Y P10Y P1Y P5Y7M6D P4Y P5Y 55475 148061 45445 106668 P2Y4M24D P7M6D 34952 0000822663 2023-01-01 2023-06-30 0000822663 2023-08-08 0000822663 2023-06-30 0000822663 2022-12-31 0000822663 2023-04-01 2023-06-30 0000822663 2022-04-01 2022-06-30 0000822663 2022-01-01 2022-06-30 0000822663 us-gaap:CommonStockMember 2022-12-31 0000822663 us-gaap:CommonStockMember 2021-12-31 0000822663 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000822663 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0000822663 us-gaap:RetainedEarningsMember 2022-12-31 0000822663 us-gaap:RetainedEarningsMember 2021-12-31 0000822663 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0000822663 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0000822663 us-gaap:TreasuryStockCommonMember 2022-12-31 0000822663 us-gaap:TreasuryStockCommonMember 2021-12-31 0000822663 us-gaap:NoncontrollingInterestMember 2022-12-31 0000822663 us-gaap:NoncontrollingInterestMember 2021-12-31 0000822663 2021-12-31 0000822663 us-gaap:CommonStockMember 2023-01-01 2023-06-30 0000822663 us-gaap:CommonStockMember 2022-01-01 2022-06-30 0000822663 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-06-30 0000822663 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-06-30 0000822663 us-gaap:RetainedEarningsMember 2023-01-01 2023-06-30 0000822663 us-gaap:RetainedEarningsMember 2022-01-01 2022-06-30 0000822663 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-06-30 0000822663 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-06-30 0000822663 us-gaap:TreasuryStockCommonMember 2023-01-01 2023-06-30 0000822663 us-gaap:TreasuryStockCommonMember 2022-01-01 2022-06-30 0000822663 us-gaap:NoncontrollingInterestMember 2023-01-01 2023-06-30 0000822663 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-06-30 0000822663 us-gaap:CommonStockMember 2023-06-30 0000822663 us-gaap:CommonStockMember 2022-06-30 0000822663 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0000822663 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0000822663 us-gaap:RetainedEarningsMember 2023-06-30 0000822663 us-gaap:RetainedEarningsMember 2022-06-30 0000822663 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0000822663 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-30 0000822663 us-gaap:TreasuryStockCommonMember 2023-06-30 0000822663 us-gaap:TreasuryStockCommonMember 2022-06-30 0000822663 us-gaap:NoncontrollingInterestMember 2023-06-30 0000822663 us-gaap:NoncontrollingInterestMember 2022-06-30 0000822663 2022-06-30 0000822663 ipar:RobertoCavalliMember 2023-01-01 2023-06-30 0000822663 ipar:LacosteMember 2023-01-01 2023-06-30 0000822663 ipar:RochasFashionMember 2023-01-01 2023-06-30 0000822663 ipar:InterparfumsSAMember 2021-04-30 0000822663 us-gaap:LandMember 2023-01-01 2023-06-30 0000822663 us-gaap:BuildingMember 2023-01-01 2023-06-30 0000822663 srt:MinimumMember 2023-06-30 0000822663 srt:MaximumMember 2023-06-30 0000822663 us-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0000822663 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2023-06-30 0000822663 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2023-06-30 0000822663 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2023-06-30 0000822663 us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000822663 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2022-12-31 0000822663 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2022-12-31 0000822663 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0000822663 currency:EUR 2022-12-31 0000822663 currency:EUR 2021-04-30 0000822663 2021-04-30 0000822663 currency:EUR us-gaap:InterestRateSwapMember 2021-04-30 0000822663 us-gaap:ForeignExchangeContractMember 2023-06-30 0000822663 currency:GBP us-gaap:ForeignExchangeContractMember 2022-12-31 0000822663 us-gaap:ForeignExchangeContractMember 2023-01-01 2023-06-30 0000822663 2022-01-01 2022-12-31 0000822663 2021-01-01 2021-12-31 0000822663 us-gaap:StockOptionMember srt:MinimumMember 2023-01-01 2023-06-30 0000822663 us-gaap:StockOptionMember srt:MaximumMember 2023-01-01 2023-06-30 0000822663 us-gaap:StockOptionMember 2023-01-01 2023-06-30 0000822663 us-gaap:StockOptionMember 2022-01-01 2022-06-30 0000822663 ipar:InterparfumsSASubsidiaryMember ipar:EmployeesMember 2018-12-31 0000822663 ipar:InterparfumsSASubsidiaryMember ipar:OfficersAndManagersMember 2018-12-31 0000822663 2022-06-01 2022-06-30 0000822663 ipar:InterparfumsSASubsidiaryMember ipar:EmployeesMember 2022-03-31 0000822663 ipar:InterparfumsSASubsidiaryMember ipar:EmployeesMember 2023-01-01 2023-06-30 0000822663 ipar:InterparfumsSASubsidiaryMember ipar:EmployeesMember 2023-06-30 0000822663 ipar:InterparfumsSASubsidiaryMember ipar:EmployeesMember 2022-01-01 2022-12-31 0000822663 country:US 2023-04-01 2023-06-30 0000822663 country:US 2022-04-01 2022-06-30 0000822663 country:US 2023-01-01 2023-06-30 0000822663 country:US 2022-01-01 2022-06-30 0000822663 srt:EuropeMember 2023-04-01 2023-06-30 0000822663 srt:EuropeMember 2022-04-01 2022-06-30 0000822663 srt:EuropeMember 2023-01-01 2023-06-30 0000822663 srt:EuropeMember 2022-01-01 2022-06-30 0000822663 ipar:EliminationsMember 2023-04-01 2023-06-30 0000822663 ipar:EliminationsMember 2022-04-01 2022-06-30 0000822663 ipar:EliminationsMember 2023-01-01 2023-06-30 0000822663 ipar:EliminationsMember 2022-01-01 2022-06-30 0000822663 country:US 2023-06-30 0000822663 country:US 2022-12-31 0000822663 srt:EuropeMember 2023-06-30 0000822663 srt:EuropeMember 2022-12-31 0000822663 ipar:EliminationsMember 2023-06-30 0000822663 ipar:EliminationsMember 2022-12-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure iso4217:JPY iso4217:EUR iso4217:GBP

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q

 

(MARK ONE)

 

Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended June 30, 2023.

 

OR

 

Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from ___________to ________.

 

Commission File No. 0-16469

 

INTER PARFUMS, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   13-3275609
(State or other jurisdiction of   (I.R.S. Employer
incorporation or organization)   Identification No.)

 

551 Fifth AvenueNew YorkNew York     10176
(Address of Principal Executive Offices)          (Zip Code)

 

(212) 983-2640
(Registrants telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which
registered
 Common Stock, $.001 par value per share   IPAR    The Nasdaq Stock Market

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days: Yes No

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act).

 

Large accelerated filer Accelerated filer ☐
Non-accelerated filer ☐ (Do not check if a smaller reporting company) Smaller reporting company
  Emerging Growth company

  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

 

At August 8, 2023, there were 31,975,670 shares of common stock, par value $.001 per share, outstanding.

 

 

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

INDEX

 

      Page Number
       
Part I. Financial Information 1
       
  Item 1. Financial Statements  
       
    Consolidated Balance Sheets
as of June 30, 2023 and December 31, 2022
2
       
    Consolidated Statements of Income
for the Three and Six Months Ended
June 30, 2023 and June 30, 2022
3
       
    Consolidated Statements of Comprehensive Income
for the Three and Six Months Ended
June 30, 2023 and June 30, 2022
4
       
    Consolidated Statements of Changes in Equity
for the Six Months Ended
June 30, 2023 and June 30, 2022
5
       
    Consolidated Statements of Cash Flows
for the Six Months Ended
June 30, 2023 and June 30, 2022
6
       
    Notes to Consolidated Financial Statements 7
       
  Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 16
       
  Item 3. Quantitative and Qualitative Disclosures About Market Risk 26
       
  Item 4. Controls and Procedures 27
       
Part II. Other Information 27
       
  Item 2. Unregistered Sales of Equity Securities and Use of Proceeds. 27
       
  Item 6. Exhibits 28
       
Signatures  

 

 

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Part I.Financial Information

 

Item 1.Financial Statements

 

In our opinion, the accompanying unaudited consolidated financial statements contain all adjustments (consisting only of normal recurring adjustments) necessary to present fairly our financial position, results of operations and cash flows for the interim periods presented. We have condensed such financial statements in accordance with the rules and regulations of the Securities and Exchange Commission (“SEC”). Therefore, such financial statements do not include all disclosures required by accounting principles generally accepted in the United States of America. In preparing these consolidated financial statements, the Company has evaluated events and transactions for potential recognition or disclosure through the date the consolidated financial statements were issued by filing with the SEC. These financial statements should be read in conjunction with our audited financial statements for the year ended December 31, 2022, included in our annual report filed on Form 10-K.

 

The results of operations for the six months ended June 30, 2023, are not necessarily indicative of the results to be expected for the entire fiscal year.

 

Page 1

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

CONSOLIDATED BALANCE SHEETS

(In thousands except share and per share data)

(Unaudited)

 

                 
ASSETS                
   June 30,
2023
   December 31,
2022
 
Current assets:          
Cash and cash equivalents  $74,311   $104,713 
Short-term investments   112,449    150,833 
Accounts receivable, net   236,554    197,584 
Inventories   360,018    289,984 
Receivables, other   14,730    28,803 
Other current assets   24,993    15,650 
Income taxes receivable   386    157 
Total current assets   823,441    787,724 
Property, equipment and leasehold improvements, net   168,264    166,722 
Right-of-use assets, net   28,005    27,964 
Trademarks, licenses and other intangible assets, net   292,319    290,853 
Deferred tax assets   14,333    11,159 
Other assets   25,302    24,120 
Total assets  $1,351,664   $1,308,542 
           
LIABILITIES AND EQUITY
Current liabilities:          
Loans payable - banks  $4,958   $ 
Current portion of long-term debt   29,080    28,547 
Current portion of lease liabilities   5,236    5,296 
Accounts payable – trade   91,040    88,388 
Accrued expenses   194,036    213,621 
Income taxes payable   17,324    8,715 
Total current liabilities   341,674    344,567 
           
Long–term debt, less current portion   138,565    151,494 
Lease liabilities, less current portion   24,491    24,335 
           
Equity:          
Inter Parfums, Inc. shareholders’ equity:          
Preferred stock, $.001 par; authorized 1,000,000 shares; none issued        
Common stock, $.001 par; authorized 100,000,000 shares; outstanding 31,975,670 and 31,967,300 shares at June 30, 2023 and December 31, 2022, respectively   32    32 
Additional paid-in capital   95,984    90,186 
Retained earnings   669,688    620,095 
Accumulated other comprehensive loss   (48,739)   (56,056)
Treasury stock, at cost, 9,949,865 and 9,864,805 shares at June 30, 2023 and December 31, 2022, respectively   (48,764)   (37,475)
Total Inter Parfums, Inc. shareholders’ equity   668,201    616,782 
Noncontrolling interest   178,733    171,364 
Total equity   846,934    788,146 
Total liabilities and equity  $1,351,664   $1,308,542 

 

See notes to consolidated financial statements.

 

Page 2

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

CONSOLIDATED STATEMENTS OF INCOME

(In thousands except per share data)

(Unaudited)

 

                             
   Three Months Ended
June 30,
   Six Months Ended
June 30,
 
   2023   2022   2023   2022 
                 
Net sales  $309,244   $244,725   $620,967   $495,403 
                     
Cost of sales   120,840    90,943    229,606    182,963 
                     
Gross margin   188,404    153,782    391,361    312,440 
                     
Selling, general and administrative expenses   133,383    108,385    246,061    205,825 
                     
Income from operations   55,021    45,397    145,300    106,615 
                     
Other expenses (income):                    
Interest expense   2,276    1,023    4,633    1,907 
(Gain) loss on foreign currency   (746)   (279)   13    (2,518)
Interest and investment (income) loss   (1,977)   (464)   (7,359)   1,002 
Other income   (7)   (328)   (48)   (444)
                     
Nonoperating Income (Expense)   (454)   (48)   (2,761)   (53)
                     
Income before income taxes   55,475    45,445    148,061    106,668 
                     
Income taxes   12,957    10,925    34,635    25,857 
                     
Net income   42,518    34,520    113,426    80,811 
                     
Less:  Net income attributable to the noncontrolling interest   7,566    6,903    24,406    17,895 
                     
Net income attributable to Inter Parfums, Inc.  $34,952   $27,617   $89,020   $62,916 
                     
Earnings per share:                    
                     
Net income attributable to Inter Parfums, Inc. common shareholders:                    
Basic  $1.09   $0.87   $2.78   $1.98 
Diluted  $1.09   $0.86   $2.77   $1.97 
                     
Weighted average number of shares outstanding:                    
Basic   32,006    31,845    32,012    31,843 
Diluted   32,162    31,952    32,161    31,981 
                     
Dividends declared per share  $0.625   $0.50   $1.30   $1.00 

 

See notes to consolidated financial statements.

 

Page 3

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(In thousands)

(Unaudited)

 

                             
   Three Months Ended
June 30,
   Six Months Ended
June 30,
 
   2023   2022   2023   2022 
Comprehensive income:                    
                     
Net income  $42,518   $34,520   $113,426   $80,811 
                     
Other comprehensive income:                    
                     
Net derivative instrument loss, net of tax   (77)   (1,749)   (4,243)   (1,488)
                     
Transfer from OCI into earnings           1,709    992 
                     
Translation adjustments, net of tax   (454)   (33,630)   13,035    (46,071)
                     
Comprehensive income (loss)   41,987    (859)   123,927    34,244 
                     
Comprehensive income attributable to the noncontrolling interests:                    
                     
Net income   7,566    6,903    24,406    17,895 
                     
Other comprehensive income (loss):                    
                     
Net derivative instrument loss, net of tax   (21)   (483)   (227)   (411)
                     
Translation adjustments, net of tax   (211)   (10,743)   3,411    (14,162)
                     
Comprehensive income (loss) attributable to the noncontrolling interests   

7,334

    (4,323)   27,590    3,322 
                     
Comprehensive income attributable to Inter Parfums, Inc.  $34,653   $3,464   $96,337   $30,922 

 

See notes to consolidated financial statements.

 

Page 4

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

(In thousands)

(Unaudited)

 

           
   Six months ended
June 30,
 
   2023   2022 
         
Common stock, beginning and end of period  $32   $32 
         
         
Additional paid-in capital, beginning of period   90,186    87,132 
Shares issued upon exercise of stock options   5,191    810 
Share-based compensation   624    679 
Purchase of subsidiary shares   (17)   (4,305)
Additional paid-in capital, end of period   95,984    84,316 
           
Retained earnings, beginning of period   620,095    560,663 
Net income   89,020    62,916 
Dividends   (40,020)   (31,844)
Share-based compensation   593    1,632 
Retained earnings, end of period   669,688    593,367 
           
Accumulated other comprehensive loss, beginning of   period   (56,056)   (38,432)
Foreign currency translation adjustment, net of tax   9,624    (31,909)
Transfer from other comprehensive income into earnings   1,709    992 
Net derivative instrument loss, net of tax   (4,016)   (1,077)
Accumulated other comprehensive loss, end of period   (48,739)   (70,426)
           
Treasury stock, beginning and end of period   (37,475)   (37,475)
Shares repurchased   (11,289)    
Treasury stock, end of period   (48,764)   (37,475)
           
Noncontrolling interest, beginning of period   171,364    166,412 
Net income   24,406    17,895 
Foreign currency translation adjustment, net of tax   3,411    (14,162)
Net derivative instrument loss, net of tax   (227)   (411)
Share-based compensation (adjustment)   97    (389)
Purchase of subsidiary shares   (17)   (152)
Transfer of subsidiary shares purchased       54 
Dividends   (20,301)   (16,056)
Noncontrolling interest, end of period   178,733    153,191 
    788,146    852,671 
    113,426    80,811 
Total equity  $846,934   $723,005 

 

See notes to consolidated financial statements.

 

Page 5

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

 

             
   Six months ended
June 30,
 
   2023   2022 
Cash flows from operating activities:          
Net income  $113,426   $80,811 
Adjustments to reconcile net income to net cash provided by (used in) operating activities:          
Depreciation and amortization   8,367    6,803 
Provision for doubtful accounts   (650)   1,241 
Noncash stock compensation   1,265    1,877 
Share of income of equity investment   (48)   (444)
Noncash lease expense   2,620    3,017 
Deferred tax provision (benefit)   (2,987)   (2,595)
Change in fair value of derivatives   164    (2,036)
Changes in:          
Accounts receivable   (35,181)   (48,085)
Inventories   (66,144)   (81,188)
Other assets   3,406    (1,872)
Operating lease liabilities   (2,579)   (2,822)
Accounts payable and accrued expenses   (23,425)   7,916 
Income taxes, net   8,531    8,869 
           
Net cash provided by (used in) operating activities   6,765    (28,508)
           
Cash flows from investing activities:          
Purchases of short-term investments   (97,079)   (2,941)
Proceeds from sale of short-term investments   138,061    6,211 
Purchases of property, equipment and leasehold improvements   (3,202)   (30,305)
Payment for intangible assets acquired   (228)   (1,016)
           
Net cash provided by (used in) investing activities   37,552    (28,051)
           
Cash flows from financing activities:          
Proceeds from loans payable, bank   4,947     
Repayment of long-term debt   (15,958)   (7,522)
Proceeds from exercise of options   5,191    810 
Purchase of subsidiary shares from noncontrolling interest       (4,403)
Dividends paid   (40,020)   (31,844)
Dividends paid to noncontrolling interest   (20,301)   (16,056)
Purchase of treasury stock   (11,289)    
           
Net cash used in financing activities   (77,430)   (59,015)
           
Effect of exchange rate changes on cash   2,711    (578)
           
Net decrease in cash and cash equivalents   (30,402)   (116,152)
           
Cash and cash equivalents - beginning of period   104,713    168,387 
           
Cash and cash equivalents - end of period  $74,311   $52,235 
           
Supplemental disclosure of cash flow information:          
Cash paid for:          
Interest  $3,189   $1,581 
Income taxes   30,096    16,369 

 

See notes to consolidated financial statements.

 

Page 6

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Notes to Consolidated Financial Statements

1.Significant Accounting Policies:

 

The accounting policies we follow are set forth in the notes to our consolidated financial statements included in our Form 10-K, which was filed with the Securities and Exchange Commission for the year ended December 31, 2022.

 

2.Impact of COVID-19 Pandemic:

 

Our business has continued to significantly improve throughout 2022 and the first half of 2023 after the disastrous effects of the COVID-19 Pandemic starting in early 2020, as retail stores reopened, and consumers increased online purchasing. While COVID-19 had significantly restricted international travel, the travel retail business has picked up. Lastly, we experienced significant strains on our supply chain causing disruptions affecting the procurement of components, the ability to transport goods, and related cost increases. These disruptions came at a time when demand for our product lines has never been stronger or more sustained. We have addressed this issue since the beginning of 2021, by ordering well in advance of need and in larger quantities. Since 2021, we have strived to carry more inventory overall, source the same components from multiple suppliers and when possible, manufacture products closer to where they are sold. The supply chain bottlenecks have been improving and while lead times remain longer than pre-COVID, we do not expect significant disruptions going forward.

 

3.Recent Agreements:

 

Roberto Cavalli

 

In July 2023, we closed a transaction agreement with Roberto Cavalli, whereby an exclusive and worldwide license was granted for the production and distribution of Roberto Cavalli brand perfumes and fragrance related products. Our rights under this license are subject to certain minimum advertising expenditures and royalty payments as are customary in our industry. The license became effective in July 2023 and will last for 6.5 years.

 

Lacoste

 

In December 2022, we closed a transaction agreement with Lacoste, whereby an exclusive and worldwide license was granted for the production and distribution of Lacoste brand perfumes and cosmetics. Our rights under this license are subject to certain minimum advertising expenditures and royalty payments as are customary in our industry. The license becomes effective in January 2024 and will last for 15 years.

 

Dunhill

 

In April 2022, we announced that the Dunhill fragrance license will expire on September 30, 2023 and will not be renewed. The Company will continue to produce and sell Dunhill fragrances until the license expires and will maintain the right to sell-off remaining Dunhill fragrance inventory for a limited time as is customary in the fragrance industry.

 

Page 7

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Notes to Consolidated Financial Statements

 

Donna Karan and DKNY

 

In September 2021, we entered into a long-term global licensing agreement for the creation, development and distribution of fragrances and fragrance related products under the Donna Karan and DKNY brands. Our rights under this license are subject to certain minimum advertising expenditures and royalty payments as are customary in our industry. With this agreement, we are gaining several well-established and valuable fragrance franchises, most notably Donna Karan Cashmere Mist and DKNY Be Delicious, as well as a significant loyal consumer base around the world. In connection with the grant of license, we issued 65,342 shares of Inter Parfums, Inc. common stock valued at $5.0 million to the licensor. The exclusive license became effective July 1, 2022, and we are planning to launch new fragrances under these brands in 2024.

 

Rochas Fashion

 

Effective January 1, 2021, we entered into a new license agreement modifying our Rochas fashion business model. The new agreement calls for a reduction in royalties to be received. As a result, in the first quarter of 2021, we took a $2.4 million impairment charge on our Rochas fashion trademark. In the fourth quarter of 2022, we again took a $6.8 million impairment charge on the Rochas fashion trademark after an independent expert concluded that the valuation of the trademark was $11.3 million. The new license also contains an option for the licensee to buy-out the Rochas fashion trademarks in June 2025 at its then fair market value.

 

Land and Building Acquisition - Headquarters in Paris

 

In April 2021, Interparfums SA, our 72% owned French Subsidiary, completed the acquisition of its headquarters at 10 rue de Solférino in the 7th arrondissement of Paris from the property developer. This is an office complex combining three buildings connected by two inner courtyards, and consists of approximately 40,000 total sq. ft.

 

The purchase price included the complete renovation of the site. As of June 30, 2023, $152 million of the purchase price, including approximately $3.1 million of acquisition costs, is included in property, equipment and leasehold improvements on the accompanying balance sheet. The purchase price has been allocated approximately $62.2 million to land and $89.6 million to the building. The building, which was delivered on February 28, 2022, includes the building structure, development of the property, façade waterproofing, general and technical installations and interior fittings that will be depreciated over a range of 7 to 50 years. The Company has elected to depreciate the building cost based on the useful lives of its components. Approximately $1.2 million of cash held in escrow is also included in property, equipment and leasehold improvements on the accompanying balance sheet as of June 30, 2023.

 

The acquisition was financed by a 10-year €120 million (approximately $130.4 million) bank loan which bears interest at one-month Euribor plus 0.75%. Approximately €80 million of the variable rate debt was swapped for variable interest rate debt with a maximum rate of 2% per annum. The swap effectively exchanges the variable interest rate to a fixed rate of approximately 1.1%.

 

 

4.Recent Accounting Pronouncements:

 

There are no recent accounting pronouncements issued but not yet adopted that would have a material effect on our consolidated financial statements.

 

Page 8

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Notes to Consolidated Financial Statements

 

5.Inventories:

 

Inventories consist of the following:

 

(In thousands)  June 30, 2023   December 31, 2022 
Raw materials and component parts  $173,660   $146,772 
Finished goods   186,358    143,212 
           
Inventories  $360,018   $289,984 

 

 

6.Fair Value Measurement:

 

The following tables present our financial assets and liabilities that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy. The fair value hierarchy has three levels based on the reliability of the inputs used to determine fair value.

 

                       
       Fair Value Measurements at June 30, 2023 
   Total   Quoted Prices in
Active Markets for
Identical Assets
(Level 1)
   Significant Other
Observable
Inputs
(Level 2)
   Significant
Unobservable
Inputs
(Level 3)
 
Assets:                    
Short-term investments  $112,449   $2,150   $109,489   $811 
Interest rate swaps   6,780        6,780     
Foreign currency forward exchange contracts not accounted for using hedge accounting   165        165     
                     
Total asset  $119,394   $2,150   $116,434   $811 
Liabilities:                    
Foreign currency forward exchange contracts accounted for using hedge accounting  $9   $   $9   $ 

 

Page 9

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Notes to Consolidated Financial Statements

 

                         
       Fair Value Measurements at December 31, 2022 
   Total   Quoted Prices in
Active Markets for
Identical Assets
(Level 1)
   Significant Other
Observable
Inputs
(Level 2)
   Significant
Unobservable
Inputs
(Level 3)
 
Assets:                    
Short-term investments  $150,833   $19,861   $130,174   $798 
Interest rate swaps   6,758        6,758     
Foreign currency forward exchange contracts accounted for using hedge accounting   1,189        1,189     
                     
Total asset  $158,780   $19,861   $138,121   $798 
Liabilities:                    
Foreign currency forward exchange contracts not accounted for using hedge accounting   68        68     
                     
Total Liabilities  $68   $   $68   $ 

 

The carrying amount of cash and cash equivalents including money market funds, short-term investments, accounts receivable, other receivables, cash held in escrow, accounts payable and accrued expenses approximate fair value due to the short terms to maturity of these instruments.

 

The carrying amount of loans payable approximates fair value as the interest rates on the Company’s indebtedness approximate current market rates. The fair value of the Company’s long-term debt was estimated based on the current rates offered to companies for debt with the same remaining maturities and is approximately equal to its carrying value.

 

Foreign currency forward exchange contracts are valued based on quotations from financial institutions and the value of interest rate swaps is the discounted net present value of the swaps using third party quotes from financial institutions.

 

7.Derivative Financial Instruments:

 

The Company enters into foreign currency forward exchange contracts to hedge exposure related to receivables denominated in a foreign currency and occasionally to manage risks related to future sales expected to be denominated in a foreign currency. Before entering into a derivative transaction for hedging purposes, it is determined that a high degree of initial effectiveness exists between the change in value of the hedged item and the change in the value of the derivative instrument from movement in exchange rates. High effectiveness means that the change in the cash flows of the derivative instrument will effectively offset the change in the cash flows of the hedged item. The effectiveness of each hedged item is measured throughout the hedged period and is based on the dollar offset methodology and excludes the portion of the fair value of the foreign currency forward exchange contract attributable to the change in spot-forward difference which is reported in current period earnings. Any hedge ineffectiveness is also recognized as a gain or loss on foreign currency in the income statement. For hedge contracts that are no longer deemed highly effective, hedge accounting is discontinued, and gains and losses accumulated in other comprehensive income are reclassified to earnings. If it is probable that the forecasted transaction will no longer occur, then any gains or losses accumulated in other comprehensive income are reclassified to current-period earnings.

 

Page 10

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Notes to Consolidated Financial Statements 

 

In December 2022, to finance the acquisition of the Lacoste trademark, the Company entered into a €50 million (approximately $54.3 million) 4-year term loan with a variable interest rate. This variable rate debt was swapped for variable interest rate debt with a maximum rate of 2% per annum. This swap is a hedged derivative instrument and is therefore recorded at fair value and changes in fair value are reflected in other comprehensive income.

 

In connection with the April 2021 acquisition of the office building complex in Paris, €120 million (approximately $130.4 million) of the purchase price was financed through a 10-year term loan. The Company entered into interest rate swap contracts related to €80 million of the loan, effectively exchanging the variable interest rate to a fixed rate of approximately 1.1%. This derivative instrument is recorded at fair value and changes in fair value are reflected in the accompanying consolidated statements of income.

 

Gains and losses in derivatives designated as hedges are accumulated in other comprehensive income and gains and losses in derivatives not designated as hedges are included in (gain) loss on foreign currency on the accompanying income statements. Such gains and losses were immaterial for the three and six months ended June 30, 2023 and 2022.

 

All derivative instruments are reported as either assets or liabilities on the balance sheet measured at fair value. The valuation of interest rate swaps is included in other assets on the accompanying balance sheets. The valuation of foreign currency forward exchange contracts at June 30, 2023 resulted in a net asset and is included in other current assets on the accompanying balance sheet.

 

At June 30, 2023, we had foreign currency contracts in the form of forward exchange contracts in the amount of approximately U.S. $38.0 million and GB £2.0 million which all have maturities of less than one year.

 

 

8.Leases:

 

The Company leases its offices and warehouses, vehicles, and certain office equipment, substantially all of which are classified as operating leases. The Company currently has no material financing leases. The Company determines if an arrangement is a lease at inception. Operating lease assets and obligations are recognized at the lease commencement date based on the present value of lease payments over the lease term.

 

In determining lease asset value, the Company considers fixed or variable payment terms, prepayments, incentives, and options to extend or terminate, depending on the lease. Renewal, termination, or purchase options affect the lease term used for determining lease asset value only if the option is reasonably certain to be exercised. The Company generally uses its incremental borrowing rate based on information available at the lease commencement date for the location in which the lease is held in determining the present value of lease payments.

 

Page 11

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Notes to Consolidated Financial Statements

 

As of June 30, 2023, the weighted average remaining lease term was 5.6 years and the weighted average discount rate used to determine the operating lease liability was 2.8%. Rental expense related to operating leases was $1.5 million and $2.9 million for the three and six months ended June 30, 2023, respectively, as compared to $1.3 million and $3.1 million for the corresponding periods of the prior year. Operating lease payments included in operating cash flows totaled $2.6 million and $2.8 million for the six months ended June 30, 2023 and 2022, respectively, and noncash additions to operating lease assets totaled $2.4 million and $0.5 million for the six months ended June 30, 2023 and 2022, respectively.

 

 

9.Share-Based Payments:

 

The Company maintains a stock option program for key employees, executives and directors. The plans, all of which have been approved by shareholder vote, provide for the granting of both nonqualified and incentive options. Options granted under the plans typically have a six-year term and vest over a four to five-year period. The fair value of shares vested during the six months ended June 30, 2023 and 2022 aggregated $0.10 million and $0.10 million, respectively. Compensation cost, net of forfeitures, is recognized on a straight-line basis over the requisite service period for the entire award. Forfeitures are estimated based on historic trends. It is generally our policy to issue new shares upon exercise of stock options.

 

The following table sets forth information with respect to nonvested options for the six months ended June 30, 2023:

 

   Number of Shares   Weighted Average Grant-Date Fair Value 
Nonvested options – beginning of period   168,730   $16.31 
Nonvested options granted        
Nonvested options vested or forfeited   (23,560)  $13.59 
Nonvested options – end of period   145,170   $16.75 

 

Share-based payment expense decreased income before income taxes by $0.63 million and $1.27 million for the three and six months ended June 30, 2023, respectively, as compared to $1.22 million and $1.88 million for the corresponding periods of the prior year. Share-base income before income d payment expense decreased income attributable to Inter Parfums, Inc. by $0.43 million and $0.86 million for the three and six months ended June 30, 2023, respectively, as compared to $0.74 million and $1.18 million for the corresponding periods of the prior year.

 

The following table summarizes stock option information as of June 30, 2023:

 

   Shares   Weighted Average Exercise Price 
         
Outstanding at January 1, 2023   441,580   $67.30 
Options forfeited   (15,960)   70.48 
Options exercised   (93,430)   55.57 
           
Outstanding at June 30, 2023   332,190   $70.44 
           
Options exercisable   187,020   $61.53 
Options available for future grants   574,935      

 

Page 12

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Notes to Consolidated Financial Statements

 

As of June 30, 2023, the weighted average remaining contractual life of options outstanding is 2.40 years (0.6 years for options exercisable); the aggregate intrinsic value of options outstanding and options exercisable is $21.5 million and $13.8 million, respectively; and unrecognized compensation cost related to stock options outstanding aggregated $2.0 million.

 

Cash proceeds, tax benefits and intrinsic value related to stock options exercised during the six months ended June 30, 2023 and 2022 were as follows:

 

(In thousands)  June 30,
2023
   June 30, 
2022
 
         
Cash proceeds from stock options exercised  $5,192   $810 
Tax benefits   840    75 
Intrinsic value of stock options exercised   5,773    698 

 

There were no options granted during the six months ended June 30, 2023 and June 30, 2022.

 

Expected volatility is estimated based on historic volatility of the Company’s common stock. The expected term of the option is estimated based on historic data. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of the grant of the option and the dividend yield reflects the assumption that the dividend payout as authorized by the Board of Directors would increase as the earnings of the Company and its stock price continues to increase.

 

In December 2018, Interparfums SA approved a plan to grant an aggregate of 26,600 shares of its stock to employees with no performance condition requirement, and an aggregate of 133,000 shares to officers and managers, subject to certain corporate performance conditions. The corporate performance conditions were met and therefore in June 2022, 211,955 shares, adjusted for stock splits, were distributed. The aggregate cost of the grant of approximately $4.8 million was recognized as compensation cost on a straight-line basis over the requisite three-year service period.

 

In March 2022, Interparfums SA approved an additional plan to grant an aggregate of 88,400 shares to all Interparfums SA employees and corporate officers having more than six months of employment at grant date, subject to certain corporate performance conditions. The shares, subject to adjustment for stock splits, will be distributed in June 2025 and will follow the same guidelines as the December 2018 plan.

 

The fair value of the grant had been determined based on the quoted stock price of Interparfums SA shares as reported by the NYSE Euronext on the date of grant. The estimated number of shares to be distributed of 93,489 has been determined taking into account employee turnover. The aggregate cost of the grant of approximately $4.2 million will be recognized as compensation cost on a straight-line basis over the requisite three and a quarter year service period.

 

Similar to the December 2018 plan, in order to avoid dilution of the Company’s ownership of Interparfums SA, all shares distributed or to be distributed pursuant to these plans will be pre-existing shares of Interparfums SA, purchased in the open market by Interparfums SA. As of June 30, 2023 the Company acquired 69,609 shares at an aggregate cost of $3.0 million.

 

In the first half of 2023, the Company initiated a share repurchase program with the primary intent of neutralizing the dilution impact of the stock option programs previously discussed. Over the course of the first half of 2023, the Company repurchased 85,060 shares at a cost of $11.3 million. These shares are classified as treasury shares on the accompanying balance sheet. The Company plans to continue repurchasing shares throughout 2023.

 

Page 13

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Notes to Consolidated Financial Statements

 

All share purchases and issuances have been classified as equity transactions on the accompanying balance sheet.

 

10.Net Income Attributable to Inter Parfums, Inc. Common Shareholders:

 

Net income attributable to Inter Parfums, Inc. per common share (“basic EPS”) is computed by dividing net income attributable to Inter Parfums, Inc. by the weighted average number of shares outstanding. Net income attributable to Inter Parfums, Inc. per share assuming dilution (“diluted EPS”), is computed using the weighted average number of shares outstanding, plus the incremental shares outstanding assuming the exercise of dilutive stock options using the treasury stock method.

 

The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows:

 

                       
  Three months ended
June 30,
   Six months ended
June 30,
 
(In thousands)  2023   2022   2023   2022 
Numerator:                
Net income attributable to Inter Parfums, Inc.  $34,952   $27,617   $89,020   $62,916 
Denominator:                    
Weighted average shares   32,006    31,845    32,012    31,843 
Effect of dilutive securities:                    
Stock options   156    107    149    138 
Denominator for diluted earnings per share   32,162    31,952    32,161    31,981 
                     
Earnings per share:                    
Net income attributable to Inter Parfums, Inc. common shareholders:                    
Basic  $1.09   $0.87   $2.78   $1.98 
Diluted   1.09    0.86    2.77    1.97 

 

There were no antidilutive potential common shares outstanding for the three and six months ended June 30, 2023 and June 30, 2022.

 

Page 14

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Notes to Consolidated Financial Statements

11.Segment and Geographic Areas:

 

The Company manufactures and distributes one product line, fragrances and fragrance related products. The Company manages its business in two segments, European based operations and United States based operations. The European assets are located, and operations are primarily conducted, in France. Both European based operations and United States based operations primarily represent the sale of prestige brand name fragrances.

 

Information on our operations by geographical areas is as follows:

 

  Three months ended
June 30,
   Six months ended
June 30,
 
(In thousands)  2023   2022   2023   2022 
Net sales:                    
United States  $111,436   $78,444   $192,890   $146,946 
Europe   197,808    166,287    428,077    348,469 
Eliminations       (6)       (12)
                     
   $309,244   $244,725   $620,967   $495,403 
                     
Net income attributable to Inter Parfums, Inc.:                    
United States  $15,567   $9,991   $25,910   $16,505 
Europe   19,385    17,626    63,110    46,411 
                     
   $34,952   $27,617   $89,020   $62,916 

 

   June 30,   December 31, 
   2023   2022 
Total Assets:          
United States  $

313,261

   $278,090 
Europe   1,048,040    1,052,004 
Eliminations   (9,637)   (21,552)
   $1,351,664   $1,308,542 

 

 

Page 15

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Item 2:MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Forward Looking Information

 

Statements in this report which are not historical in nature are forward-looking statements. Although we believe that our plans, intentions and expectations reflected in such forward-looking statements are reasonable, we can give no assurance that such plans, intentions or expectations will be achieved. In some cases, you can identify forward-looking statements by forward-looking words such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “should,” “will” and “would” or similar words. You should not rely on forward-looking statements because actual events or results may differ materially from those indicated by these forward-looking statements as a result of a number of important factors. These factors include, but are not limited to, the risks and uncertainties discussed under the headings “Forward Looking Statements” and “Risk Factors” in Inter Parfums’ annual report on Form 10-K for the fiscal year ended December 31, 2022, and the reports Inter Parfums files from time to time with the Securities and Exchange Commission (“SEC”). Inter Parfums does not intend to and undertakes no duty to update the information contained in this report.

 

Overview

 

We operate in the fragrance business, and manufacture, market and distribute a wide array of fragrances and fragrance related products. We manage our business in two segments, European based operations and United States based operations. Certain prestige fragrance products are produced and marketed by our European operations through our 72% owned subsidiary in Paris, Interparfums SA, which is also a publicly traded company as 28% of Interparfums SA shares trade on the NYSE Euronext.

 

We produce and distribute our European based fragrance products primarily under license agreements with brand owners, and European based fragrance product sales represented approximately 69% and 70% of net sales for the six months ended June 30, 2023 and 2022, respectively. We have built a portfolio of prestige brands, which include Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lanvin, Moncler, Montblanc, S.T. Dupont, Rochas and Van Cleef & Arpels, whose products are distributed in over 120 countries around the world. In addition, our exclusive and worldwide license for the production and distribution of Lacoste brand perfumes and cosmetics becomes effective in January 2024.

 

Through our United States operations, we also market fragrance and fragrance related products. United States operations represented 31% and 30% of net sales for the six months ended June 30, 2023 and 2022, respectively. These fragrance products are sold primarily pursuant to license or other agreements with the owners of the Abercrombie & Fitch, Anna Sui, Donna Karan, DKNY, Ferragamo, Graff, GUESS, Hollister, MCM, Oscar de la Renta and Ungaro brands. In addition, our exclusive and worldwide license for the production and distribution of Roberto Cavalli brand perfumes and fragrance related products became effective in July 2023.

 

Page 16

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Substantially all of our prestige fragrance brands are licensed from unaffiliated third parties, and our business is dependent upon the continuation and renewal of such licenses. With respect to the Company’s largest brands, we license the Montblanc, Coach, Jimmy Choo and GUESS brand names.

 

As a percentage of net sales, product sales for the Company’s largest brands were as follows:

 

  

Six Months Ended

June 30,

 
   2023   2022 
         
Montblanc   19%   19%
Jimmy Choo   18%   15%
Coach   15%   15%
GUESS   11%   12%

 

Quarterly sales fluctuations are influenced by the timing of new product launches as well as the third and fourth quarter holiday season. In certain markets where we sell directly to retailers, seasonality is more evident. We primarily sell directly to retailers in France and the United States.

 

We grow our business in two distinct ways. First, we grow by adding new brands to our portfolio, through new licenses, other arrangements or out-right acquisitions of brands. Second, we grow through the introduction of new products and by supporting new and established products through advertising, merchandising and sampling as well as phasing out underperforming products so we can devote greater resources to those products with greater potential. The economics of developing, producing, launching and supporting products influence our sales and operating performance each year. Our introduction of new products may have some cannibalizing effect on sales of existing products, which we take into account in our business planning.

 

Our business is not capital intensive, and it is important to note that we do not own manufacturing facilities. We act as a general contractor and source our needed components from our suppliers. These components are received at one of our distribution centers and then, based upon production needs, the components are sent to one of several third-party fillers, which manufacture the finished product for us and then deliver them to one of our distribution centers.

 

As with any global business, many aspects of our operations are subject to influences outside our control. We believe we have a strong brand portfolio with global reach and potential. As part of our strategy, we plan to continue to make investments behind fast-growing markets and channels to grow market share. 

 

Our reported net sales are impacted by changes in foreign currency exchange rates. A strong U.S. dollar has a negative impact on our net sales. However, earnings are positively affected by a strong dollar, because almost 50% of net sales of our European operations are denominated in U.S. dollars, while almost all costs of our European operations are incurred in euro. Conversely, a weak U.S. dollar has a favorable impact on our net sales while gross margins are negatively affected. We address certain financial exposures through a controlled program of risk management that includes the use of derivative financial instruments and primarily enter into foreign currency forward exchange contracts to reduce the effects of fluctuating foreign currency exchange rates.

 

Page 17

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Impact of COVID-19 Pandemic

 

Please see our discussion of the Impact of the COVID-19 Pandemic, which is incorporated by reference to note 2 to the Consolidated Financial Statements contained in this Quarterly Report on Form 10-Q for the quarter ended June 30, 2023.

 

Recent Important Events

 

Please see our discussion of Recent Important Events, which is incorporated by reference to note 3 to the Consolidated Financial Statements contained in this Quarterly Report on Form 10-Q for the quarter ended June 30, 2023.

 

Discussion of Critical Accounting Policies

 

Information regarding our critical accounting policies can be found in our 2022 Annual Report on Form 10-K filed with the SEC.

 

Results of Operations

 

Three and Six Months Ended June 30, 2023 as Compared to the Three and Six Months Ended June 30, 2022

 

Net Sales:

 

(in millions)  Three months ended June 30,   Six months ended June 30, 
   2023   2022   % Change   2023   2022   % Change 
                     
European based product sales  $197.8   $166.3    19.0%  $428.1   $348.5    22.8%
United States based product sales   111.5    78.4    42.1%   192.9    146.9    31.3%
   $309.3   $244.7    26.4%  $621.0   $495.4    25.3%

 

Net sales for the three months ended June 30, 2023, increased 26% from the three months ended June 30, 2022. At comparable foreign currency exchange rates, net sales increased 25% from the second quarter of 2022. The average dollar/euro exchange rate for the current second quarter was 1.09 compared to 1.06 in the second quarter of 2022, while for the first half of 2023, the average dollar/euro exchange rate was 1.08 compared to 1.09 in the first half of 2022. Net sales for the six months ended June 30, 2023 increased 25% as compared to the first half of 2022. At comparable foreign currency exchange rates, net sales increased 26% from the first half of 2022.

 

Continuing the trend from the first quarter 2023, the current second quarter was exceptionally strong for both European and United States based operations, as net sales increased 19% and 42%, respectively, as compared to the corresponding period of the prior year.

 

Page 18

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

For European based operations, our largest brands, Coach, Jimmy Choo, and Montblanc sales rose 28%, 21% and 16%, respectively, as compared to the corresponding period of the prior year. Continuing the growth trend of the first quarter of 2023, second quarter sales by our U.S. operations grew substantially, up 42% largely from the continued success of GUESS fragrances which performed exceedingly well during the quarter across all geographies and was up 30% from the second quarter of 2022. This is driven by the sales of our newest pillars, Seductive Blue and Uomo Acqua. Second quarter GUESS brand sales more than made up for the first quarter logjam we experienced due to the ERP implementation. Of note, the significant growth in the quarter builds upon the 39% sales increase we reported for the second quarter of 2022. We also had strong sales of Ferragamo fragrances, which we have recently enriched with sister scents for the Signorina and Storie di Seta collections. Oscar de la Renta also performed strongly during the quarter. The increase was also driven by the addition and extension of Donna Karan and DKNY to our portfolio. They have climbed to become our second largest U.S. based brand in just one year under our expertise.

 

The first half of 2023 started on a strong note, and we look forward to executing our plans for the remainder of the year. Our brands are in high demand in a robust environment for the fragrance industry. We have a large number of brand extensions across many of our brands launching in the second half of the year, plus Abercrombie & Fitch Fierce joining our portfolio and the launches of Guess Bella Vita Paradiso, Karl Lagerfeld Les Parfums Matiéres and Van Cleef & Arpels Thé Amara, later in the year. In sum, 2023 has all the earmarks of another superb year as the growth catalysts currently far outweigh the headwinds, most notably somewhat limited travel retail business in Asia and supply chain disruptions which are slowly abating.

 

Net Sales to Customers by Region  Six months ended June 30, 
(In millions)  2023   2022 
         
North America  $218.8   $167.4 
Western Europe   153.9    124.4 
Asia   98.5    87.2 
Middle East   51.0    44.9 
Central and South America   46.9    38.7 
Eastern Europe   45.6    28.4 
Other   6.3    4.4 
   $621.0   $495.4 

 

In the first half of 2023 our largest market, North America, rose 31%, followed by Western Europe and Asia where comparable half year sales in both regions increased 24% and 13%, respectively. Our sales in Eastern Europe, Central and South America and the Middle East were also robust, up 60%, 21% and 14%, respectively. Additionally, our travel retail business is continuing to show signs of renewed life.

 

Page 19

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Gross Profit margin  Three months ended   Six months ended 
   June 30,   June 30, 
(in millions)  2023   2022   2023   2022 
                 
European operations                    
Net sales  $197.8   $166.3   $428.1   $348.5 
Cost of sales   73.1    55.1    147.4    115.6 
Gross margin  $124.7   $111.2   $280.7   $232.9 
Gross margin as a % of net sales   63.0%   66.9%   65.6%   66.8%
                     
United States operations                    
Net sales  $111.5   $78.4   $192.9   $146.9 
Cost of sales   47.7    35.8    82.2    67.4 
Gross margin  $63.8   $42.6   $110.7   $79.5 
Gross margin as a % of net sales   57.2%   54.3%   57.4%   54.1%

 

For European based operations, gross profit margin as a percentage of net sales was 63.0% and 65.6% for the three and six months ended June 30, 2023, respectively, as compared to 66.9% and 66.8% for the corresponding periods of the prior year. A key driver in the decrease in gross profit margin for European based operations in 2023 is due to an increase in inventory reserves in the first half of 2023 related to certain underperforming brands. As the Company experienced long lead time in obtaining and building inventory during COVID high levels of inventory investments were required to protect service levels. Excluding these one-time adjustments, gross margin as a percentage of sales for European based operations would be more favorable as compared to the prior period, driven by increases in pricing and product mix, partially offset by cost inflation.

 

For United States operations, gross profit margin was 57.2% and 57.4% for the three and six months ended June 30, 2023, respectively, as compared to 54.3% and 54.1% for the corresponding periods of the prior year. The significant margin expansion stems from a number of factors. Firstly, for the most part, the price increases we took early 2023 weren’t fully offset yet by a higher cost of goods given our inventory coverage and FIFO accounting. Secondly, we are seeing favorable brand and channel mix, as a higher portion of our higher priced fragrances are being sold directly to retailers as opposed to third-party distributors. Lastly, the significant increase in sales in the first half of 2023 allowed us to better absorb fixed expenses such as depreciation and point of sale expenses, as compared to the corresponding period of the prior year.

 

Generally, we do not bill customers for shipping and handling costs, and such costs, which aggregated $3.6 million and $7.5 million for the three and six months ended June 30, 2023, respectively, as compared to $2.8 million and $5.5 million for the corresponding periods of the prior year, are included in selling, general and administrative expenses in the consolidated statements of income. As such, our Company’s gross profit may not be comparable to the gross profit of other companies, which may include these expenses as a component of cost of goods sold.

 

Page 20

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Selling, general and administrative expenses  Three months ended   Six months ended, 
   June 30,   June 30, 
(In millions)  2023   2022   2023   2022 
                 
European Operations                    
Selling, general and administrative expenses  $89.2   $78.8   $166.5   $147.8 
Selling, general and administrative expenses as a percent of net sales   45.1%   47.4%   38.9%   42.4%
                     
United States Operations                    
Selling, general and administrative expenses  $44.2   $29.6   $79.6   $58.1 
Selling, general and administrative expenses as a percent of net sales   39.7%   37.8%   41.3%   39.5%

 

For European operations, selling, general and administrative expenses increased 13.2% and 12.6% for the three and six months ended June 30, 2023 as compared to the corresponding period of the prior year, and represented 45.1% and 38.9% of net sales for the three and six months ended June 30, 2023, respectively, as compared to 47.4% and 42.4% for the three and six months ended June 30, 2022, respectively. For United States operations, selling, general and administrative expenses increased 49.3% and 37.1% for the three and six months ended June 30, 2023, as compared to the corresponding period of the prior year, and represented 39.7% and 41.3% of net sales for the three and six months ended June 30, 2023, respectively, as compared to 37.8% and 39.5% for the three and six months ended June 30, 2022, respectively. As discussed in more detail below, the increased selling, general and administrative expenses as a percent of net sales are primarily the result of increases in promotion and advertising expenditures as well as the annualization impact of the structural investments in our US operations that we made throughout 2022 in order to support the new licenses of $7.0 million for the first half of 2023.

 

Promotion and advertising included in selling, general and administrative expenses aggregated $54.6 million and $89.8 million for the three and six months ended June 30, 2023, respectively, as compared to $45.9 million and $80.1 million for the corresponding periods of the prior year. Promotion and advertising represented 17.7% and 14.5% of net sales for the three and six months ended June 30, 2023, respectively, as compared to 18.8% and 16.2% for the corresponding periods of the prior year. Promotion and advertising are integral parts of our industry, and we continue to invest heavily to support new product launches and to build brand awareness. We believe that our promotion and advertising efforts have had a beneficial effect on online net sales. All of our brands have benefited from newly launched and enhanced e-commerce sites in existing markets in collaboration with our retail customers on their e-commerce sites. We also continue to develop and implement omnichannel concepts and compelling content to deliver an integrated consumer experience. We anticipate that on a full year basis, promotion and advertising expenditures will aggregate approximately 21% of net sales, which is in line with pre-COVID historical averages.

 

Royalty expense included in selling, general and administrative expenses aggregated $24.0 million and $48.1 million for the three and six months ended June 30, 2023, respectively, as compared to $18.9 million and $38.3 million for the corresponding periods of the prior year. Royalty expense represented 7.8% and 7.7% of net sales for the three and six months ended June 30, 2023, respectively, as compared to 7.7% of net sales for both the corresponding periods of the prior year.

 

Page 21

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Income from Operations

 

As a result of the above analysis regarding net sales, gross profit margins and selling, general and administrative expenses, our operating margins aggregated 17.8% and 23.4% for the three and six months ended June 30, 2023, respectively, as compared to 18.6% and 21.5% for the corresponding periods of the prior year.

 

Other Income and Expense

 

Traditionally, interest expense was primarily related to the financing of brand and licensing acquisitions. However, in April 2021, we completed the acquisition of the headquarters of Interparfums SA. The acquisition was financed by a 10-year €120 million (approximately $130.4 million) bank loan which bears interest at one-month Euribor plus 0.75%. Also in 2021, approximately €80 million of the variable rate debt was swapped for variable rate debt with a maximum interest rate of 2%. The swap effectively exchanges the variable interest rate to a fixed rate of approximately 1.1%.

 

We enter into foreign currency forward exchange contracts to manage exposure related to receivables from unaffiliated third parties denominated in a foreign currency and occasionally to manage risks related to future sales expected to be denominated in a foreign currency. Gains and losses on foreign currency transactions have not been significant. Almost 50% of net sales of our European operations are denominated in U.S. dollars.

 

Interest and investment (income) loss represents interest earned on cash and cash equivalents and short-term investments. As of June 30, 2023, short-term investments include approximately $0.9 million of marketable equity securities of other companies in the luxury goods sector. In the first quarter of 2023, the Company sold marketable securities which generated a gain of $3.1 million. Interest and investment (income) loss for the three and six months ended June 30, 2023, includes approximately $3.4 million of losses on such marketable equity securities.

 

Income Taxes

 

Our consolidated effective tax rate was 23.4% and 24.2% for the six months ended June 30, 2023 and 2022, respectively.

 

The effective tax rate for European operations was 25% for each of the six months ended June 30, 2023 and June 30, 2022.

 

Our effective tax rate for U.S. operations was 17.4% for the six months ended June 30, 2023, as compared to 22% for the corresponding period of the prior year. Our effective tax rate differs from the 21% statutory rate due to benefits received from the exercise of stock options as well as deductions we are allowed for a portion of our foreign derived intangible income, slightly offset by state and local taxes.

 

Other than as discussed above, we did not experience any significant changes in tax rates, and none were expected in jurisdictions where we operate.

 

Page 22

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Net Income

 

   Three months ended
June 30,
   Six months ended
June 30,
 
(In thousands)  2023   2022   2023   2022 
                
Net income European operations  $26,950   $24,529   $87,515   $64,305 
Net income United States operations   15,568    9,991    25,911    16,506 
                     
Net income   42,518    34,520    113,426    80,811 
                     
Less: Net income attributable to the noncontrolling interest    7,566    6,903    24,406    17,895 
                     

Net income attributable to Inter Parfums, Inc.

  $34,952   $27,617   $89,020   $62,916 

 

Net income attributable to European operations was $27.0 million and $87.5 million for the three and six months ended June 30, 2023, respectively, as compared to $24.5 million and $64.3 million for the corresponding period of the prior year. Net income attributable to United States operations was $15.6 million and $25.9 million for the three and six months ended June 30, 2023, respectively, as compared to $10.0 million and $16.5 million for the corresponding period of the prior year. The significant fluctuations in net income for both European operations and United States operations are directly related to the previous discussions relating to changes in sales, gross margin, and selling, general and administrative expenses.

 

The noncontrolling interest arises from our 72% owned subsidiary in Paris, Interparfums SA, which is also a publicly traded company as 28% of Interparfums SA shares trade on the NYSE Euronext. Net income attributable to the noncontrolling interest is directly related to the profitability of our European operations and aggregated 28% of European operations net income for all periods presented. Net margins attributable to Inter Parfums, Inc. for the six months ended June 30, 2023 and 2022 aggregated 14.3% and 12.7%, respectively.

 

Liquidity and Capital Resources

 

Our conservative financial tradition has enabled us to amass significant cash balances. As of June 30, 2023, we had $187 million in cash, cash equivalents and short-term investments, most of which is held in euro by our European operations and is readily convertible into U.S. dollars. We have not had any liquidity issues to date, and do not expect any liquidity issues relating to such cash and cash equivalents and short-term investments. As of June 30, 2023, short-term investments include approximately $2.2 million of marketable equity securities.

 

As of June 30, 2023, working capital aggregated $482 million and we had a working capital ratio of 2.4 to 1. Approximately 77% of the Company’s total assets are held by European operations, and approximately $252 million of trademarks, licenses and other intangible assets are also held by European operations.

 

The Company is party to a number of licenses and other agreements for the use of trademarks and rights in connection with the manufacture and sale of its products expiring at various dates through 2039. In connection with certain of these license agreements, the Company is subject to minimum annual advertising commitments, minimum annual royalties and other commitments. See Item 8. Financial Statements and Supplementary Data – Note 12 – Commitments in our 2022 annual report on Form 10-K, which is incorporated by reference herein. Future advertising commitments are estimated based on planned future sales for the license terms that were in effect at December 31, 2022, without consideration for potential renewal periods and do not reflect the fact that our distributors share our advertising obligations.

 

Page 23

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

The Company hopes to continue to benefit from its strong financial position to potentially acquire one or more brands, either on a proprietary basis or as a licensee. In July 2023, we entered into a long-term global licensing agreement for the creation, development and distribution of fragrances and fragrance-related products under the Roberto Cavalli brand. This license took effect in July 2023, and we target to start shipping products as of November-December 2023. In December 2022, we entered into a long-term global licensing agreement for the creation, development and distribution of fragrances and fragrance-related products under the Lacoste brand. This new license takes effect January 2024.

 

Cash provided by operating activities aggregated $6.8 million for the six months ended June 30, 2023 compared to cash used in operating activities of $28.5 million for the six months ended June 30, 2022, respectively. For the six months ended June 30, 2023, working capital items used $115.4 million in cash from operating activities, as compared to $117.2 million in the 2022 period. Although from a cash flow perspective accounts receivable is up 18% from year end 2022, the balance is reasonable based on second quarter 2023 record sales levels and reflects strong collection activity as day’s sales outstanding was 68 days, down from 76 days in the corresponding period of the prior year. From a cash flow perspective, inventory levels as of June 30, 2023, increased 23% from year end 2022 in support of our overall sales growth. Since 2021, we have strived to carry more inventory overall, source the same components from multiple suppliers and when possible, manufacture products closer to where they are sold.

 

Cash flows provided by investing activities in 2023 reflect purchases and sales of short-term investments. These investments include certificates of deposit with maturities greater than three months. Approximately $34 million of such certificates of deposit contain penalties where we would forfeit a portion of the interest earned in the event of early withdrawal.

 

Our business is not capital intensive as we do not own any manufacturing facilities. On a full year basis, we typically spend approximately $5.0 million on tools and molds, depending on our new product development calendar. Capital expenditures also include amounts for office fixtures, computer equipment and industrial equipment needed at our distribution centers.

 

Our short-term financing requirements are expected to be met by available cash on hand at June 30, 2023, and short-term credit lines provided by domestic and foreign banks. The principal credit facilities for 2023 consist of a $25 million unsecured revolving line of credit provided by a domestic commercial bank and approximately $8 million in credit lines provided by a consortium of international financial institutions. There was $5 million of short-term borrowings outstanding pursuant to these facilities as of June 30, 2023 and no short-term borrowings outstanding as of June 30, 2022.

 

Page 24

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

In February 2022, our Board authorized a 100% increase in the annual dividend to $2.00 per share. In February 2023, the Board of Directors further increased the annual dividend to $2.50 per share. The next quarterly cash dividend of $0.625 per share is payable on September 30, 2023, to shareholders of record on September 15, 2023.

 

We believe that funds provided by or used in operations can be supplemented by our present cash position and available credit facilities, so that they will provide us with sufficient resources to meet all present and reasonably foreseeable future operating needs.

 

Inflation rates in the U.S. and foreign countries in which we operate did not have a significant impact on operating results for the six months ended June 30, 2023.

 

Page 25

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Item 3:QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

General

 

We address certain financial exposures through a controlled program of risk management that primarily consists of the use of derivative financial instruments. We primarily enter into foreign currency forward exchange contracts in order to reduce the effects of fluctuating foreign currency exchange rates. We do not engage in the trading of foreign currency forward exchange contracts or interest rate swaps.

 

Foreign Exchange Risk Management

 

We periodically enter into foreign currency forward exchange contracts to hedge exposure related to receivables denominated in a foreign currency and to manage risks related to future sales expected to be denominated in a currency other than our functional currency. We enter into these exchange contracts for periods consistent with our identified exposures. The purpose of the hedging activities is to minimize the effect of foreign exchange rate movements on the receivables and cash flows of Interparfums SA, whose functional currency is the euro. All foreign currency contracts are denominated in currencies of major industrial countries and are with large financial institutions, which are rated as strong investment grade.

 

All derivative instruments are required to be reflected as either assets or liabilities in the balance sheet measured at fair value. Generally, increases or decreases in fair value of derivative instruments will be recognized as gains or losses in earnings in the period of change. If the derivative is designated and qualifies as a cash flow hedge, then the changes in fair value of the derivative instrument will be recorded in other comprehensive income.

 

Before entering into a derivative transaction for hedging purposes, we determine that the change in the value of the derivative will effectively offset the change in the fair value of the hedged item from a movement in foreign currency rates. Then, we measure the effectiveness of each hedge throughout the hedged period. Any hedge ineffectiveness is recognized in the income statement.

 

At June 30, 2023, we had foreign currency contracts in the form of forward exchange contracts of approximately U.S. $38.0 million and GB £2.0 million with maturities of less than one year. We believe that our risk of loss as the result of nonperformance by any of such financial institutions is remote.

 

Interest Rate Risk Management

 

We mitigate interest rate risk by monitoring interest rates, and then determining whether fixed interest rates should be swapped for floating rate debt, or if floating rate debt should be swapped for fixed rate debt.

 

Page 26

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Item 4.CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

 

Our Chief Executive Officer and Chief Financial Officer have reviewed and evaluated the effectiveness of our disclosure controls and procedures (as defined in the Securities Exchange Act of 1934 Rule 13a-15(e)) as of the end of the period covered by this quarterly report on Form 10-Q (the “Evaluation Date”). Based on their review and evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that as of the Evaluation Date, our Company's disclosure controls and procedures were effective.

 

Changes in Internal Control Over Financial Reporting

 

There has been no change in our internal control over financial reporting (as defined in Rule 13a-15(f) of the Securities Exchange Act of 1934) that occurred during the quarterly period covered by this report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, the Company's internal control over financial reporting.

 

Part II. Other Information

 

Item 2.Unregistered Sales of Equity Securities and Use of Proceeds.

 

Item (c).

 

Inter Parfums, Inc. Purchase of Common Stock1
Period Total Number of Shares Purchased Average price paid per share Total number of shares purchased as part of publicly announced plans or programs Maximum number (or approximate dollar value) of shares that may yet be purchased under the plans or programs
April 1-30 0 n/a 43,060 123,000 shares
May 1-31 0 n/a 43,060 123,000 shares
June 1-30 42,000 $135.87 85,060 81,000 shares
Total 42,000 $135.87 85,060 81,000 shares

 

Items 1. Legal Proceedings, 1A. Risk Factors, 3. Defaults Upon Senior Securities, 4. Mine Safety Disclosures and 5. Other Information, are omitted as they are either not applicable or have been included in Part I.

 

 

1 All shares were purchased in open market transactions.

 

Page 27

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Item 6. Exhibits.

 

The following documents are filed herewith:

 

Exhibit No. Description Page Number
     
31.1 Certifications required by Rule 13a-14(a) of Chief Executive Officer 29
     
31.2 Certifications required by Rule 13a-14(a) of Chief Financial Officer and Principal Accounting Officer 30
     
32.1 Certification required by Section 906 of the Sarbanes-Oxley Act of Chief Executive Officer 31
     
32.2 Certification required by Section 906 of the Sarbanes-Oxley Act of Chief Financial Officer and Principal Accounting Officer 32
     
101 Interactive data files  

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized on the 8th day of August 2023.

 

    INTER PARFUMS, INC.
     
  By: /s/ Michel Atwood
    Chief Financial Officer

 

Page 28

EX-31.1 2 g083669_ex31-1.htm EXHIBIT 31.1

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Exhibit 31.1

 

CERTIFICATIONS

 

I, Jean Madar, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of Inter Parfums, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b) Designed such internal control over financial reporting, or caused such control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based upon such evaluation; and

 

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth quarter in case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

 

a) all significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: August 8, 2023

 

/s/ Jean Madar  
Jean Madar,  
Chief Executive Officer  

 

Page 29

EX-31.2 3 g083669_ex31-2.htm EXHIBIT 31.2

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Exhibit 31.2

 

I, Michel Atwood, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of Inter Parfums, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b) Designed such internal control over financial reporting, or caused such control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based upon such evaluation; and

 

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth quarter in case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

 

a) all significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: August 8, 2023

 

/s/ Michel Atwood  
Michel Atwood
Chief Financial Officer and
Principal Accounting Officer
 

 

Page 30

EX-32.1 4 g083669_ex32-1.htm EXHIBIT 32.1

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Exhibit 32.1

 

CERTIFICATION

 

The undersigned hereby certifies, in accordance with 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, in his capacity as an officer of Inter Parfums, Inc., that the Quarterly Report of Inter Parfums, Inc. on Form 10-Q for the period ended June 30, 2023, fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934 and that the information contained in such report fairly presents, in all material respects, the financial condition and results of operation of Inter Parfums, Inc.

 

Date: August 8, 2023 By: /s/ Jean Madar
    Jean Madar,
    Chief Executive Officer

 

A signed original of this written statement required by Section 906 has been provided to Inter Parfums, Inc. and will be retained by Inter Parfums, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

 

Page 31

EX-32.2 5 g083669_ex32-2.htm EXHIBIT 32.2

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Exhibit 32.2

 

CERTIFICATION

 

The undersigned hereby certifies, in accordance with 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, in his capacity as an officer of Inter Parfums, Inc., that the Quarterly Report of Inter Parfums, Inc. on Form 10-Q for the period ended June 30, 2023, fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934 and that the information contained in such report fairly presents, in all material respects, the financial condition and results of operation of Inter Parfums, Inc.

 

Date: August 8, 2023 By: /s/ Michel Atwood
    Michel Atwood
    Chief Financial Officer and
    Principal Accounting Officer

 

A signed original of this written statement required by Section 906 has been provided to Inter Parfums, Inc. and will be retained by Inter Parfums, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

 

Page 32

EX-101.SCH 6 ipar-20230630.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - CONSOLIDATED BALANCE SHEETS(Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - CONSOLIDATED BALANCE SHEETS(Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - CONSOLIDATED STATEMENTS OF INCOME (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS(Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Significant Accounting Policies: link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Impact of COVID-19 Pandemic: link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Recent Agreements: link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Recent Accounting Pronouncements: link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Inventories: link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Fair Value Measurement: link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Derivative Financial Instruments: link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Leases: link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Share-Based Payments: link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders: link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Segment and Geographic Areas: link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Inventories: (Tables) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Fair Value Measurement: (Tables) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Share-Based Payments: (Tables) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders: (Tables) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Segment and Geographic Areas: (Tables) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Recent Agreements: (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Inventories consist of the following: (Details) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - The following tables present our financial assets and liabilities that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy. The fair value hierarchy has three levels based on the reliability of the inputs use (Details) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Derivative Financial Instruments: (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Leases: (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - The following table sets forth information with respect to nonvested options for the six months ended June 30, 2023: (Details) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - The following table summarizes stock option information as of June 30, 2023: (Details) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Cash proceeds, tax benefits and intrinsic value related to stock options exercised during the six months ended June 30, 2023 and 2022 were as follows: (Details) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - Share-Based Payments: (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows: (Details) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders: (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - Information on our operations by geographical areas is as follows: (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 ipar-20230630_cal.xml XBRL CALCULATION FILE EX-101.DEF 8 ipar-20230630_def.xml XBRL DEFINITION FILE EX-101.LAB 9 ipar-20230630_lab.xml XBRL LABEL FILE Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] AOCI Attributable to Parent [Member] Treasury Stock, Common [Member] Noncontrolling Interest [Member] Business Acquisition [Axis] Roberto Cavalli [Member] Lacoste [Member] Rochas Fashion [Member] Ownership [Axis] Interparfums SA [Member] Long-Lived Tangible Asset [Axis] Land [Member] Building [Member] Statistical Measurement [Axis] Minimum [Member] Maximum [Member] Measurement Frequency [Axis] Fair Value, Recurring [Member] Fair Value Hierarchy and NAV [Axis] Fair Value, Inputs, Level 1 [Member] Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 3 [Member] Currency [Axis] Euro Member Countries, Euro Derivative Instrument [Axis] Interest Rate Swap [Member] Foreign Exchange Contract [Member] United Kingdom, Pounds Equity Option [Member] Consolidated Entities [Axis] Interparfums SA Subsidiary [Member] Title of Individual [Axis] Employees [Member] Officers and Managers [Member] Geographical [Axis] UNITED STATES Europe [Member] Eliminations [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Statement of Financial Position [Abstract] ASSETS Current assets: Cash and cash equivalents Short-term investments Accounts receivable, net Inventories Receivables, other Other current assets Income taxes receivable Total current assets Property, equipment and leasehold improvements, net Right-of-use assets, net Trademarks, licenses and other intangible assets, net Deferred tax assets Other assets Total assets LIABILITIES AND EQUITY Current liabilities: Loans payable - banks Current portion of long-term debt Current portion of lease liabilities Accounts payable – trade Accrued expenses Income taxes payable Total current liabilities Long–term debt, less current portion Lease liabilities, less current portion Equity: Inter Parfums, Inc. shareholders’ equity: Preferred stock, $.001 par; authorized 1,000,000 shares; none issued Common stock, $.001 par; authorized 100,000,000 shares; outstanding 31,975,670 and 31,967,300 shares at June 30, 2023 and December 31, 2022, respectively Additional paid-in capital Retained earnings Accumulated other comprehensive loss Treasury stock, at cost, 9,949,865 and 9,864,805 shares at June 30, 2023 and December 31, 2022, respectively Total Inter Parfums, Inc. shareholders’ equity Noncontrolling interest Total equity Total liabilities and equity Preferred stock, par value (in dollars per share) Preferred stock, shares authorized Preferred stock, shares issued Common stock, par or stated value per share Common stock, shares authorized Common stock, shares, outstanding Treasury stock, shares Income Statement [Abstract] Net sales Cost of sales Gross margin Selling, general and administrative expenses Income from operations Other expenses (income): Interest expense (Gain) loss on foreign currency Interest and investment (income) loss Other income Nonoperating Income (Expense) Income before income taxes Income taxes Net income Less:  Net income attributable to the noncontrolling interest Net income attributable to Inter Parfums, Inc. Earnings per share: Net income attributable to Inter Parfums, Inc. common shareholders: Basic Diluted Weighted average number of shares outstanding: Basic Diluted Dividends declared per share Comprehensive income: Net income Other comprehensive income (loss): Net derivative instrument loss, net of tax Transfer from OCI into earnings Translation adjustments, net of tax Comprehensive income (loss) Comprehensive income attributable to the noncontrolling interests: Net income Net derivative instrument loss, net of tax Translation adjustments, net of tax Comprehensive income (loss) attributable to the noncontrolling interests Comprehensive income attributable to Inter Parfums, Inc. Statement [Table] Statement [Line Items] Beginning Balance Shares issued upon exercise of stock options Dividends Foreign currency translation adjustment, net of tax Share-based compensation Purchase of subsidiary shares Transfer from other comprehensive income into earnings Net derivative instrument gain (loss), net of tax Shares repurchased Transfer of subsidiary shares purchased Ending Balance Statement of Cash Flows [Abstract] Cash flows from operating activities: Adjustments to reconcile net income to net cash provided by (used in) operating activities: Depreciation and amortization Provision for doubtful accounts Noncash stock compensation Share of income of equity investment Noncash lease expense Deferred tax provision (benefit) Change in fair value of derivatives Changes in: Accounts receivable Inventories Other assets Operating lease liabilities Accounts payable and accrued expenses Income taxes, net Net cash provided by (used in) operating activities Cash flows from investing activities: Purchases of short-term investments Proceeds from sale of short-term investments Purchases of property, equipment and leasehold improvements Payment for intangible assets acquired Net cash provided by (used in) investing activities Cash flows from financing activities: Proceeds from loans payable, bank Repayment of long-term debt Proceeds from exercise of options Purchase of subsidiary shares from noncontrolling interest Dividends paid Dividends paid to noncontrolling interest Purchase of treasury stock Net cash used in financing activities Effect of exchange rate changes on cash Net decrease in cash and cash equivalents Cash and cash equivalents - beginning of period Cash and cash equivalents - end of period Supplemental disclosure of cash flow information: Cash paid for: Interest Income taxes Accounting Policies [Abstract] Significant Accounting Policies: Unusual or Infrequent Items, or Both [Abstract] Impact of COVID-19 Pandemic: Business Combination and Asset Acquisition [Abstract] Recent Agreements: Accounting Changes and Error Corrections [Abstract] Recent Accounting Pronouncements: Inventory Disclosure [Abstract] Inventories: Fair Value Disclosures [Abstract] Fair Value Measurement: Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative Financial Instruments: Leases [Abstract] Leases: Equity [Abstract] Share-Based Payments: Earnings Per Share [Abstract] Net Income Attributable to Inter Parfums, Inc. Common Shareholders: Segment Reporting [Abstract] Segment and Geographic Areas: Inventories consist of the following: The following tables present our financial assets and liabilities that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy. The fair value hierarchy has three levels based on the reliability of the inputs used to determine fair value. The following table sets forth information with respect to nonvested options for the six months ended June 30, 2023: The following table summarizes stock option information as of June 30, 2023: Cash proceeds, tax benefits and intrinsic value related to stock options exercised during the six months ended June 30, 2023 and 2022 were as follows: The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows: Information on our operations by geographical areas is as follows: Schedule of Business Acquisitions, by Acquisition [Table] Business Acquisition [Line Items] Description of recent agreement Ownership percentage Purchase price, period cost Acquisition costs, period cost Depreciated over a range Cash held in escrow is included in other assets Long-term debt, term Long-term line of credit Description of debt instrument interest rate terms Debt instrument, face amount Variable interest rate Fixed interest rate Raw materials and component parts Finished goods Inventories Fair Value, Recurring and Nonrecurring [Table] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Assets: Short-term investments Interest rate swaps Foreign currency forward exchange contracts accounted for using hedge accounting Total asset Liabilities: Foreign currency forward exchange contracts not accounted for using hedge accounting Total Liabilities Derivative Instruments, Gain (Loss) [Table] Derivative Instruments, Gain (Loss) [Line Items] Loan amount Derivative swap interest rate Forward exchange contracts Maturity of foreign currency Operating lease, weighted average remaining lease term Operating lease, weighted average discount rate, percent Operating leases, rent expense, net Operating lease, payments Noncash additions to operating lease assets Nonvested options beginning of period Weighted average grant date fair value, beginning of year Nonvested options granted Weighted average grant date fair value, nonvested options granted Nonvested options vested or forfeited Weighted average grant date fair value, nonvested options vested or forfeited Nonvested options end of period Weighted average grant date fair value, nonvested options end of period Options shares under option - beginning of year Weighted average exercise price shares under option - beginning of year Options forfeited Weighted average exercise price options forfeited Options exercised Weighted average exercise price options exercised Options shares under option - end of year Weighted average exercise price shares under option - end of year Options exercisable Weighted average exercise price options exercisable Options available for future grants Cash proceeds from stock options exercised Tax benefits Intrinsic value of stock options exercised Schedule of Subsidiary or Equity Method Investee [Table] Subsidiary or Equity Method Investee [Line Items] Options vesting period Fair value of shares vested Income before income taxes Share-based payment arrangement, expense Weighted average remaining contractual life of options outstanding (in years) Weighted average remaining contractual life of options exercisable (in years) Aggregate intrinsic value of options outstanding and options outstanding Aggregate intrinsic value of options outstanding and options exercisable Unrecognized compensation cost Options granted Aggregate shares to offices and managers Adjusted for stock splits Recognized as compensation cost Number of share distributed Shares repurchased Shares repurchase value Numerator: Net income attributable to Inter Parfums, Inc. Denominator: Weighted average shares Stock options Denominator for diluted earnings per share Net income attributable to Inter Parfums, Inc. common shareholders: Antidilutive potential common shares outstanding Schedule of Revenues from External Customers and Long-Lived Assets [Table] Revenues from External Customers and Long-Lived Assets [Line Items] Assets The element represents loans payable banks. The element represents investment income interest and dividend. The element represents provision for doubtful accounts. The element represents change in fair value of derivatives. The element represents supplemental disclosure of cash flow information abstract. The element represents lacoste member. The element represents donna karan and DKNY member. The element represents rochas fashion member. The element represents EUR member. The element represents eliminations member. The element represents denominator for diluted earnings per share. The element representsNet income attributable to inter parfumsi Inc common shareholders. The element represents interparfums sa subsidiary member. The element represents employees member. The element represents officers and managers member. The element represents stock repurchased during period value. The element represents transfer of subsidiary shares purchased to treasury shares. The element represents operating leases rent expense net1. The element represents interparfums SA member. The element represents roberto cavalli member. Assets, Current Liabilities, Current Treasury Stock, Value Equity, Attributable to Parent Equity, Including Portion Attributable to Noncontrolling Interest Liabilities and Equity Gross Profit Operating Income (Loss) Gain (Loss), Foreign Currency Transaction, before Tax Investment Income, Net Other Nonoperating Income (Expense) Nonoperating Income (Expense) Weighted Average Number of Shares Outstanding, Diluted Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Comprehensive Income (Loss), Net of Tax, Attributable to Parent Dividends, Cash Income (Loss) from Equity Method Investments Increase (Decrease) in Accounts Receivable Increase (Decrease) in Inventories Increase (Decrease) in Other Operating Assets Net Cash Provided by (Used in) Operating Activities Payments to Acquire Investments Payments to Acquire Property, Plant, and Equipment Payments to Acquire Intangible Assets Net Cash Provided by (Used in) Investing Activities Repayments of Long-Term Debt Payments to Noncontrolling Interests Payments of Ordinary Dividends, Common Stock Payments of Ordinary Dividends, Noncontrolling Interest Payments for Repurchase of Equity Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Income Taxes Paid Investments, Fair Value Disclosure Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period EX-101.PRE 10 ipar-20230630_pre.xml XBRL PRESENTATION FILE XML 11 R1.htm IDEA: XBRL DOCUMENT v3.23.2
Cover - shares
6 Months Ended
Jun. 30, 2023
Aug. 08, 2023
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Jun. 30, 2023  
Document Fiscal Period Focus Q2  
Document Fiscal Year Focus 2023  
Current Fiscal Year End Date --12-31  
Entity File Number 0-16469  
Entity Registrant Name INTER PARFUMS, INC.  
Entity Central Index Key 0000822663  
Entity Tax Identification Number 13-3275609  
Entity Incorporation, State or Country Code DE  
Entity Address, Address Line One 551 Fifth Avenue  
Entity Address, City or Town New York  
Entity Address, State or Province NY  
Entity Address, Postal Zip Code 10176  
City Area Code (212)  
Local Phone Number 983-2640  
Title of 12(b) Security Common Stock, $.001 par value per share  
Trading Symbol IPAR  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   31,975,670
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.23.2
CONSOLIDATED BALANCE SHEETS(Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 74,311 $ 104,713
Short-term investments 112,449 150,833
Accounts receivable, net 236,554 197,584
Inventories 360,018 289,984
Receivables, other 14,730 28,803
Other current assets 24,993 15,650
Income taxes receivable 386 157
Total current assets 823,441 787,724
Property, equipment and leasehold improvements, net 168,264 166,722
Right-of-use assets, net 28,005 27,964
Trademarks, licenses and other intangible assets, net 292,319 290,853
Deferred tax assets 14,333 11,159
Other assets 25,302 24,120
Total assets 1,351,664 1,308,542
Current liabilities:    
Loans payable - banks 4,958
Current portion of long-term debt 29,080 28,547
Current portion of lease liabilities 5,236 5,296
Accounts payable – trade 91,040 88,388
Accrued expenses 194,036 213,621
Income taxes payable 17,324 8,715
Total current liabilities 341,674 344,567
Long–term debt, less current portion 138,565 151,494
Lease liabilities, less current portion 24,491 24,335
Inter Parfums, Inc. shareholders’ equity:    
Preferred stock, $.001 par; authorized 1,000,000 shares; none issued
Common stock, $.001 par; authorized 100,000,000 shares; outstanding 31,975,670 and 31,967,300 shares at June 30, 2023 and December 31, 2022, respectively 32 32
Additional paid-in capital 95,984 90,186
Retained earnings 669,688 620,095
Accumulated other comprehensive loss (48,739) (56,056)
Treasury stock, at cost, 9,949,865 and 9,864,805 shares at June 30, 2023 and December 31, 2022, respectively (48,764) (37,475)
Total Inter Parfums, Inc. shareholders’ equity 668,201 616,782
Noncontrolling interest 178,733 171,364
Total equity 846,934 788,146
Total liabilities and equity $ 1,351,664 $ 1,308,542
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.23.2
CONSOLIDATED BALANCE SHEETS(Unaudited) (Parenthetical) - $ / shares
Jun. 30, 2023
Dec. 31, 2022
Statement of Financial Position [Abstract]    
Preferred stock, par value (in dollars per share) $ 0.001 $ 0.001
Preferred stock, shares authorized 1,000,000 1,000,000
Preferred stock, shares issued 0 0
Common stock, par or stated value per share $ 0.001 $ 0.001
Common stock, shares authorized 100,000,000 100,000,000
Common stock, shares, outstanding 31,975,670 31,967,300
Treasury stock, shares 9,949,865 9,864,805
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.2
CONSOLIDATED STATEMENTS OF INCOME (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Income Statement [Abstract]        
Net sales $ 309,244 $ 244,725 $ 620,967 $ 495,403
Cost of sales 120,840 90,943 229,606 182,963
Gross margin 188,404 153,782 391,361 312,440
Selling, general and administrative expenses 133,383 108,385 246,061 205,825
Income from operations 55,021 45,397 145,300 106,615
Other expenses (income):        
Interest expense 2,276 1,023 4,633 1,907
(Gain) loss on foreign currency (746) (279) 13 (2,518)
Interest and investment (income) loss (1,977) (464) (7,359) 1,002
Other income (7) (328) (48) (444)
Nonoperating Income (Expense) (454) (48) (2,761) (53)
Income before income taxes 55,475 45,445 148,061 106,668
Income taxes 12,957 10,925 34,635 25,857
Net income 42,518 34,520 113,426 80,811
Less:  Net income attributable to the noncontrolling interest 7,566 6,903 24,406 17,895
Net income attributable to Inter Parfums, Inc. $ 34,952 $ 27,617 $ 89,020 $ 62,916
Net income attributable to Inter Parfums, Inc. common shareholders:        
Basic $ 1.09 $ 0.87 $ 2.78 $ 1.98
Diluted $ 1.09 $ 0.86 $ 2.77 $ 1.97
Weighted average number of shares outstanding:        
Basic 32,006 31,845 32,012 31,843
Diluted 32,162 31,952 32,161 31,981
Dividends declared per share $ 0.625 $ 0.50 $ 1.30 $ 1.00
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.2
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Comprehensive income:        
Net income $ 42,518 $ 34,520 $ 113,426 $ 80,811
Other comprehensive income (loss):        
Net derivative instrument loss, net of tax (77) (1,749) (4,243) (1,488)
Transfer from OCI into earnings 1,709 992
Translation adjustments, net of tax (454) (33,630) 13,035 (46,071)
Comprehensive income (loss) 41,987 (859) 123,927 34,244
Comprehensive income attributable to the noncontrolling interests:        
Net income 7,566 6,903 24,406 17,895
Net derivative instrument loss, net of tax (21) (483) (227) (411)
Translation adjustments, net of tax (211) (10,743) 3,411 (14,162)
Comprehensive income (loss) attributable to the noncontrolling interests 7,334 (4,323) 27,590 3,322
Comprehensive income attributable to Inter Parfums, Inc. $ 34,653 $ 3,464 $ 96,337 $ 30,922
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.2
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Unaudited) - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Treasury Stock, Common [Member]
Noncontrolling Interest [Member]
Total
Beginning Balance at Dec. 31, 2021 $ 32 $ 87,132 $ 560,663 $ (38,432) $ (37,475) $ 166,412 $ 852,671
Net income   62,916     17,895 80,811
Shares issued upon exercise of stock options   810          
Dividends     (31,844)     (16,056)  
Foreign currency translation adjustment, net of tax       (31,909)   (14,162)  
Share-based compensation   679 1,632     (389)  
Purchase of subsidiary shares   (4,305)       (152)  
Transfer from other comprehensive income into earnings       992      
Net derivative instrument gain (loss), net of tax       (1,077)   (411) 1,488
Shares repurchased            
Transfer of subsidiary shares purchased           54  
Ending Balance at Jun. 30, 2022 32 84,316 593,367 (70,426) (37,475) 153,191 723,005
Beginning Balance at Dec. 31, 2022 32 90,186 620,095 (56,056) (37,475) 171,364 788,146
Net income   89,020     24,406 113,426
Shares issued upon exercise of stock options   5,191          
Dividends     (40,020)     (20,301)  
Foreign currency translation adjustment, net of tax       9,624   3,411  
Share-based compensation   624 593     97  
Purchase of subsidiary shares   (17)       (17)  
Transfer from other comprehensive income into earnings       1,709      
Net derivative instrument gain (loss), net of tax       (4,016)   (227) 4,243
Shares repurchased         (11,289)    
Transfer of subsidiary shares purchased            
Ending Balance at Jun. 30, 2023 $ 32 $ 95,984 $ 669,688 $ (48,739) $ (48,764) $ 178,733 $ 846,934
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.2
CONSOLIDATED STATEMENTS OF CASH FLOWS(Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Cash flows from operating activities:    
Net income $ 113,426 $ 80,811
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Depreciation and amortization 8,367 6,803
Provision for doubtful accounts (650) 1,241
Noncash stock compensation 1,265 1,877
Share of income of equity investment (48) (444)
Noncash lease expense 2,620 3,017
Deferred tax provision (benefit) (2,987) (2,595)
Change in fair value of derivatives 164 (2,036)
Changes in:    
Accounts receivable (35,181) (48,085)
Inventories (66,144) (81,188)
Other assets 3,406 (1,872)
Operating lease liabilities (2,579) (2,822)
Accounts payable and accrued expenses (23,425) 7,916
Income taxes, net 8,531 8,869
Net cash provided by (used in) operating activities 6,765 (28,508)
Cash flows from investing activities:    
Purchases of short-term investments (97,079) (2,941)
Proceeds from sale of short-term investments 138,061 6,211
Purchases of property, equipment and leasehold improvements (3,202) (30,305)
Payment for intangible assets acquired (228) (1,016)
Net cash provided by (used in) investing activities 37,552 (28,051)
Cash flows from financing activities:    
Proceeds from loans payable, bank 4,947
Repayment of long-term debt (15,958) (7,522)
Proceeds from exercise of options 5,191 810
Purchase of subsidiary shares from noncontrolling interest (4,403)
Dividends paid (40,020) (31,844)
Dividends paid to noncontrolling interest (20,301) (16,056)
Purchase of treasury stock (11,289)
Net cash used in financing activities (77,430) (59,015)
Effect of exchange rate changes on cash 2,711 (578)
Net decrease in cash and cash equivalents (30,402) (116,152)
Cash and cash equivalents - beginning of period 104,713 168,387
Cash and cash equivalents - end of period 74,311 52,235
Cash paid for:    
Interest 3,189 1,581
Income taxes $ 30,096 $ 16,369
XML 18 R8.htm IDEA: XBRL DOCUMENT v3.23.2
Significant Accounting Policies:
6 Months Ended
Jun. 30, 2023
Accounting Policies [Abstract]  
Significant Accounting Policies:

1.Significant Accounting Policies:

 

The accounting policies we follow are set forth in the notes to our consolidated financial statements included in our Form 10-K, which was filed with the Securities and Exchange Commission for the year ended December 31, 2022.

XML 19 R9.htm IDEA: XBRL DOCUMENT v3.23.2
Impact of COVID-19 Pandemic:
6 Months Ended
Jun. 30, 2023
Unusual or Infrequent Items, or Both [Abstract]  
Impact of COVID-19 Pandemic:

2.Impact of COVID-19 Pandemic:

 

Our business has continued to significantly improve throughout 2022 and the first half of 2023 after the disastrous effects of the COVID-19 Pandemic starting in early 2020, as retail stores reopened, and consumers increased online purchasing. While COVID-19 had significantly restricted international travel, the travel retail business has picked up. Lastly, we experienced significant strains on our supply chain causing disruptions affecting the procurement of components, the ability to transport goods, and related cost increases. These disruptions came at a time when demand for our product lines has never been stronger or more sustained. We have addressed this issue since the beginning of 2021, by ordering well in advance of need and in larger quantities. Since 2021, we have strived to carry more inventory overall, source the same components from multiple suppliers and when possible, manufacture products closer to where they are sold. The supply chain bottlenecks have been improving and while lead times remain longer than pre-COVID, we do not expect significant disruptions going forward.

XML 20 R10.htm IDEA: XBRL DOCUMENT v3.23.2
Recent Agreements:
6 Months Ended
Jun. 30, 2023
Business Combination and Asset Acquisition [Abstract]  
Recent Agreements:

3.Recent Agreements:

 

Roberto Cavalli

 

In July 2023, we closed a transaction agreement with Roberto Cavalli, whereby an exclusive and worldwide license was granted for the production and distribution of Roberto Cavalli brand perfumes and fragrance related products. Our rights under this license are subject to certain minimum advertising expenditures and royalty payments as are customary in our industry. The license became effective in July 2023 and will last for 6.5 years.

 

Lacoste

 

In December 2022, we closed a transaction agreement with Lacoste, whereby an exclusive and worldwide license was granted for the production and distribution of Lacoste brand perfumes and cosmetics. Our rights under this license are subject to certain minimum advertising expenditures and royalty payments as are customary in our industry. The license becomes effective in January 2024 and will last for 15 years.

 

Dunhill

 

In April 2022, we announced that the Dunhill fragrance license will expire on September 30, 2023 and will not be renewed. The Company will continue to produce and sell Dunhill fragrances until the license expires and will maintain the right to sell-off remaining Dunhill fragrance inventory for a limited time as is customary in the fragrance industry.

 

Donna Karan and DKNY

 

In September 2021, we entered into a long-term global licensing agreement for the creation, development and distribution of fragrances and fragrance related products under the Donna Karan and DKNY brands. Our rights under this license are subject to certain minimum advertising expenditures and royalty payments as are customary in our industry. With this agreement, we are gaining several well-established and valuable fragrance franchises, most notably Donna Karan Cashmere Mist and DKNY Be Delicious, as well as a significant loyal consumer base around the world. In connection with the grant of license, we issued 65,342 shares of Inter Parfums, Inc. common stock valued at $5.0 million to the licensor. The exclusive license became effective July 1, 2022, and we are planning to launch new fragrances under these brands in 2024.

 

Rochas Fashion

 

Effective January 1, 2021, we entered into a new license agreement modifying our Rochas fashion business model. The new agreement calls for a reduction in royalties to be received. As a result, in the first quarter of 2021, we took a $2.4 million impairment charge on our Rochas fashion trademark. In the fourth quarter of 2022, we again took a $6.8 million impairment charge on the Rochas fashion trademark after an independent expert concluded that the valuation of the trademark was $11.3 million. The new license also contains an option for the licensee to buy-out the Rochas fashion trademarks in June 2025 at its then fair market value.

 

Land and Building Acquisition - Headquarters in Paris

 

In April 2021, Interparfums SA, our 72% owned French Subsidiary, completed the acquisition of its headquarters at 10 rue de Solférino in the 7th arrondissement of Paris from the property developer. This is an office complex combining three buildings connected by two inner courtyards, and consists of approximately 40,000 total sq. ft.

 

The purchase price included the complete renovation of the site. As of June 30, 2023, $152 million of the purchase price, including approximately $3.1 million of acquisition costs, is included in property, equipment and leasehold improvements on the accompanying balance sheet. The purchase price has been allocated approximately $62.2 million to land and $89.6 million to the building. The building, which was delivered on February 28, 2022, includes the building structure, development of the property, façade waterproofing, general and technical installations and interior fittings that will be depreciated over a range of 7 to 50 years. The Company has elected to depreciate the building cost based on the useful lives of its components. Approximately $1.2 million of cash held in escrow is also included in property, equipment and leasehold improvements on the accompanying balance sheet as of June 30, 2023.

 

The acquisition was financed by a 10-year €120 million (approximately $130.4 million) bank loan which bears interest at one-month Euribor plus 0.75%. Approximately €80 million of the variable rate debt was swapped for variable interest rate debt with a maximum rate of 2% per annum. The swap effectively exchanges the variable interest rate to a fixed rate of approximately 1.1%.

XML 21 R11.htm IDEA: XBRL DOCUMENT v3.23.2
Recent Accounting Pronouncements:
6 Months Ended
Jun. 30, 2023
Accounting Changes and Error Corrections [Abstract]  
Recent Accounting Pronouncements:

 

4.Recent Accounting Pronouncements:

 

There are no recent accounting pronouncements issued but not yet adopted that would have a material effect on our consolidated financial statements.

XML 22 R12.htm IDEA: XBRL DOCUMENT v3.23.2
Inventories:
6 Months Ended
Jun. 30, 2023
Inventory Disclosure [Abstract]  
Inventories:

 

5.Inventories:

 

Inventories consist of the following:

 

(In thousands)  June 30, 2023   December 31, 2022 
Raw materials and component parts  $173,660   $146,772 
Finished goods   186,358    143,212 
           
Inventories  $360,018   $289,984 

 

XML 23 R13.htm IDEA: XBRL DOCUMENT v3.23.2
Fair Value Measurement:
6 Months Ended
Jun. 30, 2023
Fair Value Disclosures [Abstract]  
Fair Value Measurement:

6.Fair Value Measurement:

 

The following tables present our financial assets and liabilities that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy. The fair value hierarchy has three levels based on the reliability of the inputs used to determine fair value.

 

                       
       Fair Value Measurements at June 30, 2023 
   Total   Quoted Prices in
Active Markets for
Identical Assets
(Level 1)
   Significant Other
Observable
Inputs
(Level 2)
   Significant
Unobservable
Inputs
(Level 3)
 
Assets:                    
Short-term investments  $112,449   $2,150   $109,489   $811 
Interest rate swaps   6,780        6,780     
Foreign currency forward exchange contracts not accounted for using hedge accounting   165        165     
                     
Total asset  $119,394   $2,150   $116,434   $811 
Liabilities:                    
Foreign currency forward exchange contracts accounted for using hedge accounting  $9   $   $9   $ 

 

                         
       Fair Value Measurements at December 31, 2022 
   Total   Quoted Prices in
Active Markets for
Identical Assets
(Level 1)
   Significant Other
Observable
Inputs
(Level 2)
   Significant
Unobservable
Inputs
(Level 3)
 
Assets:                    
Short-term investments  $150,833   $19,861   $130,174   $798 
Interest rate swaps   6,758        6,758     
Foreign currency forward exchange contracts accounted for using hedge accounting   1,189        1,189     
                     
Total asset  $158,780   $19,861   $138,121   $798 
Liabilities:                    
Foreign currency forward exchange contracts not accounted for using hedge accounting   68        68     
                     
Total Liabilities  $68   $   $68   $ 

 

The carrying amount of cash and cash equivalents including money market funds, short-term investments, accounts receivable, other receivables, cash held in escrow, accounts payable and accrued expenses approximate fair value due to the short terms to maturity of these instruments.

 

The carrying amount of loans payable approximates fair value as the interest rates on the Company’s indebtedness approximate current market rates. The fair value of the Company’s long-term debt was estimated based on the current rates offered to companies for debt with the same remaining maturities and is approximately equal to its carrying value.

 

Foreign currency forward exchange contracts are valued based on quotations from financial institutions and the value of interest rate swaps is the discounted net present value of the swaps using third party quotes from financial institutions.

XML 24 R14.htm IDEA: XBRL DOCUMENT v3.23.2
Derivative Financial Instruments:
6 Months Ended
Jun. 30, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Financial Instruments:

7.Derivative Financial Instruments:

 

The Company enters into foreign currency forward exchange contracts to hedge exposure related to receivables denominated in a foreign currency and occasionally to manage risks related to future sales expected to be denominated in a foreign currency. Before entering into a derivative transaction for hedging purposes, it is determined that a high degree of initial effectiveness exists between the change in value of the hedged item and the change in the value of the derivative instrument from movement in exchange rates. High effectiveness means that the change in the cash flows of the derivative instrument will effectively offset the change in the cash flows of the hedged item. The effectiveness of each hedged item is measured throughout the hedged period and is based on the dollar offset methodology and excludes the portion of the fair value of the foreign currency forward exchange contract attributable to the change in spot-forward difference which is reported in current period earnings. Any hedge ineffectiveness is also recognized as a gain or loss on foreign currency in the income statement. For hedge contracts that are no longer deemed highly effective, hedge accounting is discontinued, and gains and losses accumulated in other comprehensive income are reclassified to earnings. If it is probable that the forecasted transaction will no longer occur, then any gains or losses accumulated in other comprehensive income are reclassified to current-period earnings.

 

In December 2022, to finance the acquisition of the Lacoste trademark, the Company entered into a €50 million (approximately $54.3 million) 4-year term loan with a variable interest rate. This variable rate debt was swapped for variable interest rate debt with a maximum rate of 2% per annum. This swap is a hedged derivative instrument and is therefore recorded at fair value and changes in fair value are reflected in other comprehensive income.

 

In connection with the April 2021 acquisition of the office building complex in Paris, €120 million (approximately $130.4 million) of the purchase price was financed through a 10-year term loan. The Company entered into interest rate swap contracts related to €80 million of the loan, effectively exchanging the variable interest rate to a fixed rate of approximately 1.1%. This derivative instrument is recorded at fair value and changes in fair value are reflected in the accompanying consolidated statements of income.

 

Gains and losses in derivatives designated as hedges are accumulated in other comprehensive income and gains and losses in derivatives not designated as hedges are included in (gain) loss on foreign currency on the accompanying income statements. Such gains and losses were immaterial for the three and six months ended June 30, 2023 and 2022.

 

All derivative instruments are reported as either assets or liabilities on the balance sheet measured at fair value. The valuation of interest rate swaps is included in other assets on the accompanying balance sheets. The valuation of foreign currency forward exchange contracts at June 30, 2023 resulted in a net asset and is included in other current assets on the accompanying balance sheet.

 

At June 30, 2023, we had foreign currency contracts in the form of forward exchange contracts in the amount of approximately U.S. $38.0 million and GB £2.0 million which all have maturities of less than one year.

XML 25 R15.htm IDEA: XBRL DOCUMENT v3.23.2
Leases:
6 Months Ended
Jun. 30, 2023
Leases [Abstract]  
Leases:

 

8.Leases:

 

The Company leases its offices and warehouses, vehicles, and certain office equipment, substantially all of which are classified as operating leases. The Company currently has no material financing leases. The Company determines if an arrangement is a lease at inception. Operating lease assets and obligations are recognized at the lease commencement date based on the present value of lease payments over the lease term.

 

In determining lease asset value, the Company considers fixed or variable payment terms, prepayments, incentives, and options to extend or terminate, depending on the lease. Renewal, termination, or purchase options affect the lease term used for determining lease asset value only if the option is reasonably certain to be exercised. The Company generally uses its incremental borrowing rate based on information available at the lease commencement date for the location in which the lease is held in determining the present value of lease payments.

 

As of June 30, 2023, the weighted average remaining lease term was 5.6 years and the weighted average discount rate used to determine the operating lease liability was 2.8%. Rental expense related to operating leases was $1.5 million and $2.9 million for the three and six months ended June 30, 2023, respectively, as compared to $1.3 million and $3.1 million for the corresponding periods of the prior year. Operating lease payments included in operating cash flows totaled $2.6 million and $2.8 million for the six months ended June 30, 2023 and 2022, respectively, and noncash additions to operating lease assets totaled $2.4 million and $0.5 million for the six months ended June 30, 2023 and 2022, respectively.

XML 26 R16.htm IDEA: XBRL DOCUMENT v3.23.2
Share-Based Payments:
6 Months Ended
Jun. 30, 2023
Equity:  
Share-Based Payments:

 

9.Share-Based Payments:

 

The Company maintains a stock option program for key employees, executives and directors. The plans, all of which have been approved by shareholder vote, provide for the granting of both nonqualified and incentive options. Options granted under the plans typically have a six-year term and vest over a four to five-year period. The fair value of shares vested during the six months ended June 30, 2023 and 2022 aggregated $0.10 million and $0.10 million, respectively. Compensation cost, net of forfeitures, is recognized on a straight-line basis over the requisite service period for the entire award. Forfeitures are estimated based on historic trends. It is generally our policy to issue new shares upon exercise of stock options.

 

The following table sets forth information with respect to nonvested options for the six months ended June 30, 2023:

 

   Number of Shares   Weighted Average Grant-Date Fair Value 
Nonvested options – beginning of period   168,730   $16.31 
Nonvested options granted        
Nonvested options vested or forfeited   (23,560)  $13.59 
Nonvested options – end of period   145,170   $16.75 

 

Share-based payment expense decreased income before income taxes by $0.63 million and $1.27 million for the three and six months ended June 30, 2023, respectively, as compared to $1.22 million and $1.88 million for the corresponding periods of the prior year. Share-base income before income d payment expense decreased income attributable to Inter Parfums, Inc. by $0.43 million and $0.86 million for the three and six months ended June 30, 2023, respectively, as compared to $0.74 million and $1.18 million for the corresponding periods of the prior year.

 

The following table summarizes stock option information as of June 30, 2023:

 

   Shares   Weighted Average Exercise Price 
         
Outstanding at January 1, 2023   441,580   $67.30 
Options forfeited   (15,960)   70.48 
Options exercised   (93,430)   55.57 
           
Outstanding at June 30, 2023   332,190   $70.44 
           
Options exercisable   187,020   $61.53 
Options available for future grants   574,935      

 

 

As of June 30, 2023, the weighted average remaining contractual life of options outstanding is 2.40 years (0.6 years for options exercisable); the aggregate intrinsic value of options outstanding and options exercisable is $21.5 million and $13.8 million, respectively; and unrecognized compensation cost related to stock options outstanding aggregated $2.0 million.

 

Cash proceeds, tax benefits and intrinsic value related to stock options exercised during the six months ended June 30, 2023 and 2022 were as follows:

 

(In thousands)  June 30,
2023
   June 30, 
2022
 
         
Cash proceeds from stock options exercised  $5,192   $810 
Tax benefits   840    75 
Intrinsic value of stock options exercised   5,773    698 

 

There were no options granted during the six months ended June 30, 2023 and June 30, 2022.

 

Expected volatility is estimated based on historic volatility of the Company’s common stock. The expected term of the option is estimated based on historic data. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of the grant of the option and the dividend yield reflects the assumption that the dividend payout as authorized by the Board of Directors would increase as the earnings of the Company and its stock price continues to increase.

 

In December 2018, Interparfums SA approved a plan to grant an aggregate of 26,600 shares of its stock to employees with no performance condition requirement, and an aggregate of 133,000 shares to officers and managers, subject to certain corporate performance conditions. The corporate performance conditions were met and therefore in June 2022, 211,955 shares, adjusted for stock splits, were distributed. The aggregate cost of the grant of approximately $4.8 million was recognized as compensation cost on a straight-line basis over the requisite three-year service period.

 

In March 2022, Interparfums SA approved an additional plan to grant an aggregate of 88,400 shares to all Interparfums SA employees and corporate officers having more than six months of employment at grant date, subject to certain corporate performance conditions. The shares, subject to adjustment for stock splits, will be distributed in June 2025 and will follow the same guidelines as the December 2018 plan.

 

The fair value of the grant had been determined based on the quoted stock price of Interparfums SA shares as reported by the NYSE Euronext on the date of grant. The estimated number of shares to be distributed of 93,489 has been determined taking into account employee turnover. The aggregate cost of the grant of approximately $4.2 million will be recognized as compensation cost on a straight-line basis over the requisite three and a quarter year service period.

 

Similar to the December 2018 plan, in order to avoid dilution of the Company’s ownership of Interparfums SA, all shares distributed or to be distributed pursuant to these plans will be pre-existing shares of Interparfums SA, purchased in the open market by Interparfums SA. As of June 30, 2023 the Company acquired 69,609 shares at an aggregate cost of $3.0 million.

 

In the first half of 2023, the Company initiated a share repurchase program with the primary intent of neutralizing the dilution impact of the stock option programs previously discussed. Over the course of the first half of 2023, the Company repurchased 85,060 shares at a cost of $11.3 million. These shares are classified as treasury shares on the accompanying balance sheet. The Company plans to continue repurchasing shares throughout 2023.

 

All share purchases and issuances have been classified as equity transactions on the accompanying balance sheet.

XML 27 R17.htm IDEA: XBRL DOCUMENT v3.23.2
Net Income Attributable to Inter Parfums, Inc. Common Shareholders:
6 Months Ended
Jun. 30, 2023
Earnings per share:  
Net Income Attributable to Inter Parfums, Inc. Common Shareholders:

10.Net Income Attributable to Inter Parfums, Inc. Common Shareholders:

 

Net income attributable to Inter Parfums, Inc. per common share (“basic EPS”) is computed by dividing net income attributable to Inter Parfums, Inc. by the weighted average number of shares outstanding. Net income attributable to Inter Parfums, Inc. per share assuming dilution (“diluted EPS”), is computed using the weighted average number of shares outstanding, plus the incremental shares outstanding assuming the exercise of dilutive stock options using the treasury stock method.

 

The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows:

 

                       
  Three months ended
June 30,
   Six months ended
June 30,
 
(In thousands)  2023   2022   2023   2022 
Numerator:                
Net income attributable to Inter Parfums, Inc.  $34,952   $27,617   $89,020   $62,916 
Denominator:                    
Weighted average shares   32,006    31,845    32,012    31,843 
Effect of dilutive securities:                    
Stock options   156    107    149    138 
Denominator for diluted earnings per share   32,162    31,952    32,161    31,981 
                     
Earnings per share:                    
Net income attributable to Inter Parfums, Inc. common shareholders:                    
Basic  $1.09   $0.87   $2.78   $1.98 
Diluted   1.09    0.86    2.77    1.97 

 

There were no antidilutive potential common shares outstanding for the three and six months ended June 30, 2023 and June 30, 2022.

XML 28 R18.htm IDEA: XBRL DOCUMENT v3.23.2
Segment and Geographic Areas:
6 Months Ended
Jun. 30, 2023
Segment Reporting [Abstract]  
Segment and Geographic Areas:

11.Segment and Geographic Areas:

 

The Company manufactures and distributes one product line, fragrances and fragrance related products. The Company manages its business in two segments, European based operations and United States based operations. The European assets are located, and operations are primarily conducted, in France. Both European based operations and United States based operations primarily represent the sale of prestige brand name fragrances.

 

Information on our operations by geographical areas is as follows:

 

  Three months ended
June 30,
   Six months ended
June 30,
 
(In thousands)  2023   2022   2023   2022 
Net sales:                    
United States  $111,436   $78,444   $192,890   $146,946 
Europe   197,808    166,287    428,077    348,469 
Eliminations       (6)       (12)
                     
   $309,244   $244,725   $620,967   $495,403 
                     
Net income attributable to Inter Parfums, Inc.:                    
United States  $15,567   $9,991   $25,910   $16,505 
Europe   19,385    17,626    63,110    46,411 
                     
   $34,952   $27,617   $89,020   $62,916 

 

   June 30,   December 31, 
   2023   2022 
Total Assets:          
United States  $

313,261

   $278,090 
Europe   1,048,040    1,052,004 
Eliminations   (9,637)   (21,552)
   $1,351,664   $1,308,542 

 

XML 29 R19.htm IDEA: XBRL DOCUMENT v3.23.2
Inventories: (Tables)
6 Months Ended
Jun. 30, 2023
Inventory Disclosure [Abstract]  
Inventories consist of the following:

Inventories consist of the following:

 

(In thousands)  June 30, 2023   December 31, 2022 
Raw materials and component parts  $173,660   $146,772 
Finished goods   186,358    143,212 
           
Inventories  $360,018   $289,984 
XML 30 R20.htm IDEA: XBRL DOCUMENT v3.23.2
Fair Value Measurement: (Tables)
6 Months Ended
Jun. 30, 2023
Fair Value Disclosures [Abstract]  
The following tables present our financial assets and liabilities that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy. The fair value hierarchy has three levels based on the reliability of the inputs used to determine fair value.

The following tables present our financial assets and liabilities that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy. The fair value hierarchy has three levels based on the reliability of the inputs used to determine fair value.

 

                       
       Fair Value Measurements at June 30, 2023 
   Total   Quoted Prices in
Active Markets for
Identical Assets
(Level 1)
   Significant Other
Observable
Inputs
(Level 2)
   Significant
Unobservable
Inputs
(Level 3)
 
Assets:                    
Short-term investments  $112,449   $2,150   $109,489   $811 
Interest rate swaps   6,780        6,780     
Foreign currency forward exchange contracts not accounted for using hedge accounting   165        165     
                     
Total asset  $119,394   $2,150   $116,434   $811 
Liabilities:                    
Foreign currency forward exchange contracts accounted for using hedge accounting  $9   $   $9   $ 

 

                         
       Fair Value Measurements at December 31, 2022 
   Total   Quoted Prices in
Active Markets for
Identical Assets
(Level 1)
   Significant Other
Observable
Inputs
(Level 2)
   Significant
Unobservable
Inputs
(Level 3)
 
Assets:                    
Short-term investments  $150,833   $19,861   $130,174   $798 
Interest rate swaps   6,758        6,758     
Foreign currency forward exchange contracts accounted for using hedge accounting   1,189        1,189     
                     
Total asset  $158,780   $19,861   $138,121   $798 
Liabilities:                    
Foreign currency forward exchange contracts not accounted for using hedge accounting   68        68     
                     
Total Liabilities  $68   $   $68   $ 
XML 31 R21.htm IDEA: XBRL DOCUMENT v3.23.2
Share-Based Payments: (Tables)
6 Months Ended
Jun. 30, 2023
Equity:  
The following table sets forth information with respect to nonvested options for the six months ended June 30, 2023:

The following table sets forth information with respect to nonvested options for the six months ended June 30, 2023:

 

   Number of Shares   Weighted Average Grant-Date Fair Value 
Nonvested options – beginning of period   168,730   $16.31 
Nonvested options granted        
Nonvested options vested or forfeited   (23,560)  $13.59 
Nonvested options – end of period   145,170   $16.75 
The following table summarizes stock option information as of June 30, 2023:

The following table summarizes stock option information as of June 30, 2023:

 

   Shares   Weighted Average Exercise Price 
         
Outstanding at January 1, 2023   441,580   $67.30 
Options forfeited   (15,960)   70.48 
Options exercised   (93,430)   55.57 
           
Outstanding at June 30, 2023   332,190   $70.44 
           
Options exercisable   187,020   $61.53 
Options available for future grants   574,935      
Cash proceeds, tax benefits and intrinsic value related to stock options exercised during the six months ended June 30, 2023 and 2022 were as follows:

Cash proceeds, tax benefits and intrinsic value related to stock options exercised during the six months ended June 30, 2023 and 2022 were as follows:

 

(In thousands)  June 30,
2023
   June 30, 
2022
 
         
Cash proceeds from stock options exercised  $5,192   $810 
Tax benefits   840    75 
Intrinsic value of stock options exercised   5,773    698 
XML 32 R22.htm IDEA: XBRL DOCUMENT v3.23.2
Net Income Attributable to Inter Parfums, Inc. Common Shareholders: (Tables)
6 Months Ended
Jun. 30, 2023
Earnings per share:  
The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows:

The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows:

 

                       
  Three months ended
June 30,
   Six months ended
June 30,
 
(In thousands)  2023   2022   2023   2022 
Numerator:                
Net income attributable to Inter Parfums, Inc.  $34,952   $27,617   $89,020   $62,916 
Denominator:                    
Weighted average shares   32,006    31,845    32,012    31,843 
Effect of dilutive securities:                    
Stock options   156    107    149    138 
Denominator for diluted earnings per share   32,162    31,952    32,161    31,981 
                     
Earnings per share:                    
Net income attributable to Inter Parfums, Inc. common shareholders:                    
Basic  $1.09   $0.87   $2.78   $1.98 
Diluted   1.09    0.86    2.77    1.97 
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.23.2
Segment and Geographic Areas: (Tables)
6 Months Ended
Jun. 30, 2023
Segment Reporting [Abstract]  
Information on our operations by geographical areas is as follows:

Information on our operations by geographical areas is as follows:

 

  Three months ended
June 30,
   Six months ended
June 30,
 
(In thousands)  2023   2022   2023   2022 
Net sales:                    
United States  $111,436   $78,444   $192,890   $146,946 
Europe   197,808    166,287    428,077    348,469 
Eliminations       (6)       (12)
                     
   $309,244   $244,725   $620,967   $495,403 
                     
Net income attributable to Inter Parfums, Inc.:                    
United States  $15,567   $9,991   $25,910   $16,505 
Europe   19,385    17,626    63,110    46,411 
                     
   $34,952   $27,617   $89,020   $62,916 

 

   June 30,   December 31, 
   2023   2022 
Total Assets:          
United States  $

313,261

   $278,090 
Europe   1,048,040    1,052,004 
Eliminations   (9,637)   (21,552)
   $1,351,664   $1,308,542 
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.23.2
Recent Agreements: (Details Narrative)
$ in Millions
6 Months Ended
Jun. 30, 2023
USD ($)
Jun. 30, 2023
EUR (€)
Dec. 31, 2022
Apr. 30, 2021
Business Acquisition [Line Items]        
Purchase price, period cost $ 152.0      
Acquisition costs, period cost 3.1      
Cash held in escrow is included in other assets $ 1.2      
Long-term debt, term 10 years 10 years 4 years 10 years
Long-term line of credit $ 130.4 € 120,000,000    
Description of debt instrument interest rate terms one-month Euribor plus 0.75%      
Debt instrument, face amount | €   € 80,000,000    
Variable interest rate 2.00% 2.00%    
Fixed interest rate 1.10% 1.10%    
Minimum [Member]        
Business Acquisition [Line Items]        
Depreciated over a range 7 years 7 years    
Maximum [Member]        
Business Acquisition [Line Items]        
Depreciated over a range 50 years 50 years    
Land [Member]        
Business Acquisition [Line Items]        
Purchase price, period cost $ 62.2      
Building [Member]        
Business Acquisition [Line Items]        
Purchase price, period cost $ 89.6      
Interparfums SA [Member]        
Business Acquisition [Line Items]        
Ownership percentage       72.00%
Roberto Cavalli [Member]        
Business Acquisition [Line Items]        
Description of recent agreement The license became effective in July 2023 and will last for 6.5 years.      
Lacoste [Member]        
Business Acquisition [Line Items]        
Description of recent agreement The license becomes effective in January 2024 and will last for 15 years.      
Rochas Fashion [Member]        
Business Acquisition [Line Items]        
Description of recent agreement we entered into a new license agreement modifying our Rochas fashion business model. The new agreement calls for a reduction in royalties to be received. As a result, in the first quarter of 2021, we took a $2.4 million impairment charge on our Rochas fashion trademark. In the fourth quarter of 2022, we again took a $6.8 million impairment charge on the Rochas fashion trademark after an independent expert concluded that the valuation of the trademark was $11.3 million. The new license also contains an option for the licensee to buy-out the Rochas fashion trademarks in June 2025 at its then fair market value.      
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.23.2
Inventories consist of the following: (Details) - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Inventory Disclosure [Abstract]    
Raw materials and component parts $ 173,660 $ 146,772
Finished goods 186,358 143,212
Inventories $ 360,018 $ 289,984
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.23.2
The following tables present our financial assets and liabilities that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy. The fair value hierarchy has three levels based on the reliability of the inputs use (Details) - Fair Value, Recurring [Member] - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Assets:    
Short-term investments $ 112,449 $ 150,833
Interest rate swaps 6,780 6,758
Foreign currency forward exchange contracts accounted for using hedge accounting 165 1,189
Total asset 119,394 158,780
Liabilities:    
Foreign currency forward exchange contracts not accounted for using hedge accounting 9 68
Total Liabilities   68
Fair Value, Inputs, Level 1 [Member]    
Assets:    
Short-term investments 2,150 19,861
Interest rate swaps
Foreign currency forward exchange contracts accounted for using hedge accounting
Total asset 2,150 19,861
Liabilities:    
Foreign currency forward exchange contracts not accounted for using hedge accounting
Total Liabilities  
Fair Value, Inputs, Level 2 [Member]    
Assets:    
Short-term investments 109,489 130,174
Interest rate swaps 6,780 6,758
Foreign currency forward exchange contracts accounted for using hedge accounting 165 1,189
Total asset 116,434 138,121
Liabilities:    
Foreign currency forward exchange contracts not accounted for using hedge accounting 9 68
Total Liabilities   68
Fair Value, Inputs, Level 3 [Member]    
Assets:    
Short-term investments 811 798
Interest rate swaps
Foreign currency forward exchange contracts accounted for using hedge accounting
Total asset 811 798
Liabilities:    
Foreign currency forward exchange contracts not accounted for using hedge accounting
Total Liabilities  
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.23.2
Derivative Financial Instruments: (Details Narrative)
€ in Millions, £ in Millions
6 Months Ended
Jun. 30, 2023
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2022
EUR (€)
Dec. 31, 2022
GBP (£)
Apr. 30, 2021
USD ($)
Apr. 30, 2021
EUR (€)
Derivative Instruments, Gain (Loss) [Line Items]            
Loan amount | $   $ 54,300,000     $ 130,400,000  
Long-term debt, term 10 years 4 years 4 years 4 years 10 years 10 years
Derivative swap interest rate   2.00% 2.00% 2.00% 1.10% 1.10%
Foreign Exchange Contract [Member]            
Derivative Instruments, Gain (Loss) [Line Items]            
Forward exchange contracts | $ $ 38,000,000.0          
Maturity of foreign currency 1 year          
Euro Member Countries, Euro            
Derivative Instruments, Gain (Loss) [Line Items]            
Loan amount | €     € 50     € 120
Euro Member Countries, Euro | Interest Rate Swap [Member]            
Derivative Instruments, Gain (Loss) [Line Items]            
Loan amount | €           € 80
United Kingdom, Pounds | Foreign Exchange Contract [Member]            
Derivative Instruments, Gain (Loss) [Line Items]            
Loan amount | £       £ 2    
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.23.2
Leases: (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2023
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Leases [Abstract]          
Operating lease, weighted average remaining lease term 5 years 7 months 6 days 5 years 7 months 6 days      
Operating lease, weighted average discount rate, percent 2.80% 2.80%      
Operating leases, rent expense, net $ 1,500,000 $ 2,900,000   $ 1,300,000 $ 3,100,000
Operating lease, payments   2,600,000 $ 2,800,000    
Noncash additions to operating lease assets   $ 2,400,000 $ 500,000    
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.23.2
The following table sets forth information with respect to nonvested options for the six months ended June 30, 2023: (Details)
6 Months Ended
Jun. 30, 2023
$ / shares
shares
Equity:  
Nonvested options beginning of period | shares 168,730
Weighted average grant date fair value, beginning of year | $ / shares $ 16.31
Nonvested options granted | shares
Weighted average grant date fair value, nonvested options granted | $ / shares
Nonvested options vested or forfeited | shares (23,560)
Weighted average grant date fair value, nonvested options vested or forfeited | $ / shares $ 13.59
Nonvested options end of period | shares 145,170
Weighted average grant date fair value, nonvested options end of period | $ / shares $ 16.75
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.23.2
The following table summarizes stock option information as of June 30, 2023: (Details)
6 Months Ended
Jun. 30, 2023
$ / shares
shares
Equity:  
Options shares under option - beginning of year 441,580
Weighted average exercise price shares under option - beginning of year | $ / shares $ 67.30
Options forfeited (15,960)
Weighted average exercise price options forfeited | $ / shares $ 70.48
Options exercised (93,430)
Weighted average exercise price options exercised | $ / shares $ 55.57
Options shares under option - end of year 332,190
Weighted average exercise price shares under option - end of year | $ / shares $ 70.44
Options exercisable 187,020
Weighted average exercise price options exercisable | $ / shares $ 61.53
Options available for future grants 574,935
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.23.2
Cash proceeds, tax benefits and intrinsic value related to stock options exercised during the six months ended June 30, 2023 and 2022 were as follows: (Details) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Equity:    
Cash proceeds from stock options exercised $ 5,192 $ 810
Tax benefits 840 75
Intrinsic value of stock options exercised $ 5,773 $ 698
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.23.2
Share-Based Payments: (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Mar. 31, 2022
Dec. 31, 2018
Subsidiary or Equity Method Investee [Line Items]                
Income before income taxes   $ 55,475,000 $ 45,445,000 $ 148,061,000 $ 106,668,000      
Share-based payment arrangement, expense   430,000 $ 740,000 $ 860,000 $ 1,180,000      
Weighted average remaining contractual life of options outstanding (in years)       2 years 4 months 24 days        
Weighted average remaining contractual life of options exercisable (in years)       7 months 6 days        
Aggregate intrinsic value of options outstanding and options outstanding   21,500,000   $ 21,500,000        
Aggregate intrinsic value of options outstanding and options exercisable   13,800,000   13,800,000        
Unrecognized compensation cost   $ 2,000,000.0   $ 2,000,000.0        
Options granted       0 0      
Adjusted for stock splits 211,955              
Recognized as compensation cost $ 4,800,000              
Treasury Stock, Common [Member]                
Subsidiary or Equity Method Investee [Line Items]                
Shares repurchased       85,060        
Shares repurchase value       $ 11,289,000      
Interparfums SA Subsidiary [Member] | Employees [Member]                
Subsidiary or Equity Method Investee [Line Items]                
Aggregate shares to offices and managers   69,609   69,609     88,400 26,600
Recognized as compensation cost       $ 4,200,000   $ 3,000,000.0    
Number of share distributed       93,489        
Interparfums SA Subsidiary [Member] | Officers and Managers [Member]                
Subsidiary or Equity Method Investee [Line Items]                
Aggregate shares to offices and managers               133,000
Equity Option [Member]                
Subsidiary or Equity Method Investee [Line Items]                
Fair value of shares vested       $ 100,000 $ 100,000      
Equity Option [Member] | Minimum [Member]                
Subsidiary or Equity Method Investee [Line Items]                
Options vesting period       4 years        
Equity Option [Member] | Maximum [Member]                
Subsidiary or Equity Method Investee [Line Items]                
Options vesting period       5 years        
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.23.2
The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows: (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Numerator:        
Net income attributable to Inter Parfums, Inc. $ 34,952 $ 27,617 $ 89,020 $ 62,916
Denominator:        
Weighted average shares 32,006 31,845 32,012 31,843
Stock options 156 107 149 138
Denominator for diluted earnings per share 32,162 31,952 32,161 31,981
Net income attributable to Inter Parfums, Inc. common shareholders:        
Basic $ 1.09 $ 0.87 $ 2.78 $ 1.98
Diluted $ 1.09 $ 0.86 $ 2.77 $ 1.97
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.23.2
Net Income Attributable to Inter Parfums, Inc. Common Shareholders: (Details Narrative) - shares
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Earnings per share:        
Antidilutive potential common shares outstanding 0 0 0 0
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.23.2
Information on our operations by geographical areas is as follows: (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Revenues from External Customers and Long-Lived Assets [Line Items]          
Net sales $ 309,244 $ 244,725 $ 620,967 $ 495,403  
Net income attributable to Inter Parfums, Inc. 34,952 27,617 89,020 62,916  
Assets 1,351,664   1,351,664   $ 1,308,542
UNITED STATES          
Revenues from External Customers and Long-Lived Assets [Line Items]          
Net sales 111,436 78,444 192,890 146,946  
Net income attributable to Inter Parfums, Inc. 15,567 9,991 25,910 16,505  
Assets 313,261   313,261   278,090
Europe [Member]          
Revenues from External Customers and Long-Lived Assets [Line Items]          
Net sales 197,808 166,287 428,077 348,469  
Net income attributable to Inter Parfums, Inc. 19,385 17,626 63,110 46,411  
Assets 1,048,040   1,048,040   1,052,004
Eliminations [Member]          
Revenues from External Customers and Long-Lived Assets [Line Items]          
Net sales $ (6) $ (12)  
Assets $ (9,637)   $ (9,637)   $ (21,552)
XML 46 g083669_10q_htm.xml IDEA: XBRL DOCUMENT 0000822663 2023-01-01 2023-06-30 0000822663 2023-08-08 0000822663 2023-06-30 0000822663 2022-12-31 0000822663 2023-04-01 2023-06-30 0000822663 2022-04-01 2022-06-30 0000822663 2022-01-01 2022-06-30 0000822663 us-gaap:CommonStockMember 2022-12-31 0000822663 us-gaap:CommonStockMember 2021-12-31 0000822663 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000822663 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0000822663 us-gaap:RetainedEarningsMember 2022-12-31 0000822663 us-gaap:RetainedEarningsMember 2021-12-31 0000822663 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0000822663 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0000822663 us-gaap:TreasuryStockCommonMember 2022-12-31 0000822663 us-gaap:TreasuryStockCommonMember 2021-12-31 0000822663 us-gaap:NoncontrollingInterestMember 2022-12-31 0000822663 us-gaap:NoncontrollingInterestMember 2021-12-31 0000822663 2021-12-31 0000822663 us-gaap:CommonStockMember 2023-01-01 2023-06-30 0000822663 us-gaap:CommonStockMember 2022-01-01 2022-06-30 0000822663 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-06-30 0000822663 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-06-30 0000822663 us-gaap:RetainedEarningsMember 2023-01-01 2023-06-30 0000822663 us-gaap:RetainedEarningsMember 2022-01-01 2022-06-30 0000822663 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-06-30 0000822663 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-06-30 0000822663 us-gaap:TreasuryStockCommonMember 2023-01-01 2023-06-30 0000822663 us-gaap:TreasuryStockCommonMember 2022-01-01 2022-06-30 0000822663 us-gaap:NoncontrollingInterestMember 2023-01-01 2023-06-30 0000822663 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-06-30 0000822663 us-gaap:CommonStockMember 2023-06-30 0000822663 us-gaap:CommonStockMember 2022-06-30 0000822663 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0000822663 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0000822663 us-gaap:RetainedEarningsMember 2023-06-30 0000822663 us-gaap:RetainedEarningsMember 2022-06-30 0000822663 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0000822663 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-30 0000822663 us-gaap:TreasuryStockCommonMember 2023-06-30 0000822663 us-gaap:TreasuryStockCommonMember 2022-06-30 0000822663 us-gaap:NoncontrollingInterestMember 2023-06-30 0000822663 us-gaap:NoncontrollingInterestMember 2022-06-30 0000822663 2022-06-30 0000822663 ipar:RobertoCavalliMember 2023-01-01 2023-06-30 0000822663 ipar:LacosteMember 2023-01-01 2023-06-30 0000822663 ipar:RochasFashionMember 2023-01-01 2023-06-30 0000822663 ipar:InterparfumsSAMember 2021-04-30 0000822663 us-gaap:LandMember 2023-01-01 2023-06-30 0000822663 us-gaap:BuildingMember 2023-01-01 2023-06-30 0000822663 srt:MinimumMember 2023-06-30 0000822663 srt:MaximumMember 2023-06-30 0000822663 us-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0000822663 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0000822663 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0000822663 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0000822663 us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000822663 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000822663 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000822663 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000822663 currency:EUR 2022-12-31 0000822663 currency:EUR 2021-04-30 0000822663 2021-04-30 0000822663 currency:EUR us-gaap:InterestRateSwapMember 2021-04-30 0000822663 us-gaap:ForeignExchangeContractMember 2023-06-30 0000822663 currency:GBP us-gaap:ForeignExchangeContractMember 2022-12-31 0000822663 us-gaap:ForeignExchangeContractMember 2023-01-01 2023-06-30 0000822663 2022-01-01 2022-12-31 0000822663 2021-01-01 2021-12-31 0000822663 srt:MinimumMember us-gaap:StockOptionMember 2023-01-01 2023-06-30 0000822663 srt:MaximumMember us-gaap:StockOptionMember 2023-01-01 2023-06-30 0000822663 us-gaap:StockOptionMember 2023-01-01 2023-06-30 0000822663 us-gaap:StockOptionMember 2022-01-01 2022-06-30 0000822663 ipar:InterparfumsSASubsidiaryMember ipar:EmployeesMember 2018-12-31 0000822663 ipar:InterparfumsSASubsidiaryMember ipar:OfficersAndManagersMember 2018-12-31 0000822663 2022-06-01 2022-06-30 0000822663 ipar:InterparfumsSASubsidiaryMember ipar:EmployeesMember 2022-03-31 0000822663 ipar:InterparfumsSASubsidiaryMember ipar:EmployeesMember 2023-01-01 2023-06-30 0000822663 ipar:InterparfumsSASubsidiaryMember ipar:EmployeesMember 2023-06-30 0000822663 ipar:InterparfumsSASubsidiaryMember ipar:EmployeesMember 2022-01-01 2022-12-31 0000822663 country:US 2023-04-01 2023-06-30 0000822663 country:US 2022-04-01 2022-06-30 0000822663 country:US 2023-01-01 2023-06-30 0000822663 country:US 2022-01-01 2022-06-30 0000822663 srt:EuropeMember 2023-04-01 2023-06-30 0000822663 srt:EuropeMember 2022-04-01 2022-06-30 0000822663 srt:EuropeMember 2023-01-01 2023-06-30 0000822663 srt:EuropeMember 2022-01-01 2022-06-30 0000822663 ipar:EliminationsMember 2023-04-01 2023-06-30 0000822663 ipar:EliminationsMember 2022-04-01 2022-06-30 0000822663 ipar:EliminationsMember 2023-01-01 2023-06-30 0000822663 ipar:EliminationsMember 2022-01-01 2022-06-30 0000822663 country:US 2023-06-30 0000822663 country:US 2022-12-31 0000822663 srt:EuropeMember 2023-06-30 0000822663 srt:EuropeMember 2022-12-31 0000822663 ipar:EliminationsMember 2023-06-30 0000822663 ipar:EliminationsMember 2022-12-31 iso4217:USD shares iso4217:USD shares pure iso4217:JPY iso4217:EUR iso4217:GBP 0000822663 false 2023 Q2 --12-31 2023-06-30 NY P7Y P50Y P10Y 120000000 80000000 P4Y P10Y P1Y P5Y7M6D P4Y P5Y 55475000 148061000 45445000 106668000 P2Y4M24D P7M6D 34952000 10-Q true false 0-16469 INTER PARFUMS, INC. DE 13-3275609 551 Fifth Avenue New York 10176 (212) 983-2640 Common Stock, $.001 par value per share IPAR NASDAQ Yes Yes Large Accelerated Filer false false false 31975670 74311000 104713000 112449000 150833000 236554000 197584000 360018000 289984000 14730000 28803000 24993000 15650000 386000 157000 823441000 787724000 168264000 166722000 28005000 27964000 292319000 290853000 14333000 11159000 25302000 24120000 1351664000 1308542000 4958000 29080000 28547000 5236000 5296000 91040000 88388000 194036000 213621000 17324000 8715000 341674000 344567000 138565000 151494000 24491000 24335000 0.001 0.001 1000000 1000000 0 0 0.001 0.001 100000000 100000000 31975670 31967300 32000 32000 95984000 90186000 669688000 620095000 -48739000 -56056000 9949865 9864805 48764000 37475000 668201000 616782000 178733000 171364000 846934000 788146000 1351664000 1308542000 309244000 244725000 620967000 495403000 120840000 90943000 229606000 182963000 188404000 153782000 391361000 312440000 133383000 108385000 246061000 205825000 55021000 45397000 145300000 106615000 2276000 1023000 4633000 1907000 746000 279000 -13000 2518000 1977000 464000 7359000 -1002000 7000 328000 48000 444000 454000 48000 2761000 53000 55475000 45445000 148061000 106668000 12957000 10925000 34635000 25857000 42518000 34520000 113426000 80811000 7566000 6903000 24406000 17895000 34952000 27617000 89020000 62916000 1.09 0.87 2.78 1.98 1.09 0.86 2.77 1.97 32006 31845 32012 31843 32162 31952 32161 31981 0.625 0.50 1.30 1.00 42518000 34520000 113426000 80811000 77000 1749000 4243000 1488000 -1709000 -992000 -454000 -33630000 13035000 -46071000 41987000 -859000 123927000 34244000 7566000 6903000 24406000 17895000 -21000 -483000 -227000 -411000 211000 10743000 -3411000 14162000 7334000 -4323000 27590000 3322000 34653000 3464000 96337000 30922000 32000 32000 32000 32000 90186000 87132000 5191000 810000 624000 679000 -17000 -4305000 95984000 84316000 620095000 560663000 89020000 62916000 40020000 31844000 593000 1632000 669688000 593367000 -56056000 -38432000 9624000 -31909000 1709000 992000 -4016000 -1077000 -48739000 -70426000 -37475000 -37475000 11289000 -48764000 -37475000 171364000 166412000 24406000 17895000 3411000 -14162000 -227000 -411000 97000 -389000 -17000 -152000 54000 20301000 16056000 178733000 153191000 788146000 852671000 113426000 80811000 846934000 723005000 113426000 80811000 8367000 6803000 -650000 1241000 1265000 1877000 48000 444000 2620000 3017000 -2987000 -2595000 164000 -2036000 35181000 48085000 66144000 81188000 -3406000 1872000 -2579000 -2822000 -23425000 7916000 8531000 8869000 6765000 -28508000 97079000 2941000 138061000 6211000 3202000 30305000 228000 1016000 37552000 -28051000 4947000 15958000 7522000 5191000 810000 4403000 40020000 31844000 20301000 16056000 11289000 -77430000 -59015000 2711000 -578000 -30402000 -116152000 104713000 168387000 74311000 52235000 3189000 1581000 30096000 16369000 <p id="xdx_80A_eus-gaap--SignificantAccountingPoliciesTextBlock_zeVcUxpZeMz7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 0.5in"><b>1.</b></td><td style="padding-right: 0.5in"><b><span style="text-decoration: underline"><span id="xdx_82C_zxqzCbyKm5Ig">Significant Accounting Policies:</span></span></b></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The accounting policies we follow are set forth in the notes to our consolidated financial statements included in our Form 10-K, which was filed with the Securities and Exchange Commission for the year ended December 31, 2022.</p> <p id="xdx_809_eus-gaap--UnusualOrInfrequentItemsDisclosureTextBlock_zxAoW4x08Z48" style="margin-top: 0; margin-bottom: 0"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 0.5in"><b>2.</b></td><td><b><span style="text-decoration: underline"><span id="xdx_82A_zDJiiV5BtTkj">Impact of COVID-19 Pandemic:</span></span></b></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Our business has continued to significantly improve throughout 2022 and the first half of 2023 after the disastrous effects of the COVID-19 Pandemic starting in early 2020, as retail stores reopened, and consumers increased online purchasing. While COVID-19 had significantly restricted international travel, the travel retail business has picked up. Lastly, we experienced significant strains on our supply chain causing disruptions affecting the procurement of components, the ability to transport goods, and related cost increases. These disruptions came at a time when demand for our product lines has never been stronger or more sustained. We have addressed this issue since the beginning of 2021, by ordering well in advance of need and in larger quantities. Since 2021, we have strived to carry more inventory overall, source the same components from multiple suppliers and when possible, manufacture products closer to where they are sold. The supply chain bottlenecks have been improving and while lead times remain longer than pre-COVID, we do not expect significant disruptions going forward.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p> <p id="xdx_80D_eus-gaap--BusinessCombinationDisclosureTextBlock_zWFHQz2YKtJ6" style="margin-top: 0; margin-bottom: 0"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0"></td><td style="width: 0.5in; text-align: left"><b>3.</b></td><td style="text-align: justify"><b><span style="text-decoration: underline"><span id="xdx_827_ztJyKRAM5Lug">Recent Agreements:</span></span></b></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i>Roberto Cavalli</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In July 2023, we closed a transaction agreement with Roberto Cavalli, whereby an exclusive and worldwide license was granted for the production and distribution of Roberto Cavalli brand perfumes and fragrance related products. Our rights under this license are subject to certain minimum advertising expenditures and royalty payments as are customary in our industry. <span id="xdx_90A_eus-gaap--BusinessAcquisitionDescriptionOfAcquiredEntity_c20230101__20230630__us-gaap--BusinessAcquisitionAxis__custom--RobertoCavalliMember_zkj7cfGCLDql" title="Description of recent agreement">The license became effective in July 2023 and will last for 6.5 years.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i>Lacoste</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In December 2022, we closed a transaction agreement with Lacoste, whereby an exclusive and worldwide license was granted for the production and distribution of Lacoste brand perfumes and cosmetics. Our rights under this license are subject to certain minimum advertising expenditures and royalty payments as are customary in our industry. <span id="xdx_907_eus-gaap--BusinessAcquisitionDescriptionOfAcquiredEntity_c20230101__20230630__us-gaap--BusinessAcquisitionAxis__custom--LacosteMember_zXlQhN7wfqu9">The license becomes effective in January 2024 and will last for 15 years.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i>Dunhill</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In April 2022, we announced that the Dunhill fragrance license will expire on September 30, 2023 and will not be renewed. The Company will continue to produce and sell Dunhill fragrances until the license expires and will maintain the right to sell-off remaining Dunhill fragrance inventory for a limited time as is customary in the fragrance industry.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i>Donna Karan and DKNY </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In September 2021, we entered into a long-term global licensing agreement for the creation, development and distribution of fragrances and fragrance related products under the Donna Karan and DKNY brands. Our rights under this license are subject to certain minimum advertising expenditures and royalty payments as are customary in our industry. With this agreement, we are gaining several well-established and valuable fragrance franchises, most notably Donna Karan <i>Cashmere Mist</i> and DKNY <i>Be Delicious</i>, as well as a significant loyal consumer base around the world. In connection with the grant of license, we issued 65,342 shares of Inter Parfums, Inc. common stock valued at $5.0 million to the licensor. The exclusive license became effective July 1, 2022, and we are planning to launch new fragrances under these brands in 2024.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i>Rochas Fashion</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Effective January 1, 2021, <span id="xdx_90D_eus-gaap--BusinessAcquisitionDescriptionOfAcquiredEntity_c20230101__20230630__us-gaap--BusinessAcquisitionAxis__custom--RochasFashionMember_zJRuqzLFNgU3" title="Description of recent agreement">we entered into a new license agreement modifying our Rochas fashion business model. The new agreement calls for a reduction in royalties to be received. As a result, in the first quarter of 2021, we took a $2.4 million impairment charge on our Rochas fashion trademark. In the fourth quarter of 2022, we again took a $6.8 million impairment charge on the Rochas fashion trademark after an independent expert concluded that the valuation of the trademark was $11.3 million. The new license also contains an option for the licensee to buy-out the Rochas fashion trademarks in June 2025 at its then fair market value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i>Land and Building Acquisition - Headquarters in Paris</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In April 2021, Interparfums SA, our <span id="xdx_90A_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20210430__srt--OwnershipAxis__custom--InterparfumsSAMember_zIvPnytzhCCb" title="Ownership percentage">72</span>% owned French Subsidiary, completed the acquisition of its headquarters at 10 rue de Solférino in the 7th arrondissement of Paris from the property developer. This is an office complex combining three buildings connected by two inner courtyards, and consists of approximately 40,000 total sq. ft.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The purchase price included the complete renovation of the site. As of June 30, 2023, $<span id="xdx_907_eus-gaap--PaymentsToAcquireProductiveAssets_pn5n6_uUSD_c20230101__20230630_zXXowappa7wk" title="Purchase price, period cost">152</span> million of the purchase price, including approximately $<span id="xdx_902_eus-gaap--AcquisitionCosts_pn5n6_c20230101__20230630_zuDYE0JgQ1yg" title="Acquisition costs, period cost">3.1</span> million of acquisition costs, is included in property, equipment and leasehold improvements on the accompanying balance sheet. The purchase price has been allocated approximately $<span id="xdx_90D_eus-gaap--PaymentsToAcquireProductiveAssets_pn5n6_c20230101__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LandMember_zo19DzY49Cxc" title="Purchase price, period cost">62.2</span> million to land and $<span id="xdx_90E_eus-gaap--PaymentsToAcquireProductiveAssets_pn5n6_c20230101__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zXg0WVIslrek" title="Purchase price, period cost">89.6</span> million to the building. The building, which was delivered on February 28, 2022, includes the building structure, development of the property, façade waterproofing, general and technical installations and interior fittings that will be depreciated over a range of <span id="xdx_904_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dxL_c20230630__srt--RangeAxis__srt--MinimumMember_zH25jjhcWfs2" title="Depreciated over a range::XDX::P7Y"><span style="-sec-ix-hidden: xdx2ixbrl0629">7</span></span> to <span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dxL_c20230630__srt--RangeAxis__srt--MaximumMember_zcTaNp9euETc" title="Depreciated over a range::XDX::P50Y"><span style="-sec-ix-hidden: xdx2ixbrl0631">50</span></span> years. The Company has elected to depreciate the building cost based on the useful lives of its components. Approximately $<span id="xdx_909_eus-gaap--EscrowDeposit_iI_pn5n6_c20230630_zJELMXPGdLEk" title="Cash held in escrow is included in other assets">1.2</span> million of cash held in escrow is also included in property, equipment and leasehold improvements on the accompanying balance sheet as of June 30, 2023.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The acquisition was financed by a <span id="xdx_902_eus-gaap--LongTermDebtTerm_iI_dxL_c20230630_zFzcZQwWSMi4" title="Long-term debt, term::XDX::P10Y"><span style="-sec-ix-hidden: xdx2ixbrl0635">10</span></span>-year €<span id="xdx_901_eus-gaap--LineOfCredit_iI_dxL_uUSDEUR_c20230630_zr9BG1pjmjna" title="Long-term line of credit::XDX::120000000"><span style="-sec-ix-hidden: xdx2ixbrl0637">120 million</span></span> (approximately $<span id="xdx_90C_eus-gaap--LineOfCredit_iI_pn5n6_c20230630_z2Pduivyi6Wa" title="Long-term line of credit">130.4</span> million) bank loan which bears interest at <span id="xdx_902_eus-gaap--DebtInstrumentInterestRateTerms_c20230101__20230630_zx6N8qzVlon6" title="Description of debt instrument interest rate terms">one-month Euribor plus 0.75%</span>. Approximately €<span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_dxL_uUSDEUR_c20230630_zlzjCYkY0lbd" title="Debt instrument, face amount::XDX::80000000"><span style="-sec-ix-hidden: xdx2ixbrl0643">80 million</span></span> of the variable rate debt was swapped for variable interest rate debt with a maximum rate of <span id="xdx_901_eus-gaap--DerivativeVariableInterestRate_iI_dp_c20230630_zC9ZjvWZhqHf" title="Variable interest rate">2</span>% per annum. The swap effectively exchanges the variable interest rate to a fixed rate of approximately <span id="xdx_903_eus-gaap--DerivativeFixedInterestRate_iI_dp_c20230630_zqDDwwDG27Ie" title="Fixed interest rate">1.1</span>%.</p> The license became effective in July 2023 and will last for 6.5 years. The license becomes effective in January 2024 and will last for 15 years. we entered into a new license agreement modifying our Rochas fashion business model. The new agreement calls for a reduction in royalties to be received. As a result, in the first quarter of 2021, we took a $2.4 million impairment charge on our Rochas fashion trademark. In the fourth quarter of 2022, we again took a $6.8 million impairment charge on the Rochas fashion trademark after an independent expert concluded that the valuation of the trademark was $11.3 million. The new license also contains an option for the licensee to buy-out the Rochas fashion trademarks in June 2025 at its then fair market value. 0.72 152000000 3100000 62200000 89600000 1200000 130400000 one-month Euribor plus 0.75% 0.02 0.011 <p id="xdx_800_eus-gaap--NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_zrZQFJvFhGb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 0.5in"><b>4.</b></td><td style="padding-right: 0.5in"><b><span style="text-decoration: underline"><span><span id="xdx_82B_zXCDLMFyqQhj">Recent Accounting Pronouncements:</span></span></span></b></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">There are no recent accounting pronouncements issued but not yet adopted that would have a material effect on our consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p> <p id="xdx_80F_eus-gaap--InventoryDisclosureTextBlock_z08QHtOwgVma" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: center"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.5in; text-align: left"><span style="font-variant: small-caps"><b>5.</b></span></td><td style="text-align: justify"><b><span style="text-decoration: underline"><span><span id="xdx_828_zrwxBwL0JCU2">Inventories:</span></span></span></b></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_898_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zcC3mthjIHk9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_8B4_zpMUURpwFXS2">Inventories consist of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="text-align: justify">(In thousands)</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_490_20230630_zuw21Ofdsizl" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2023</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_495_20221231_zbiuwR6EHw5d" style="border-bottom: Black 1pt solid; text-align: center">December 31, 2022</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_405_eus-gaap--InventoryRawMaterials_iI_pn3n3_uUSD_zeHz1gdUPMWb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 63%; text-align: left">Raw materials and component parts</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">173,660</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">146,772</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--InventoryFinishedGoods_iI_pn3n3_uUSD_z7Bbe63Zm4w2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Finished goods</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">186,358</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">143,212</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--InventoryNet_iTI_pn3n3_zipONW49gBub" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"><b style="display: none; visibility: hidden">Inventories</b></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">360,018</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">289,984</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A9_zZnCBCDMB6P9" style="margin-top: 0; margin-bottom: 0"> </p> <p id="xdx_898_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zcC3mthjIHk9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_8B4_zpMUURpwFXS2">Inventories consist of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="text-align: justify">(In thousands)</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_490_20230630_zuw21Ofdsizl" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2023</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_495_20221231_zbiuwR6EHw5d" style="border-bottom: Black 1pt solid; text-align: center">December 31, 2022</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_405_eus-gaap--InventoryRawMaterials_iI_pn3n3_uUSD_zeHz1gdUPMWb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 63%; text-align: left">Raw materials and component parts</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">173,660</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">146,772</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--InventoryFinishedGoods_iI_pn3n3_uUSD_z7Bbe63Zm4w2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Finished goods</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">186,358</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">143,212</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--InventoryNet_iTI_pn3n3_zipONW49gBub" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"><b style="display: none; visibility: hidden">Inventories</b></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">360,018</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">289,984</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 173660000 146772000 186358000 143212000 360018000 289984000 <p id="xdx_800_eus-gaap--FairValueDisclosuresTextBlock_zslQjL4qiZ6" style="margin-top: 0; margin-bottom: 0"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 0.5in"><b>6.</b></td><td><b><span style="text-decoration: underline"><span id="xdx_82A_zEBHTb7gqIG9">Fair Value Measurement:</span></span></b></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> </p> <p id="xdx_897_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_z7jHxxA2w4Tg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8B4_zzAsejuqcp87">The following tables present our financial assets and liabilities that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy. The fair value hierarchy has three levels based on the reliability of the inputs used to determine fair value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_497_20230630__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zkW2ZlHG1Gtj"> </td><td style="padding-bottom: 1pt"> </td><td style="font-weight: normal; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: center"> </td> <td id="xdx_49C_20230630__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z2t5OJNS7ke4" style="border-bottom: Black 1pt solid; font-weight: normal; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: center"> </td> <td id="xdx_497_20230630__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z0Qw54GG1ui7" style="border-bottom: Black 1pt solid; font-weight: normal; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: center"> </td> <td colspan="3" id="xdx_49D_20230630__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zHueJrM3I025" style="border-bottom: Black 1pt solid; font-weight: normal; text-align: center"> </td><td style="padding-bottom: 1pt; font-weight: normal"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><b> </b></td><td style="padding-bottom: 1pt"><b> </b></td> <td colspan="2"><b> </b></td><td style="padding-bottom: 1pt"><b> </b></td><td style="font-weight: normal; padding-bottom: 1pt"><b> </b></td> <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: normal; text-align: center"><b>Fair Value Measurements at June 30, 2023</b></td><td style="padding-bottom: 1pt; font-weight: normal"><b> </b></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-bottom: 1pt"><b> </b></td><td style="font-weight: normal; padding-bottom: 1pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: normal; text-align: right"><b>Total</b></td><td style="font-weight: normal; padding-bottom: 1pt"><b> </b></td><td style="font-weight: normal; padding-bottom: 1pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: normal; text-align: right"><b>Quoted Prices in <br/> Active Markets for <br/> Identical Assets <br/> (Level 1)</b></td><td style="font-weight: normal; padding-bottom: 1pt"><b> </b></td><td style="font-weight: normal; padding-bottom: 1pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: normal; text-align: right"><b>Significant Other <br/> Observable <br/> Inputs <br/> (Level 2)</b></td><td style="font-weight: normal; padding-bottom: 1pt"><b> </b></td><td style="font-weight: normal; padding-bottom: 1pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: normal; text-align: right"><b>Significant <br/> Unobservable <br/> Inputs <br/> (Level 3)</b></td><td style="font-weight: normal; padding-bottom: 1pt"><b> </b></td></tr> <tr id="xdx_402_eus-gaap--AssetsFairValueDisclosureAbstract_iB_zwkIz2oIii0e" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: normal; text-align: left">Assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--InvestmentsFairValueDisclosure_i01I_zRMYbvuSLqw3" style="vertical-align: bottom; background-color: White"> <td style="width: 33%; font-weight: normal; text-align: left; padding-left: 0.125in">Short-term investments</td><td style="width: 1%; font-weight: normal"> </td> <td style="width: 1%; font-weight: normal; text-align: left">$</td><td style="width: 12%; font-weight: normal; text-align: right">112,449</td><td style="width: 1%; font-weight: normal; text-align: left"> </td><td style="width: 1%; font-weight: normal"> </td> <td style="width: 1%; font-weight: normal; text-align: left">$</td><td style="width: 12%; font-weight: normal; text-align: right">2,150</td><td style="width: 1%; font-weight: normal; text-align: left"> </td><td style="width: 1%; font-weight: normal"> </td> <td style="width: 1%; font-weight: normal; text-align: left">$</td><td style="width: 12%; font-weight: normal; text-align: right">109,489</td><td style="width: 1%; font-weight: normal; text-align: left"> </td><td style="width: 1%; font-weight: normal"> </td> <td style="width: 1%; font-weight: normal; text-align: left">$</td><td style="width: 12%; font-weight: normal; text-align: right">811</td><td style="width: 1%; font-weight: normal; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--DerivativeAssets_i01I_zEBFfxLmGMR8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: normal; text-align: left; padding-left: 0.125in">Interest rate swaps</td><td style="font-weight: normal"> </td> <td style="font-weight: normal; text-align: left"> </td><td style="font-weight: normal; text-align: right">6,780</td><td style="font-weight: normal; text-align: left"> </td><td style="font-weight: normal"> </td> <td style="font-weight: normal; text-align: left"> </td><td style="font-weight: normal; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0679">—</span></td><td style="font-weight: normal; text-align: left"> </td><td style="font-weight: normal"> </td> <td style="font-weight: normal; text-align: left"> </td><td style="font-weight: normal; text-align: right">6,780</td><td style="font-weight: normal; text-align: left"> </td><td style="font-weight: normal"> </td> <td style="font-weight: normal; text-align: left"> </td><td style="font-weight: normal; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0681">—</span></td><td style="font-weight: normal; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--ForeignCurrencyFairValueHedgeAssetAtFairValue_i01I_z2uiNeJOmxY" style="vertical-align: bottom; background-color: White"> <td style="font-weight: normal; text-align: left; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in">Foreign currency forward exchange contracts not accounted for using hedge accounting</td><td style="font-weight: normal; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: right">165</td><td style="padding-bottom: 1pt; font-weight: normal; text-align: left"> </td><td style="font-weight: normal; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0684">—</span></td><td style="padding-bottom: 1pt; font-weight: normal; text-align: left"> </td><td style="font-weight: normal; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: right">165</td><td style="padding-bottom: 1pt; font-weight: normal; text-align: left"> </td><td style="font-weight: normal; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0686">—</span></td><td style="padding-bottom: 1pt; font-weight: normal; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--AssetsFairValueDisclosure_i01I_zX1xpBn9fbLh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt"><b style="display: none; visibility: hidden">Total asset</b></td><td style="font-weight: normal; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; text-align: right">119,394</td><td style="padding-bottom: 2.5pt; font-weight: normal; text-align: left"> </td><td style="font-weight: normal; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; text-align: right">2,150</td><td style="padding-bottom: 2.5pt; font-weight: normal; text-align: left"> </td><td style="font-weight: normal; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; text-align: right">116,434</td><td style="padding-bottom: 2.5pt; font-weight: normal; text-align: left"> </td><td style="font-weight: normal; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; text-align: right">811</td><td style="padding-bottom: 2.5pt; font-weight: normal; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--LiabilitiesAbstract_iB_zuZZg9EgwpT" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: normal; text-align: left">Liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--ForeignCurrencyFairValueHedgeLiabilityAtFairValue_i01I_zVaxeBabePE8" style="vertical-align: bottom; background-color: White"> <td style="font-weight: normal; text-align: left; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in">Foreign currency forward exchange contracts accounted for using hedge accounting</td><td style="font-weight: normal; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: right">9</td><td style="padding-bottom: 1pt; font-weight: normal; text-align: left"> </td><td style="font-weight: normal; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0699">—</span></td><td style="padding-bottom: 1pt; font-weight: normal; text-align: left"> </td><td style="font-weight: normal; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: right">9</td><td style="padding-bottom: 1pt; font-weight: normal; text-align: left"> </td><td style="font-weight: normal; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0701">—</span></td><td style="padding-bottom: 1pt; font-weight: normal; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_492_20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zrdayt36AUkf"> </td><td style="padding-bottom: 1pt"> </td><td style="font-weight: normal; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: center"> </td> <td id="xdx_496_20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zWMQqFhOmYh4" style="border-bottom: Black 1pt solid; font-weight: normal; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: center"> </td> <td id="xdx_49A_20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zzx0Om9S2UG4" style="border-bottom: Black 1pt solid; font-weight: normal; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: center"> </td> <td colspan="2" id="xdx_49C_20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zlNtFLy0f02h" style="border-bottom: Black 1pt solid; font-weight: normal; text-align: center"> </td><td style="padding-bottom: 1pt; font-weight: normal"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><b> </b></td><td style="padding-bottom: 1pt"><b> </b></td> <td colspan="2"><b> </b></td><td style="padding-bottom: 1pt"><b> </b></td><td style="font-weight: normal; padding-bottom: 1pt"><b> </b></td> <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: normal; text-align: center"><b>Fair Value Measurements at December 31, 2022</b></td><td style="padding-bottom: 1pt; font-weight: normal"><b> </b></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-bottom: 1pt"><b> </b></td><td style="font-weight: normal; padding-bottom: 1pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: normal; text-align: right"><b>Total</b></td><td style="font-weight: normal; padding-bottom: 1pt"><b> </b></td><td style="font-weight: normal; padding-bottom: 1pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: normal; text-align: right"><b>Quoted Prices in <br/> Active Markets for <br/> Identical Assets <br/> (Level 1)</b></td><td style="font-weight: normal; padding-bottom: 1pt"><b> </b></td><td style="font-weight: normal; padding-bottom: 1pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: normal; text-align: right"><b>Significant Other <br/> Observable <br/> Inputs <br/> (Level 2)</b></td><td style="font-weight: normal; padding-bottom: 1pt"><b> </b></td><td style="font-weight: normal; padding-bottom: 1pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: normal; text-align: right"><b>Significant <br/> Unobservable <br/> Inputs <br/> (Level 3)</b></td><td style="font-weight: normal; padding-bottom: 1pt"><b> </b></td></tr> <tr id="xdx_406_eus-gaap--AssetsFairValueDisclosureAbstract_iB_zFKqKSYB61D3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: normal; text-align: left; padding-left: 0.125in; text-indent: -0.125in">Assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--InvestmentsFairValueDisclosure_i01I_zjHfbUwxAhDc" style="vertical-align: bottom; background-color: White"> <td style="width: 33%; font-weight: normal; text-align: left; padding-left: 0.25in; text-indent: -0.125in">Short-term investments</td><td style="width: 1%; font-weight: normal"> </td> <td style="width: 1%; font-weight: normal; text-align: left">$</td><td style="width: 12%; font-weight: normal; text-align: right">150,833</td><td style="width: 1%; font-weight: normal; text-align: left"> </td><td style="width: 1%; font-weight: normal"> </td> <td style="width: 1%; font-weight: normal; text-align: left">$</td><td style="width: 12%; font-weight: normal; text-align: right">19,861</td><td style="width: 1%; font-weight: normal; text-align: left"> </td><td style="width: 1%; font-weight: normal"> </td> <td style="width: 1%; font-weight: normal; text-align: left">$</td><td style="width: 12%; font-weight: normal; text-align: right">130,174</td><td style="width: 1%; font-weight: normal; text-align: left"> </td><td style="width: 1%; font-weight: normal"> </td> <td style="width: 1%; font-weight: normal; text-align: left">$</td><td style="width: 12%; font-weight: normal; text-align: right">798</td><td style="width: 1%; font-weight: normal; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--DerivativeAssets_iI_zMDujPGB4te7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: normal; text-align: left; padding-left: 0.25in; text-indent: -0.125in">Interest rate swaps</td><td style="font-weight: normal"> </td> <td style="font-weight: normal; text-align: left"> </td><td style="font-weight: normal; text-align: right">6,758</td><td style="font-weight: normal; text-align: left"> </td><td style="font-weight: normal"> </td> <td style="font-weight: normal; text-align: left"> </td><td style="font-weight: normal; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0718">—</span></td><td style="font-weight: normal; text-align: left"> </td><td style="font-weight: normal"> </td> <td style="font-weight: normal; text-align: left"> </td><td style="font-weight: normal; text-align: right">6,758</td><td style="font-weight: normal; text-align: left"> </td><td style="font-weight: normal"> </td> <td style="font-weight: normal; text-align: left"> </td><td style="font-weight: normal; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0720">—</span></td><td style="font-weight: normal; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--ForeignCurrencyFairValueHedgeAssetAtFairValue_i01I_z2rXeA4YbPj1" style="vertical-align: bottom; background-color: White"> <td style="font-weight: normal; text-align: left; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in">Foreign currency forward exchange contracts accounted for using hedge accounting</td><td style="font-weight: normal; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: right">1,189</td><td style="padding-bottom: 1pt; font-weight: normal; text-align: left"> </td><td style="font-weight: normal; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0723">—</span></td><td style="padding-bottom: 1pt; font-weight: normal; text-align: left"> </td><td style="font-weight: normal; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: right">1,189</td><td style="padding-bottom: 1pt; font-weight: normal; text-align: left"> </td><td style="font-weight: normal; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0725">—</span></td><td style="padding-bottom: 1pt; font-weight: normal; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--AssetsFairValueDisclosure_iI_zdgXuNB7qx2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0.125in; text-indent: -0.125in"><b style="display: none; visibility: hidden">Total asset</b></td><td style="font-weight: normal; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; text-align: right">158,780</td><td style="padding-bottom: 2.5pt; font-weight: normal; text-align: left"> </td><td style="font-weight: normal; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; text-align: right">19,861</td><td style="padding-bottom: 2.5pt; font-weight: normal; text-align: left"> </td><td style="font-weight: normal; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; text-align: right">138,121</td><td style="padding-bottom: 2.5pt; font-weight: normal; text-align: left"> </td><td style="font-weight: normal; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; text-align: right">798</td><td style="padding-bottom: 2.5pt; font-weight: normal; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--LiabilitiesAbstract_iB_zz1GfrIWguKd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: normal; text-align: left; padding-left: 0.125in; text-indent: -0.125in">Liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--ForeignCurrencyFairValueHedgeLiabilityAtFairValue_i01I_zOL4h87ftaJl" style="vertical-align: bottom; background-color: White"> <td style="font-weight: normal; text-align: left; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Foreign currency forward exchange contracts not accounted for using hedge accounting</td><td style="font-weight: normal; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: right">68</td><td style="font-weight: normal; text-align: left; padding-bottom: 1pt"> </td><td style="font-weight: normal; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0738">—</span></td><td style="font-weight: normal; text-align: left; padding-bottom: 1pt"> </td><td style="font-weight: normal; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: right">68</td><td style="font-weight: normal; text-align: left; padding-bottom: 1pt"> </td><td style="font-weight: normal; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0740">—</span></td><td style="font-weight: normal; text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--LiabilitiesFairValueDisclosure_i01I_zcQFJnHHSu87" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt"><b style="display: none; visibility: hidden">Total Liabilities</b></td><td style="font-weight: normal; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; text-align: right">68</td><td style="font-weight: normal; text-align: left; padding-bottom: 2.5pt"> </td><td style="font-weight: normal; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0743">—</span></td><td style="font-weight: normal; text-align: left; padding-bottom: 2.5pt"> </td><td style="font-weight: normal; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; text-align: right">68</td><td style="font-weight: normal; text-align: left; padding-bottom: 2.5pt"> </td><td style="font-weight: normal; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0745">—</span></td><td style="font-weight: normal; text-align: left; padding-bottom: 2.5pt"> </td></tr> </table> <p id="xdx_8A3_zpzuVg5mv7ob" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The carrying amount of cash and cash equivalents including money market funds, short-term investments, accounts receivable, other receivables, cash held in escrow, accounts payable and accrued expenses approximate fair value due to the short terms to maturity of these instruments.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The carrying amount of loans payable approximates fair value as the interest rates on the Company’s indebtedness approximate current market rates. The fair value of the Company’s long-term debt was estimated based on the current rates offered to companies for debt with the same remaining maturities and is approximately equal to its carrying value.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Foreign currency forward exchange contracts are valued based on quotations from financial institutions and the value of interest rate swaps is the discounted net present value of the swaps using third party quotes from financial institutions.</p> <p id="xdx_897_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_z7jHxxA2w4Tg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8B4_zzAsejuqcp87">The following tables present our financial assets and liabilities that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy. The fair value hierarchy has three levels based on the reliability of the inputs used to determine fair value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_497_20230630__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zkW2ZlHG1Gtj"> </td><td style="padding-bottom: 1pt"> </td><td style="font-weight: normal; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: center"> </td> <td id="xdx_49C_20230630__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z2t5OJNS7ke4" style="border-bottom: Black 1pt solid; font-weight: normal; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: center"> </td> <td id="xdx_497_20230630__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z0Qw54GG1ui7" style="border-bottom: Black 1pt solid; font-weight: normal; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: center"> </td> <td colspan="3" id="xdx_49D_20230630__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zHueJrM3I025" style="border-bottom: Black 1pt solid; font-weight: normal; text-align: center"> </td><td style="padding-bottom: 1pt; font-weight: normal"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><b> </b></td><td style="padding-bottom: 1pt"><b> </b></td> <td colspan="2"><b> </b></td><td style="padding-bottom: 1pt"><b> </b></td><td style="font-weight: normal; padding-bottom: 1pt"><b> </b></td> <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: normal; text-align: center"><b>Fair Value Measurements at June 30, 2023</b></td><td style="padding-bottom: 1pt; font-weight: normal"><b> </b></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-bottom: 1pt"><b> </b></td><td style="font-weight: normal; padding-bottom: 1pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: normal; text-align: right"><b>Total</b></td><td style="font-weight: normal; padding-bottom: 1pt"><b> </b></td><td style="font-weight: normal; padding-bottom: 1pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: normal; text-align: right"><b>Quoted Prices in <br/> Active Markets for <br/> Identical Assets <br/> (Level 1)</b></td><td style="font-weight: normal; padding-bottom: 1pt"><b> </b></td><td style="font-weight: normal; padding-bottom: 1pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: normal; text-align: right"><b>Significant Other <br/> Observable <br/> Inputs <br/> (Level 2)</b></td><td style="font-weight: normal; padding-bottom: 1pt"><b> </b></td><td style="font-weight: normal; padding-bottom: 1pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: normal; text-align: right"><b>Significant <br/> Unobservable <br/> Inputs <br/> (Level 3)</b></td><td style="font-weight: normal; padding-bottom: 1pt"><b> </b></td></tr> <tr id="xdx_402_eus-gaap--AssetsFairValueDisclosureAbstract_iB_zwkIz2oIii0e" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: normal; text-align: left">Assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--InvestmentsFairValueDisclosure_i01I_zRMYbvuSLqw3" style="vertical-align: bottom; background-color: White"> <td style="width: 33%; font-weight: normal; text-align: left; padding-left: 0.125in">Short-term investments</td><td style="width: 1%; font-weight: normal"> </td> <td style="width: 1%; font-weight: normal; text-align: left">$</td><td style="width: 12%; font-weight: normal; text-align: right">112,449</td><td style="width: 1%; font-weight: normal; text-align: left"> </td><td style="width: 1%; font-weight: normal"> </td> <td style="width: 1%; font-weight: normal; text-align: left">$</td><td style="width: 12%; font-weight: normal; text-align: right">2,150</td><td style="width: 1%; font-weight: normal; text-align: left"> </td><td style="width: 1%; font-weight: normal"> </td> <td style="width: 1%; font-weight: normal; text-align: left">$</td><td style="width: 12%; font-weight: normal; text-align: right">109,489</td><td style="width: 1%; font-weight: normal; text-align: left"> </td><td style="width: 1%; font-weight: normal"> </td> <td style="width: 1%; font-weight: normal; text-align: left">$</td><td style="width: 12%; font-weight: normal; text-align: right">811</td><td style="width: 1%; font-weight: normal; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--DerivativeAssets_i01I_zEBFfxLmGMR8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: normal; text-align: left; padding-left: 0.125in">Interest rate swaps</td><td style="font-weight: normal"> </td> <td style="font-weight: normal; text-align: left"> </td><td style="font-weight: normal; text-align: right">6,780</td><td style="font-weight: normal; text-align: left"> </td><td style="font-weight: normal"> </td> <td style="font-weight: normal; text-align: left"> </td><td style="font-weight: normal; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0679">—</span></td><td style="font-weight: normal; text-align: left"> </td><td style="font-weight: normal"> </td> <td style="font-weight: normal; text-align: left"> </td><td style="font-weight: normal; text-align: right">6,780</td><td style="font-weight: normal; text-align: left"> </td><td style="font-weight: normal"> </td> <td style="font-weight: normal; text-align: left"> </td><td style="font-weight: normal; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0681">—</span></td><td style="font-weight: normal; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--ForeignCurrencyFairValueHedgeAssetAtFairValue_i01I_z2uiNeJOmxY" style="vertical-align: bottom; background-color: White"> <td style="font-weight: normal; text-align: left; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in">Foreign currency forward exchange contracts not accounted for using hedge accounting</td><td style="font-weight: normal; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: right">165</td><td style="padding-bottom: 1pt; font-weight: normal; text-align: left"> </td><td style="font-weight: normal; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0684">—</span></td><td style="padding-bottom: 1pt; font-weight: normal; text-align: left"> </td><td style="font-weight: normal; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: right">165</td><td style="padding-bottom: 1pt; font-weight: normal; text-align: left"> </td><td style="font-weight: normal; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0686">—</span></td><td style="padding-bottom: 1pt; font-weight: normal; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--AssetsFairValueDisclosure_i01I_zX1xpBn9fbLh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt"><b style="display: none; visibility: hidden">Total asset</b></td><td style="font-weight: normal; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; text-align: right">119,394</td><td style="padding-bottom: 2.5pt; font-weight: normal; text-align: left"> </td><td style="font-weight: normal; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; text-align: right">2,150</td><td style="padding-bottom: 2.5pt; font-weight: normal; text-align: left"> </td><td style="font-weight: normal; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; text-align: right">116,434</td><td style="padding-bottom: 2.5pt; font-weight: normal; text-align: left"> </td><td style="font-weight: normal; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; text-align: right">811</td><td style="padding-bottom: 2.5pt; font-weight: normal; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--LiabilitiesAbstract_iB_zuZZg9EgwpT" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: normal; text-align: left">Liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--ForeignCurrencyFairValueHedgeLiabilityAtFairValue_i01I_zVaxeBabePE8" style="vertical-align: bottom; background-color: White"> <td style="font-weight: normal; text-align: left; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in">Foreign currency forward exchange contracts accounted for using hedge accounting</td><td style="font-weight: normal; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: right">9</td><td style="padding-bottom: 1pt; font-weight: normal; text-align: left"> </td><td style="font-weight: normal; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0699">—</span></td><td style="padding-bottom: 1pt; font-weight: normal; text-align: left"> </td><td style="font-weight: normal; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: right">9</td><td style="padding-bottom: 1pt; font-weight: normal; text-align: left"> </td><td style="font-weight: normal; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0701">—</span></td><td style="padding-bottom: 1pt; font-weight: normal; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_492_20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zrdayt36AUkf"> </td><td style="padding-bottom: 1pt"> </td><td style="font-weight: normal; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: center"> </td> <td id="xdx_496_20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zWMQqFhOmYh4" style="border-bottom: Black 1pt solid; font-weight: normal; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: center"> </td> <td id="xdx_49A_20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zzx0Om9S2UG4" style="border-bottom: Black 1pt solid; font-weight: normal; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: center"> </td> <td colspan="2" id="xdx_49C_20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zlNtFLy0f02h" style="border-bottom: Black 1pt solid; font-weight: normal; text-align: center"> </td><td style="padding-bottom: 1pt; font-weight: normal"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><b> </b></td><td style="padding-bottom: 1pt"><b> </b></td> <td colspan="2"><b> </b></td><td style="padding-bottom: 1pt"><b> </b></td><td style="font-weight: normal; padding-bottom: 1pt"><b> </b></td> <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: normal; text-align: center"><b>Fair Value Measurements at December 31, 2022</b></td><td style="padding-bottom: 1pt; font-weight: normal"><b> </b></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-bottom: 1pt"><b> </b></td><td style="font-weight: normal; padding-bottom: 1pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: normal; text-align: right"><b>Total</b></td><td style="font-weight: normal; padding-bottom: 1pt"><b> </b></td><td style="font-weight: normal; padding-bottom: 1pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: normal; text-align: right"><b>Quoted Prices in <br/> Active Markets for <br/> Identical Assets <br/> (Level 1)</b></td><td style="font-weight: normal; padding-bottom: 1pt"><b> </b></td><td style="font-weight: normal; padding-bottom: 1pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: normal; text-align: right"><b>Significant Other <br/> Observable <br/> Inputs <br/> (Level 2)</b></td><td style="font-weight: normal; padding-bottom: 1pt"><b> </b></td><td style="font-weight: normal; padding-bottom: 1pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: normal; text-align: right"><b>Significant <br/> Unobservable <br/> Inputs <br/> (Level 3)</b></td><td style="font-weight: normal; padding-bottom: 1pt"><b> </b></td></tr> <tr id="xdx_406_eus-gaap--AssetsFairValueDisclosureAbstract_iB_zFKqKSYB61D3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: normal; text-align: left; padding-left: 0.125in; text-indent: -0.125in">Assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--InvestmentsFairValueDisclosure_i01I_zjHfbUwxAhDc" style="vertical-align: bottom; background-color: White"> <td style="width: 33%; font-weight: normal; text-align: left; padding-left: 0.25in; text-indent: -0.125in">Short-term investments</td><td style="width: 1%; font-weight: normal"> </td> <td style="width: 1%; font-weight: normal; text-align: left">$</td><td style="width: 12%; font-weight: normal; text-align: right">150,833</td><td style="width: 1%; font-weight: normal; text-align: left"> </td><td style="width: 1%; font-weight: normal"> </td> <td style="width: 1%; font-weight: normal; text-align: left">$</td><td style="width: 12%; font-weight: normal; text-align: right">19,861</td><td style="width: 1%; font-weight: normal; text-align: left"> </td><td style="width: 1%; font-weight: normal"> </td> <td style="width: 1%; font-weight: normal; text-align: left">$</td><td style="width: 12%; font-weight: normal; text-align: right">130,174</td><td style="width: 1%; font-weight: normal; text-align: left"> </td><td style="width: 1%; font-weight: normal"> </td> <td style="width: 1%; font-weight: normal; text-align: left">$</td><td style="width: 12%; font-weight: normal; text-align: right">798</td><td style="width: 1%; font-weight: normal; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--DerivativeAssets_iI_zMDujPGB4te7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: normal; text-align: left; padding-left: 0.25in; text-indent: -0.125in">Interest rate swaps</td><td style="font-weight: normal"> </td> <td style="font-weight: normal; text-align: left"> </td><td style="font-weight: normal; text-align: right">6,758</td><td style="font-weight: normal; text-align: left"> </td><td style="font-weight: normal"> </td> <td style="font-weight: normal; text-align: left"> </td><td style="font-weight: normal; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0718">—</span></td><td style="font-weight: normal; text-align: left"> </td><td style="font-weight: normal"> </td> <td style="font-weight: normal; text-align: left"> </td><td style="font-weight: normal; text-align: right">6,758</td><td style="font-weight: normal; text-align: left"> </td><td style="font-weight: normal"> </td> <td style="font-weight: normal; text-align: left"> </td><td style="font-weight: normal; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0720">—</span></td><td style="font-weight: normal; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--ForeignCurrencyFairValueHedgeAssetAtFairValue_i01I_z2rXeA4YbPj1" style="vertical-align: bottom; background-color: White"> <td style="font-weight: normal; text-align: left; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in">Foreign currency forward exchange contracts accounted for using hedge accounting</td><td style="font-weight: normal; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: right">1,189</td><td style="padding-bottom: 1pt; font-weight: normal; text-align: left"> </td><td style="font-weight: normal; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0723">—</span></td><td style="padding-bottom: 1pt; font-weight: normal; text-align: left"> </td><td style="font-weight: normal; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: right">1,189</td><td style="padding-bottom: 1pt; font-weight: normal; text-align: left"> </td><td style="font-weight: normal; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0725">—</span></td><td style="padding-bottom: 1pt; font-weight: normal; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--AssetsFairValueDisclosure_iI_zdgXuNB7qx2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0.125in; text-indent: -0.125in"><b style="display: none; visibility: hidden">Total asset</b></td><td style="font-weight: normal; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; text-align: right">158,780</td><td style="padding-bottom: 2.5pt; font-weight: normal; text-align: left"> </td><td style="font-weight: normal; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; text-align: right">19,861</td><td style="padding-bottom: 2.5pt; font-weight: normal; text-align: left"> </td><td style="font-weight: normal; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; text-align: right">138,121</td><td style="padding-bottom: 2.5pt; font-weight: normal; text-align: left"> </td><td style="font-weight: normal; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; text-align: right">798</td><td style="padding-bottom: 2.5pt; font-weight: normal; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--LiabilitiesAbstract_iB_zz1GfrIWguKd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: normal; text-align: left; padding-left: 0.125in; text-indent: -0.125in">Liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--ForeignCurrencyFairValueHedgeLiabilityAtFairValue_i01I_zOL4h87ftaJl" style="vertical-align: bottom; background-color: White"> <td style="font-weight: normal; text-align: left; padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1pt">Foreign currency forward exchange contracts not accounted for using hedge accounting</td><td style="font-weight: normal; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: right">68</td><td style="font-weight: normal; text-align: left; padding-bottom: 1pt"> </td><td style="font-weight: normal; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0738">—</span></td><td style="font-weight: normal; text-align: left; padding-bottom: 1pt"> </td><td style="font-weight: normal; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: right">68</td><td style="font-weight: normal; text-align: left; padding-bottom: 1pt"> </td><td style="font-weight: normal; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0740">—</span></td><td style="font-weight: normal; text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--LiabilitiesFairValueDisclosure_i01I_zcQFJnHHSu87" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt"><b style="display: none; visibility: hidden">Total Liabilities</b></td><td style="font-weight: normal; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; text-align: right">68</td><td style="font-weight: normal; text-align: left; padding-bottom: 2.5pt"> </td><td style="font-weight: normal; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0743">—</span></td><td style="font-weight: normal; text-align: left; padding-bottom: 2.5pt"> </td><td style="font-weight: normal; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; text-align: right">68</td><td style="font-weight: normal; text-align: left; padding-bottom: 2.5pt"> </td><td style="font-weight: normal; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0745">—</span></td><td style="font-weight: normal; text-align: left; padding-bottom: 2.5pt"> </td></tr> </table> 112449000 2150000 109489000 811000 6780000 6780000 165000 165000 119394000 2150000 116434000 811000 9000 9000 150833000 19861000 130174000 798000 6758000 6758000 1189000 1189000 158780000 19861000 138121000 798000 68000 68000 68000 68000 <p id="xdx_800_eus-gaap--DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_zzcaU45eQPv2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 0.5in"><b>7.</b></td><td style="text-align: justify"><b><span style="text-decoration: underline"><span id="xdx_82A_zmcstLCYCHr9">Derivative Financial Instruments:</span></span></b></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company enters into foreign currency forward exchange contracts to hedge exposure related to receivables denominated in a foreign currency and occasionally to manage risks related to future sales expected to be denominated in a foreign currency. Before entering into a derivative transaction for hedging purposes, it is determined that a high degree of initial effectiveness exists between the change in value of the hedged item and the change in the value of the derivative instrument from movement in exchange rates. High effectiveness means that the change in the cash flows of the derivative instrument will effectively offset the change in the cash flows of the hedged item. The effectiveness of each hedged item is measured throughout the hedged period and is based on the dollar offset methodology and excludes the portion of the fair value of the foreign currency forward exchange contract attributable to the change in spot-forward difference which is reported in current period earnings. Any hedge ineffectiveness is also recognized as a gain or loss on foreign currency in the income statement. For hedge contracts that are no longer deemed highly effective, hedge accounting is discontinued, and gains and losses accumulated in other comprehensive income are reclassified to earnings. If it is probable that the forecasted transaction will no longer occur, then any gains or losses accumulated in other comprehensive income are reclassified to current-period earnings.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In December 2022, to finance the acquisition of the Lacoste trademark, the Company entered into a €<span id="xdx_90B_eus-gaap--DerivativeNotionalAmount_iI_pn6n6_uUSDEUR_c20221231__srt--CurrencyAxis__currency--EUR_zGbuAu6mDZCe" title="Loan amount">50</span> million (approximately $<span id="xdx_90B_eus-gaap--DerivativeNotionalAmount_iI_dm_uUSD_c20221231_zDWbR8fkynE2" title="Loan amount">54.3 million</span>) <span id="xdx_90D_eus-gaap--LongTermDebtTerm_iI_dxL_c20221231_z9mQTMIbZF19" title="Long-term debt, term::XDX::P4Y"><span style="-sec-ix-hidden: xdx2ixbrl0757">4</span></span>-year term loan with a variable interest rate. This variable rate debt was swapped for variable interest rate debt with a maximum rate of <span id="xdx_90F_eus-gaap--DerivativeSwaptionInterestRate_iI_dp_c20221231_zGxWLJcBSP9" title="Derivative swap interest rate">2</span>% per annum. This swap is a hedged derivative instrument and is therefore recorded at fair value and changes in fair value are reflected in other comprehensive income.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In connection with the April 2021 acquisition of the office building complex in Paris, €<span id="xdx_904_eus-gaap--DerivativeNotionalAmount_iI_pn6n6_uUSDEUR_c20210430__srt--CurrencyAxis__currency--EUR_ze1Ia969r9Bl" title="Loan amount">120</span> million (approximately $<span id="xdx_901_eus-gaap--DerivativeNotionalAmount_iI_pn5n6_c20210430_zAsVC5fnAupd" title="Loan amount">130.4</span> million) of the purchase price was financed through a <span id="xdx_902_eus-gaap--LongTermDebtTerm_iI_dxL_c20210430_z3wH8InIeDva" title="Long-term debt, term::XDX::P10Y"><span style="-sec-ix-hidden: xdx2ixbrl0765">10</span></span>-year term loan. The Company entered into interest rate swap contracts related to €<span id="xdx_90D_eus-gaap--DerivativeNotionalAmount_iI_pn6n6_uUSDEUR_c20210430__srt--CurrencyAxis__currency--EUR__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--InterestRateSwapMember_z3ZqaNyc9Zaj" title="Loan amount">80</span> million of the loan, effectively exchanging the variable interest rate to a fixed rate of approximately <span id="xdx_90F_eus-gaap--DerivativeSwaptionInterestRate_iI_pid_dp_uPure_c20210430_zOcp7ttx54g4" title="Derivative swap interest rate">1.1</span>%. This derivative instrument is recorded at fair value and changes in fair value are reflected in the accompanying consolidated statements of income.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Gains and losses in derivatives designated as hedges are accumulated in other comprehensive income and gains and losses in derivatives not designated as hedges are included in (gain) loss on foreign currency on the accompanying income statements. Such gains and losses were immaterial for the three and six months ended June 30, 2023 and 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">All derivative instruments are reported as either assets or liabilities on the balance sheet measured at fair value. The valuation of interest rate swaps is included in other assets on the accompanying balance sheets. The valuation of foreign currency forward exchange contracts at June 30, 2023 resulted in a net asset and is included in other current assets on the accompanying balance sheet.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">At June 30, 2023, we had foreign currency contracts in the form of forward exchange contracts in the amount of approximately U.S. $<span id="xdx_90B_eus-gaap--ForeignCurrencyContractsLiabilityFairValueDisclosure_iI_pn6n6_c20230630__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--ForeignExchangeContractMember_zAcO4CQdXiOl" title="Forward exchange contracts">38.0</span> million and GB £<span id="xdx_90D_eus-gaap--DerivativeNotionalAmount_iI_pn6n6_uUSDGBP_c20221231__srt--CurrencyAxis__currency--GBP__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--ForeignExchangeContractMember_zhbEplcWyN2f" title="Loan amount">2</span>.0 million which all have maturities of less than <span id="xdx_907_eus-gaap--MaximumRemainingMaturityOfForeignCurrencyDerivatives1_dxL_c20230101__20230630__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--ForeignExchangeContractMember_zXha06kRK1nl" title="Maturity of foreign currency::XDX::P1Y"><span style="-sec-ix-hidden: xdx2ixbrl0775">one</span></span> year.</p> 50000000 54300000 0.02 120000000 130400000 80000000 0.011 38000000.0 2000000 <p id="xdx_80C_eus-gaap--LesseeOperatingLeasesTextBlock_zgQqRV8u0h3g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.5in; text-align: left"><b>8.</b></td><td style="text-align: justify"><b><span style="text-decoration: underline"><span id="xdx_820_zqyVOpgWBqph">Leases:</span></span></b></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company leases its offices and warehouses, vehicles, and certain office equipment, substantially all of which are classified as operating leases. The Company currently has no material financing leases. The Company determines if an arrangement is a lease at inception. Operating lease assets and obligations are recognized at the lease commencement date based on the present value of lease payments over the lease term.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In determining lease asset value, the Company considers fixed or variable payment terms, prepayments, incentives, and options to extend or terminate, depending on the lease. Renewal, termination, or purchase options affect the lease term used for determining lease asset value only if the option is reasonably certain to be exercised. The Company generally uses its incremental borrowing rate based on information available at the lease commencement date for the location in which the lease is held in determining the present value of lease payments.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">As of June 30, 2023, the weighted average remaining lease term was <span id="xdx_90B_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dxL_c20230630_zCn44D05B31g" title="Operating lease, weighted average remaining lease term::XDX::P5Y7M6D"><span style="-sec-ix-hidden: xdx2ixbrl0783">5.6</span></span> years and the weighted average discount rate used to determine the operating lease liability was <span id="xdx_90F_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20230630_zWXPVDuiMs7b" title="Operating lease, weighted average discount rate, percent">2.8</span>%. Rental expense related to operating leases was $<span id="xdx_905_eus-gaap--RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_dm_c20230401__20230630_z0698UuCabak" title="Operating leases, rent expense, net">1.5 million</span> and $<span id="xdx_90E_eus-gaap--RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_dm_c20230101__20230630_z23tK884SNi8" title="Operating leases, rent expense, net">2.9 million</span> for the three and six months ended June 30, 2023, respectively, as compared to $<span id="xdx_90C_eus-gaap--RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_pn5n6_c20220101__20221231_zAqeisLrgy9a" title="Operating leases, rent expense, net">1.3</span> million and $<span id="xdx_905_eus-gaap--RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_pn5n6_c20210101__20211231_zXyKFLisF32" title="Operating leases, rent expense, net">3.1</span> million for the corresponding periods of the prior year. Operating lease payments included in operating cash flows totaled $<span id="xdx_905_eus-gaap--OperatingLeasePayments_dm_c20230101__20230630_zo0nVdNZjYM" title="Operating lease, payments">2.6 million</span> and $<span id="xdx_90D_eus-gaap--OperatingLeasePayments_dm_c20220101__20220630_zqS2s9L7qav6" title="Operating lease, payments">2.8 million</span> for the six months ended June 30, 2023 and 2022, respectively, and noncash additions to operating lease assets totaled $<span id="xdx_905_eus-gaap--OperatingLeaseCost_pn5n6_c20230101__20230630_zuvRIdDloc5a" title="Noncash additions to operating lease assets">2.4</span> million and $<span id="xdx_90D_eus-gaap--OperatingLeaseCost_pn5n6_c20220101__20220630_z9ACG2UTwK93" title="Noncash additions to operating lease assets">0.5</span> million for the six months ended June 30, 2023 and 2022, respectively.</p> 0.028 1500000 2900000 1300000 3100000 2600000 2800000 2400000 500000 <p id="xdx_80E_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zb7mL3ASJZZ2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.5in; text-align: left"><b>9.</b></td><td style="text-align: justify"><b><span style="text-decoration: underline"><span id="xdx_823_zxZGJs4IFK06">Share-Based Payments:</span></span></b></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company maintains a stock option program for key employees, executives and directors. The plans, all of which have been approved by shareholder vote, provide for the granting of both nonqualified and incentive options. Options granted under the plans typically have a six-year term and vest over a <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dtxL_c20230101__20230630__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember__srt--RangeAxis__srt--MinimumMember_zn5MKJp3GRk9" title="Options vesting period::XDX::P4Y"><span style="-sec-ix-hidden: xdx2ixbrl0805">four</span></span> to <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dtxL_c20230101__20230630__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember__srt--RangeAxis__srt--MaximumMember_zRuMu6emLZyh" title="Options vesting period::XDX::P5Y"><span style="-sec-ix-hidden: xdx2ixbrl0807">five</span></span>-year period. The fair value of shares vested during the six months ended June 30, 2023 and 2022 aggregated $<span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_pn5n6_c20230101__20230630__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zzprESIsQ0c4" title="Fair value of shares vested">0.10</span> million and $<span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_pn5n6_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zpnj8pN0LXp4">0.10</span> million, respectively. Compensation cost, net of forfeitures, is recognized on a straight-line basis over the requisite service period for the entire award. Forfeitures are estimated based on historic trends. It is generally our policy to issue new shares upon exercise of stock options.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p id="xdx_894_eus-gaap--ScheduleOfNonvestedShareActivityTableTextBlock_zTvxNIJFbmY5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8B0_zY5JXPsATwPa">The following table sets forth information with respect to nonvested options for the six months ended June 30, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Number of Shares</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted Average Grant-Date Fair Value</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 63%; text-align: left">Nonvested options – beginning of period</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_pid_uShares_c20230101__20230630_zCSOwhiHm7E8" style="width: 12%; text-align: right" title="Nonvested options beginning of period">168,730</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20230101__20230630_znp6UpQl6a5h" style="width: 12%; text-align: right" title="Weighted average grant date fair value, beginning of year">16.31</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Nonvested options granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20230101__20230630_zyC6zihXQFk3" style="text-align: right" title="Nonvested options granted"><span style="-sec-ix-hidden: xdx2ixbrl0818">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20230101__20230630_zHvEXidBzFx9" style="text-align: right" title="Weighted average grant date fair value, nonvested options granted"><span style="-sec-ix-hidden: xdx2ixbrl0820">—</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Nonvested options vested or forfeited</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_iN_pid_di_uShares_c20230101__20230630_zre2lBoXIni3" style="border-bottom: Black 1pt solid; text-align: right" title="Nonvested options vested or forfeited">(23,560</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left">$</td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_pid_c20230101__20230630_z7b5dpvqmkid" style="padding-bottom: 1pt; text-align: right" title="Weighted average grant date fair value, nonvested options vested or forfeited">13.59</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Nonvested options – end of period</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_pid_uShares_c20230101__20230630_zTpYsftGuMF9" style="border-bottom: Black 2.5pt double; text-align: right" title="Nonvested options end of period">145,170</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pid_c20230101__20230630_zeYwPdLQuPLd" style="padding-bottom: 2.5pt; text-align: right" title="Weighted average grant date fair value, nonvested options end of period">16.75</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A8_zFzqRXtCzHck" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Share-based payment expense decreased income before income taxes by $<span id="xdx_907_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_pn3n3_dxL_c20230401__20230630_zg1YlxJ1SSDl" title="Income before income taxes::XDX::55475"><span style="-sec-ix-hidden: xdx2ixbrl0830">0.63</span></span> million and $<span id="xdx_90C_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_pn3n3_dxL_c20230101__20230630_zSzwLyTUTPsc" title="::XDX::148061"><span style="-sec-ix-hidden: xdx2ixbrl0831">1.27</span></span> million for the three and six months ended June 30, 2023, respectively, as compared to $<span id="xdx_900_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_pn3n3_dxL_c20220401__20220630_zNJydD8nMhlc" title="::XDX::45445"><span style="-sec-ix-hidden: xdx2ixbrl0832">1.22</span></span> million and $<span id="xdx_909_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_pn3n3_dxL_c20220101__20220630_zcGzXIY59eKe" title="::XDX::106668"><span style="-sec-ix-hidden: xdx2ixbrl0833">1.88</span></span> million for the corresponding periods of the prior year. Share-base income before income d payment expense decreased income attributable to Inter Parfums, Inc. by $<span id="xdx_903_eus-gaap--AllocatedShareBasedCompensationExpense_dm_c20230401__20230630_ziIN43sGUkje" title="Share-based payment arrangement, expense">0.43 million</span> and $<span id="xdx_907_eus-gaap--AllocatedShareBasedCompensationExpense_dm_c20230101__20230630_zRwcP39UE6jf" title="Share-based payment arrangement, expense">0.86 million</span> for the three and six months ended June 30, 2023, respectively, as compared to $<span id="xdx_90A_eus-gaap--AllocatedShareBasedCompensationExpense_dm_c20220401__20220630_zE5pwMSQQSp6" title="Share-based payment arrangement, expense">0.74 million</span> and $<span id="xdx_909_eus-gaap--AllocatedShareBasedCompensationExpense_dm_c20220101__20220630_zyrUJkkkD0r1" title="Share-based payment arrangement, expense">1.18 million</span> for the corresponding periods of the prior year.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p id="xdx_896_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zW4xnazoRrhh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8B4_zrej63Aqltsg">The following table summarizes stock option information as of June 30, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="font-family: Courier New, Courier, Monospace; text-align: justify"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Shares</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted Average Exercise Price</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 63%">Outstanding at January 1, 2023</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20230101__20230630_zPWlHVWBcXhc" style="width: 12%; text-align: right" title="Options shares under option - beginning of year">441,580</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230101__20230630_zZQL6YiwYUCe" style="width: 12%; text-align: right" title="Weighted average exercise price shares under option - beginning of year">67.30</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Options forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20230101__20230630_zEaAjIul9vJe" style="text-align: right" title="Options forfeited">(15,960</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20230101__20230630_zindIkf7D1J4" style="text-align: right" title="Weighted average exercise price options forfeited">70.48</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Options exercised</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20230101__20230630_zctC6Ohu3bf8" style="border-bottom: Black 1pt solid; text-align: right" title="Options exercised">(93,430</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20230101__20230630_zUkqg2Zecn0j" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price options exercised">55.57</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Outstanding at June 30, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_uShares_c20230101__20230630_zTQ1Ex4qGJs4" style="border-bottom: Black 2.5pt double; text-align: right" title="Options shares under option - end of year">332,190</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230101__20230630_zjpwKIU3DcP6" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price shares under option - end of year">70.44</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Options exercisable</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_uShares_c20230630_zBgBpGxNkFya" style="text-align: right" title="Options exercisable">187,020</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_pid_c20230630_zmdGXhSGXWp1" style="text-align: right" title="Weighted average exercise price options exercisable">61.53</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Options available for future grants</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_pid_uShares_c20230630_zNmzQnXr8PSh" style="text-align: right" title="Options available for future grants">574,935</td><td style="text-align: left"> </td><td style="font-family: Courier New, Courier, Monospace"> </td> <td style="font-family: Courier New, Courier, Monospace; text-align: left"> </td><td style="font-family: Courier New, Courier, Monospace; text-align: right"> </td><td style="font-family: Courier New, Courier, Monospace; text-align: left"> </td></tr> </table> <p id="xdx_8A8_z8z5UHDPcVF9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">As of June 30, 2023, the weighted average remaining contractual life of options outstanding is <span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dxL_c20230101__20230630_zuAPipk6rx7h" title="Weighted average remaining contractual life of options outstanding (in years)::XDX::P2Y4M24D"><span style="-sec-ix-hidden: xdx2ixbrl0870">2.40</span></span> years (<span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dxL_c20230101__20230630_z3LSb5vtD8q3" title="Weighted average remaining contractual life of options exercisable (in years)::XDX::P7M6D"><span style="-sec-ix-hidden: xdx2ixbrl0872">0.6</span></span> years for options exercisable); the aggregate intrinsic value of options outstanding and options exercisable is $<span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_pn5n6_c20230630_zQkg9UkwUrnd" title="Aggregate intrinsic value of options outstanding and options outstanding">21.5</span> million and $<span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_pn5n6_c20230630_zc32Iws7buQ2" title="Aggregate intrinsic value of options outstanding and options exercisable">13.8</span> million, respectively; and unrecognized compensation cost related to stock options outstanding aggregated $<span id="xdx_90D_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_iI_pn6n6_c20230630_zfK2Uxe53o71" title="Unrecognized compensation cost">2.0</span> million.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p id="xdx_89C_eus-gaap--CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock_zMHnFvlkuW0f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8B7_zYKhfWxTgeH9">Cash proceeds, tax benefits and intrinsic value related to stock options exercised during the six months ended June 30, 2023 and 2022 were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="text-align: justify; padding-bottom: 1pt">(In thousands)</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">June 30, <br/>2023</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">June 30,  <br/>2022</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 63%; text-align: left">Cash proceeds from stock options exercised</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--ProceedsFromSaleAndCollectionOfReceivables_pn3n3_c20230101__20230630_z6FHlkqRq0id" style="width: 12%; text-align: right" title="Cash proceeds from stock options exercised">5,192</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--ProceedsFromSaleAndCollectionOfReceivables_pn3n3_c20220101__20220630_zcMppIzsMVo7" style="width: 12%; text-align: right" title="Cash proceeds from stock options exercised">810</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Tax benefits</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--DeferredTaxExpenseFromStockOptionsExercised_pn3n3_c20230101__20230630_zbtu3pUQlf2g" style="text-align: right" title="Tax benefits">840</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--DeferredTaxExpenseFromStockOptionsExercised_pn3n3_c20220101__20220630_z4Y41Kj4mbRg" style="text-align: right" title="Tax benefits">75</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Intrinsic value of stock options exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_pn3n3_c20230101__20230630_zsxoXrHJxShd" style="text-align: right" title="Intrinsic value of stock options exercised">5,773</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_pn3n3_c20220101__20220630_zer9k6Y92V8a" style="text-align: right" title="Intrinsic value of stock options exercised">698</td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8AA_ztdw5icjCXSi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">There were <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_pid_do_uShares_c20230101__20230630_zleymWzXwO8k" title="Options granted"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_pid_do_uShares_c20220101__20220630_zwXAJwDO58n3" title="Options granted">no</span></span> options granted during the six months ended June 30, 2023 and June 30, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Expected volatility is estimated based on historic volatility of the Company’s common stock. The expected term of the option is estimated based on historic data. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of the grant of the option and the dividend yield reflects the assumption that the dividend payout as authorized by the Board of Directors would increase as the earnings of the Company and its stock price continues to increase.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In December 2018, Interparfums SA approved a plan to grant an aggregate of <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_pid_uShares_c20181231__srt--ConsolidatedEntitiesAxis__custom--InterparfumsSASubsidiaryMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_zsjbOiq3SOs1" title="Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized">26,600</span> shares of its stock to employees with no performance condition requirement, and an aggregate of <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_pid_uShares_c20181231__srt--ConsolidatedEntitiesAxis__custom--InterparfumsSASubsidiaryMember__srt--TitleOfIndividualAxis__custom--OfficersAndManagersMember_zPSlMKEXiUmj" title="Aggregate shares to offices and managers">133,000</span> shares to officers and managers, subject to certain corporate performance conditions. The corporate performance conditions were met and therefore in June 2022, <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesStockSplits_pid_uShares_c20220601__20220630_zdR1IV2Xrpg" title="Adjusted for stock splits">211,955</span> shares, adjusted for stock splits, were distributed. The aggregate cost of the grant of approximately $<span id="xdx_900_eus-gaap--EmployeeStockOwnershipPlanESOPCompensationExpense_pn5n6_c20220601__20220630_z4AUCiguT146" title="Recognized as compensation cost">4.8</span> million was recognized as compensation cost on a straight-line basis over the requisite three-year service period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In March 2022, Interparfums SA approved an additional plan to grant an aggregate of <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_pid_uShares_c20220331__srt--ConsolidatedEntitiesAxis__custom--InterparfumsSASubsidiaryMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_z8hA4OBjSwgb">88,400</span> shares to all Interparfums SA employees and corporate officers having more than six months of employment at grant date, subject to certain corporate performance conditions. The shares, subject to adjustment for stock splits, will be distributed in June 2025 and will follow the same guidelines as the December 2018 plan.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The fair value of the grant had been determined based on the quoted stock price of Interparfums SA shares as reported by the NYSE Euronext on the date of grant. The estimated number of shares to be distributed of <span id="xdx_90A_eus-gaap--DistributionMadeToLimitedPartnerUnitDistribution_pid_uShares_c20230101__20230630__srt--ConsolidatedEntitiesAxis__custom--InterparfumsSASubsidiaryMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_zsufQCFBHUN" title="Number of share distributed">93,489</span> has been determined taking into account employee turnover. The aggregate cost of the grant of approximately $<span id="xdx_908_eus-gaap--EmployeeStockOwnershipPlanESOPCompensationExpense_dm_c20230101__20230630__srt--ConsolidatedEntitiesAxis__custom--InterparfumsSASubsidiaryMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_zURcNYmddva6" title="Recognized as compensation cost">4.2 million</span> will be recognized as compensation cost on a straight-line basis over the requisite three and a quarter year service period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Similar to the December 2018 plan, in order to avoid dilution of the Company’s ownership of Interparfums SA, all shares distributed or to be distributed pursuant to these plans will be pre-existing shares of Interparfums SA, purchased in the open market by Interparfums SA. As of June 30, 2023 the Company acquired <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_pid_uShares_c20230630__srt--ConsolidatedEntitiesAxis__custom--InterparfumsSASubsidiaryMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_z4MU7NX7L1g3">69,609</span> shares at an aggregate cost of $<span id="xdx_90E_eus-gaap--EmployeeStockOwnershipPlanESOPCompensationExpense_pn6n6_c20220101__20221231__srt--ConsolidatedEntitiesAxis__custom--InterparfumsSASubsidiaryMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_zWx3HBnMq1v" title="Recognized as compensation cost">3.0</span> million.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In the first half of 2023, the Company initiated a share repurchase program with the primary intent of neutralizing the dilution impact of the stock option programs previously discussed. Over the course of the first half of 2023, the Company repurchased <span id="xdx_906_eus-gaap--StockRepurchasedDuringPeriodShares_pid_uShares_c20230101__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockCommonMember_zy4hTab5Fxs8" title="Shares repurchased">85,060</span> shares at a cost of $<span id="xdx_900_eus-gaap--StockRepurchasedDuringPeriodValue_pn5n6_c20230101__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockCommonMember_zq8jI8hSPiKb" title="Shares repurchase value">11.3</span> million. These shares are classified as treasury shares on the accompanying balance sheet. The Company plans to continue repurchasing shares throughout 2023.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">All share purchases and issuances have been classified as equity transactions on the accompanying balance sheet.</p> 100000 100000 <p id="xdx_894_eus-gaap--ScheduleOfNonvestedShareActivityTableTextBlock_zTvxNIJFbmY5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8B0_zY5JXPsATwPa">The following table sets forth information with respect to nonvested options for the six months ended June 30, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Number of Shares</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted Average Grant-Date Fair Value</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 63%; text-align: left">Nonvested options – beginning of period</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_pid_uShares_c20230101__20230630_zCSOwhiHm7E8" style="width: 12%; text-align: right" title="Nonvested options beginning of period">168,730</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20230101__20230630_znp6UpQl6a5h" style="width: 12%; text-align: right" title="Weighted average grant date fair value, beginning of year">16.31</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Nonvested options granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20230101__20230630_zyC6zihXQFk3" style="text-align: right" title="Nonvested options granted"><span style="-sec-ix-hidden: xdx2ixbrl0818">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20230101__20230630_zHvEXidBzFx9" style="text-align: right" title="Weighted average grant date fair value, nonvested options granted"><span style="-sec-ix-hidden: xdx2ixbrl0820">—</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Nonvested options vested or forfeited</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_iN_pid_di_uShares_c20230101__20230630_zre2lBoXIni3" style="border-bottom: Black 1pt solid; text-align: right" title="Nonvested options vested or forfeited">(23,560</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left">$</td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_pid_c20230101__20230630_z7b5dpvqmkid" style="padding-bottom: 1pt; text-align: right" title="Weighted average grant date fair value, nonvested options vested or forfeited">13.59</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Nonvested options – end of period</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_pid_uShares_c20230101__20230630_zTpYsftGuMF9" style="border-bottom: Black 2.5pt double; text-align: right" title="Nonvested options end of period">145,170</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pid_c20230101__20230630_zeYwPdLQuPLd" style="padding-bottom: 2.5pt; text-align: right" title="Weighted average grant date fair value, nonvested options end of period">16.75</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 168730 16.31 23560 13.59 145170 16.75 430000 860000 740000 1180000 <p id="xdx_896_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zW4xnazoRrhh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8B4_zrej63Aqltsg">The following table summarizes stock option information as of June 30, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="font-family: Courier New, Courier, Monospace; text-align: justify"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Shares</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted Average Exercise Price</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 63%">Outstanding at January 1, 2023</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20230101__20230630_zPWlHVWBcXhc" style="width: 12%; text-align: right" title="Options shares under option - beginning of year">441,580</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230101__20230630_zZQL6YiwYUCe" style="width: 12%; text-align: right" title="Weighted average exercise price shares under option - beginning of year">67.30</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Options forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20230101__20230630_zEaAjIul9vJe" style="text-align: right" title="Options forfeited">(15,960</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20230101__20230630_zindIkf7D1J4" style="text-align: right" title="Weighted average exercise price options forfeited">70.48</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Options exercised</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20230101__20230630_zctC6Ohu3bf8" style="border-bottom: Black 1pt solid; text-align: right" title="Options exercised">(93,430</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20230101__20230630_zUkqg2Zecn0j" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price options exercised">55.57</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Outstanding at June 30, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_uShares_c20230101__20230630_zTQ1Ex4qGJs4" style="border-bottom: Black 2.5pt double; text-align: right" title="Options shares under option - end of year">332,190</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230101__20230630_zjpwKIU3DcP6" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price shares under option - end of year">70.44</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Options exercisable</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_uShares_c20230630_zBgBpGxNkFya" style="text-align: right" title="Options exercisable">187,020</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_pid_c20230630_zmdGXhSGXWp1" style="text-align: right" title="Weighted average exercise price options exercisable">61.53</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Options available for future grants</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_pid_uShares_c20230630_zNmzQnXr8PSh" style="text-align: right" title="Options available for future grants">574,935</td><td style="text-align: left"> </td><td style="font-family: Courier New, Courier, Monospace"> </td> <td style="font-family: Courier New, Courier, Monospace; text-align: left"> </td><td style="font-family: Courier New, Courier, Monospace; text-align: right"> </td><td style="font-family: Courier New, Courier, Monospace; text-align: left"> </td></tr> </table> 441580 67.30 15960 70.48 93430 55.57 332190 70.44 187020 61.53 574935 21500000 13800000 2000000.0 <p id="xdx_89C_eus-gaap--CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock_zMHnFvlkuW0f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8B7_zYKhfWxTgeH9">Cash proceeds, tax benefits and intrinsic value related to stock options exercised during the six months ended June 30, 2023 and 2022 were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="text-align: justify; padding-bottom: 1pt">(In thousands)</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">June 30, <br/>2023</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">June 30,  <br/>2022</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 63%; text-align: left">Cash proceeds from stock options exercised</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--ProceedsFromSaleAndCollectionOfReceivables_pn3n3_c20230101__20230630_z6FHlkqRq0id" style="width: 12%; text-align: right" title="Cash proceeds from stock options exercised">5,192</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--ProceedsFromSaleAndCollectionOfReceivables_pn3n3_c20220101__20220630_zcMppIzsMVo7" style="width: 12%; text-align: right" title="Cash proceeds from stock options exercised">810</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Tax benefits</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--DeferredTaxExpenseFromStockOptionsExercised_pn3n3_c20230101__20230630_zbtu3pUQlf2g" style="text-align: right" title="Tax benefits">840</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--DeferredTaxExpenseFromStockOptionsExercised_pn3n3_c20220101__20220630_z4Y41Kj4mbRg" style="text-align: right" title="Tax benefits">75</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Intrinsic value of stock options exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_pn3n3_c20230101__20230630_zsxoXrHJxShd" style="text-align: right" title="Intrinsic value of stock options exercised">5,773</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_pn3n3_c20220101__20220630_zer9k6Y92V8a" style="text-align: right" title="Intrinsic value of stock options exercised">698</td><td style="text-align: left"> </td></tr> </table> 5192000 810000 840000 75000 5773000 698000 0 0 26600 133000 211955 4800000 88400 93489 4200000 69609 3000000.0 85060 11300000 <p id="xdx_80E_eus-gaap--EarningsPerShareTextBlock_zRvDk07efsSf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 0.5in"><b>10.</b></td><td style="text-align: justify; padding-right: 0.5in"><b><span style="text-decoration: underline"><span id="xdx_828_zTp1lGUsrXI6">Net Income Attributable to Inter Parfums, Inc. Common Shareholders:</span></span></b></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Net income attributable to Inter Parfums, Inc. per common share (“basic EPS”) is computed by dividing net income attributable to Inter Parfums, Inc. by the weighted average number of shares outstanding. Net income attributable to Inter Parfums, Inc. per share assuming dilution (“diluted EPS”), is computed using the weighted average number of shares outstanding, plus the incremental shares outstanding assuming the exercise of dilutive stock options using the treasury stock method.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p id="xdx_89C_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zhTkqsmGq025" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BC_zFYLNqDM20M2">The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="font-weight: normal; text-align: left; padding-left: 0.125in; text-indent: -0.125in"> </td><td style="font-weight: normal; text-align: center"> </td> <td style="font-weight: normal; text-align: center"> </td> <td id="xdx_49A_20230401__20230630_zPKsDQ45SdUj" style="font-weight: normal; text-align: center"> </td> <td style="font-weight: normal; text-align: center"> </td> <td colspan="3" id="xdx_491_20220401__20220630_zJBp1iSVwLYc" style="font-weight: normal; text-align: center"> </td><td style="font-weight: normal; text-align: center"> </td><td style="font-weight: normal; text-align: center"> </td> <td style="font-weight: normal; text-align: center"> </td> <td id="xdx_49D_20230101__20230630_zQkHWVdt5uX9" style="font-weight: normal; text-align: center"> </td> <td style="font-weight: normal; text-align: center"> </td> <td style="font-weight: normal; text-align: center"> </td> <td colspan="2" id="xdx_492_20220101__20220630_zQFaziFik7Ee" style="font-weight: normal; text-align: center"> </td><td style="font-weight: normal; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: normal; text-align: left; padding-left: 0.125in; text-indent: -0.125in"></td><td style="font-weight: normal; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="font-weight: normal; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three months ended <br/> June 30,</span></td><td style="font-weight: normal; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="font-weight: normal; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Six months ended <br/> June 30,</span></td><td style="font-weight: normal; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(In thousands)</span></td><td style="font-weight: normal; padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: normal; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="padding-bottom: 1pt; font-weight: normal; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal; padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: normal; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="padding-bottom: 1pt; font-weight: normal; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal; padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: normal; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="padding-bottom: 1pt; font-weight: normal; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal; padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: normal; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="padding-bottom: 1pt; font-weight: normal; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eus-gaap--WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_iB_z45w01tGbPe4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: normal; text-align: left; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Numerator:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 33%; font-weight: normal; text-align: left; padding-bottom: 2.5pt; padding-left: 0.25in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net income attributable to Inter Parfums, Inc.</span></td><td style="width: 1%; font-weight: normal; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98B_eus-gaap--NetIncomeLoss_dxL_c20230401__20230630_zTd80myui6Pb" style="border-bottom: Black 2.5pt double; width: 12%; font-weight: normal; text-align: right" title="Net income attributable to Inter Parfums, Inc.::XDX::34952"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0931">34,952</span></span></td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 1%; font-weight: normal; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_985_eus-gaap--NetIncomeLoss_c20220401__20220630_zUVditrv6sYk" style="border-bottom: Black 2.5pt double; width: 12%; font-weight: normal; text-align: right" title="Net income attributable to Inter Parfums, Inc."><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27,617</span></td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 1%; font-weight: normal; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_eus-gaap--NetIncomeLoss_c20230101__20230630_zdxq1CgWOap5" style="border-bottom: Black 2.5pt double; width: 12%; font-weight: normal; text-align: right" title="Net income attributable to Inter Parfums, Inc."><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">89,020</span></td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 1%; font-weight: normal; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_988_eus-gaap--NetIncomeLoss_c20220101__20220630_zhNybrQO3Qe4" style="border-bottom: Black 2.5pt double; width: 12%; font-weight: normal; text-align: right" title="Net income attributable to Inter Parfums, Inc."><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">62,916</span></td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eus-gaap--WeightedAverageNumberOfSharesOutstandingAbstract_iB_z6DVLcSy559d" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Denominator:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_uShares_madpes_zmaSBJF3B8Ne" style="vertical-align: bottom; background-color: White"> <td style="font-weight: normal; text-align: left; padding-left: 0.25in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted average shares</span></td><td style="font-weight: normal"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32,006</span></td><td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31,845</span></td><td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32,012</span></td><td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31,843</span></td><td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: normal; text-align: left; padding-left: 0.25in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effect of dilutive securities:</span></td><td style="font-weight: normal"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pid_uShares_madpes_zkoJHA3NuUb8" style="vertical-align: bottom; background-color: White"> <td style="font-weight: normal; text-align: left; padding-bottom: 1pt; padding-left: 0.375in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock options</span></td><td style="font-weight: normal; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">156</span></td><td style="padding-bottom: 1pt; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">107</span></td><td style="padding-bottom: 1pt; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">149</span></td><td style="padding-bottom: 1pt; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">138</span></td><td style="padding-bottom: 1pt; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eus-gaap--ProFormaWeightedAverageSharesOutstandingDiluted_i01_pid_uShares_mtdpes_z4f8BrtjbGWg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: normal; text-align: left; padding-bottom: 2.5pt; padding-left: 0.5in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Denominator for diluted earnings per share</span></td><td style="font-weight: normal; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32,162</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31,952</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32,161</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31,981</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: normal; text-align: left; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earnings per share:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasicAbstract_iB_zFaCkxCNPey6" style="vertical-align: bottom; background-color: White"> <td style="font-weight: normal; text-align: left; padding-left: 0.25in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net income attributable to Inter Parfums, Inc. common shareholders:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--EarningsPerShareBasic_i01_pid_uUSDPShares_zFErsG8Wvo0j" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: normal; text-align: left; padding-left: 0.5in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic</span></td><td style="font-weight: normal"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.09</span></td><td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.87</span></td><td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.78</span></td><td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.98</span></td><td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eus-gaap--EarningsPerShareDiluted_i01_pid_uUSDPShares_za8HXuPmA4Nb" style="vertical-align: bottom; background-color: White"> <td style="font-weight: normal; text-align: left; padding-left: 0.5in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Diluted</span></td><td style="font-weight: normal"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.09</span></td><td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.86</span></td><td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.77</span></td><td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.97</span></td><td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A6_zQPtfyhcZcY1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">There were <span id="xdx_908_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_do_uShares_c20230401__20230630_zxVuzgkCgqVj" title="Antidilutive potential common shares outstanding"><span id="xdx_90A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_do_c20220401__20220630_z6FtlLd7Z0M1" title="Antidilutive potential common shares outstanding"><span id="xdx_90B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_do_c20230101__20230630_zr2vYVYcpcKl" title="Antidilutive potential common shares outstanding"><span id="xdx_90E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_do_c20220101__20220630_zSkjoauGiKTk" title="Antidilutive potential common shares outstanding">no</span></span></span></span> antidilutive potential common shares outstanding for the three and six months ended June 30, 2023 and June 30, 2022.</p> <p id="xdx_89C_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zhTkqsmGq025" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BC_zFYLNqDM20M2">The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="font-weight: normal; text-align: left; padding-left: 0.125in; text-indent: -0.125in"> </td><td style="font-weight: normal; text-align: center"> </td> <td style="font-weight: normal; text-align: center"> </td> <td id="xdx_49A_20230401__20230630_zPKsDQ45SdUj" style="font-weight: normal; text-align: center"> </td> <td style="font-weight: normal; text-align: center"> </td> <td colspan="3" id="xdx_491_20220401__20220630_zJBp1iSVwLYc" style="font-weight: normal; text-align: center"> </td><td style="font-weight: normal; text-align: center"> </td><td style="font-weight: normal; text-align: center"> </td> <td style="font-weight: normal; text-align: center"> </td> <td id="xdx_49D_20230101__20230630_zQkHWVdt5uX9" style="font-weight: normal; text-align: center"> </td> <td style="font-weight: normal; text-align: center"> </td> <td style="font-weight: normal; text-align: center"> </td> <td colspan="2" id="xdx_492_20220101__20220630_zQFaziFik7Ee" style="font-weight: normal; text-align: center"> </td><td style="font-weight: normal; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: normal; text-align: left; padding-left: 0.125in; text-indent: -0.125in"></td><td style="font-weight: normal; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="font-weight: normal; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three months ended <br/> June 30,</span></td><td style="font-weight: normal; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="font-weight: normal; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Six months ended <br/> June 30,</span></td><td style="font-weight: normal; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(In thousands)</span></td><td style="font-weight: normal; padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: normal; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="padding-bottom: 1pt; font-weight: normal; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal; padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: normal; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="padding-bottom: 1pt; font-weight: normal; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal; padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: normal; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="padding-bottom: 1pt; font-weight: normal; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal; padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: normal; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="padding-bottom: 1pt; font-weight: normal; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eus-gaap--WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_iB_z45w01tGbPe4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: normal; text-align: left; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Numerator:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 33%; font-weight: normal; text-align: left; padding-bottom: 2.5pt; padding-left: 0.25in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net income attributable to Inter Parfums, Inc.</span></td><td style="width: 1%; font-weight: normal; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98B_eus-gaap--NetIncomeLoss_dxL_c20230401__20230630_zTd80myui6Pb" style="border-bottom: Black 2.5pt double; width: 12%; font-weight: normal; text-align: right" title="Net income attributable to Inter Parfums, Inc.::XDX::34952"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0931">34,952</span></span></td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 1%; font-weight: normal; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_985_eus-gaap--NetIncomeLoss_c20220401__20220630_zUVditrv6sYk" style="border-bottom: Black 2.5pt double; width: 12%; font-weight: normal; text-align: right" title="Net income attributable to Inter Parfums, Inc."><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27,617</span></td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 1%; font-weight: normal; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_eus-gaap--NetIncomeLoss_c20230101__20230630_zdxq1CgWOap5" style="border-bottom: Black 2.5pt double; width: 12%; font-weight: normal; text-align: right" title="Net income attributable to Inter Parfums, Inc."><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">89,020</span></td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 1%; font-weight: normal; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_988_eus-gaap--NetIncomeLoss_c20220101__20220630_zhNybrQO3Qe4" style="border-bottom: Black 2.5pt double; width: 12%; font-weight: normal; text-align: right" title="Net income attributable to Inter Parfums, Inc."><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">62,916</span></td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eus-gaap--WeightedAverageNumberOfSharesOutstandingAbstract_iB_z6DVLcSy559d" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Denominator:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_uShares_madpes_zmaSBJF3B8Ne" style="vertical-align: bottom; background-color: White"> <td style="font-weight: normal; text-align: left; padding-left: 0.25in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted average shares</span></td><td style="font-weight: normal"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32,006</span></td><td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31,845</span></td><td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32,012</span></td><td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31,843</span></td><td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: normal; text-align: left; padding-left: 0.25in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effect of dilutive securities:</span></td><td style="font-weight: normal"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pid_uShares_madpes_zkoJHA3NuUb8" style="vertical-align: bottom; background-color: White"> <td style="font-weight: normal; text-align: left; padding-bottom: 1pt; padding-left: 0.375in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock options</span></td><td style="font-weight: normal; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">156</span></td><td style="padding-bottom: 1pt; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">107</span></td><td style="padding-bottom: 1pt; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">149</span></td><td style="padding-bottom: 1pt; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">138</span></td><td style="padding-bottom: 1pt; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eus-gaap--ProFormaWeightedAverageSharesOutstandingDiluted_i01_pid_uShares_mtdpes_z4f8BrtjbGWg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: normal; text-align: left; padding-bottom: 2.5pt; padding-left: 0.5in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Denominator for diluted earnings per share</span></td><td style="font-weight: normal; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32,162</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31,952</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32,161</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31,981</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: normal; text-align: left; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earnings per share:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasicAbstract_iB_zFaCkxCNPey6" style="vertical-align: bottom; background-color: White"> <td style="font-weight: normal; text-align: left; padding-left: 0.25in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net income attributable to Inter Parfums, Inc. common shareholders:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--EarningsPerShareBasic_i01_pid_uUSDPShares_zFErsG8Wvo0j" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: normal; text-align: left; padding-left: 0.5in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic</span></td><td style="font-weight: normal"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.09</span></td><td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.87</span></td><td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.78</span></td><td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.98</span></td><td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eus-gaap--EarningsPerShareDiluted_i01_pid_uUSDPShares_za8HXuPmA4Nb" style="vertical-align: bottom; background-color: White"> <td style="font-weight: normal; text-align: left; padding-left: 0.5in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Diluted</span></td><td style="font-weight: normal"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.09</span></td><td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.86</span></td><td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.77</span></td><td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.97</span></td><td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 27617000 89020000 62916000 32006 31845 32012 31843 156 107 149 138 32162 31952 32161 31981 1.09 0.87 2.78 1.98 1.09 0.86 2.77 1.97 0 0 0 0 <p id="xdx_802_eus-gaap--SegmentReportingDisclosureTextBlock_zM8UcqFQOsHa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: center"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.5in; text-align: left"><b>11.</b></td><td style="text-align: justify"><b><span style="text-decoration: underline"><span id="xdx_82B_zEND684HBCfe">Segment and Geographic Areas:</span></span></b></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company manufactures and distributes one product line, fragrances and fragrance related products. The Company manages its business in two segments, European based operations and United States based operations. The European assets are located, and operations are primarily conducted, in France. Both European based operations and United States based operations primarily represent the sale of prestige brand name fragrances.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p id="xdx_89E_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zxSLjvunMqB5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8B3_zchb0rfH7Zwj">Information on our operations by geographical areas is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="text-align: justify"></td><td> </td> <td colspan="6" style="text-align: center">Three months ended<br/> June 30,</td><td> </td><td> </td> <td colspan="6" style="text-align: center">Six months ended<br/> June 30,</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify">(In thousands)</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2022</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2022</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Net sales:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 33%; text-align: justify; padding-left: 10pt">United States</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20230401__20230630__srt--StatementGeographicalAxis__country--US_z6c2fSUpk303" style="width: 12%; text-align: right" title="Net sales">111,436</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20220401__20220630__srt--StatementGeographicalAxis__country--US_zoYinVpoQ1Dj" style="width: 12%; text-align: right" title="Net sales">78,444</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20230101__20230630__srt--StatementGeographicalAxis__country--US_z5VGPZjfyjPi" style="width: 12%; text-align: right" title="Net sales">192,890</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20220101__20220630__srt--StatementGeographicalAxis__country--US_zRkhKzwHrye" style="width: 12%; text-align: right" title="Net sales">146,946</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 10pt">Europe</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20230401__20230630__srt--StatementGeographicalAxis__srt--EuropeMember_znIUpdcn3Cl1" style="text-align: right" title="Net sales">197,808</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20220401__20220630__srt--StatementGeographicalAxis__srt--EuropeMember_zHw2ve4bTkg7" style="text-align: right" title="Net sales">166,287</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20230101__20230630__srt--StatementGeographicalAxis__srt--EuropeMember_zTc1MKEmesWa" style="text-align: right" title="Net sales">428,077</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20220101__20220630__srt--StatementGeographicalAxis__srt--EuropeMember_zmXmr898UPM6" style="text-align: right" title="Net sales">348,469</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 10pt">Eliminations</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20230401__20230630__srt--StatementGeographicalAxis__custom--EliminationsMember_zqkSTYtPhw08" style="border-bottom: Black 1pt solid; text-align: right" title="Net sales"><span style="-sec-ix-hidden: xdx2ixbrl1002">—</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20220401__20220630__srt--StatementGeographicalAxis__custom--EliminationsMember_zEe5I90o6p8d" style="border-bottom: Black 1pt solid; text-align: right" title="Net sales">(6</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20230101__20230630__srt--StatementGeographicalAxis__custom--EliminationsMember_zBsjeFPMO7e" style="border-bottom: Black 1pt solid; text-align: right" title="Net sales"><span style="-sec-ix-hidden: xdx2ixbrl1006">—</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20220101__20220630__srt--StatementGeographicalAxis__custom--EliminationsMember_zj4f0EqOaqTh" style="border-bottom: Black 1pt solid; text-align: right" title="Net sales">(12</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20230401__20230630_zFmbGuNtsJEe" style="border-bottom: Black 2.5pt double; text-align: right" title="Net sales">309,244</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20220401__20220630_zxecCUsTi2A9" style="border-bottom: Black 2.5pt double; text-align: right" title="Net sales">244,725</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20230101__20230630_zphNhI049RDk" style="border-bottom: Black 2.5pt double; text-align: right" title="Net sales">620,967</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20220101__20220630_zjTDyGloUXRb" style="border-bottom: Black 2.5pt double; text-align: right" title="Net sales">495,403</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Net income attributable to Inter Parfums, Inc.:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 10pt">United States</td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--NetIncomeLoss_pn3n3_c20230401__20230630__srt--StatementGeographicalAxis__country--US_zAnFYHJQQQOk" style="text-align: right" title="Net income attributable to Inter Parfums, Inc.">15,567</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--NetIncomeLoss_pn3n3_c20220401__20220630__srt--StatementGeographicalAxis__country--US_ztvIl6Vfojld" style="text-align: right" title="Net income attributable to Inter Parfums, Inc.">9,991</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--NetIncomeLoss_pn3n3_c20230101__20230630__srt--StatementGeographicalAxis__country--US_znZ8gaSsVRal" style="text-align: right" title="Net income attributable to Inter Parfums, Inc.">25,910</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--NetIncomeLoss_pn3n3_c20220101__20220630__srt--StatementGeographicalAxis__country--US_zy5GqPr7LHak" style="text-align: right" title="Net income attributable to Inter Parfums, Inc.">16,505</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 10pt">Europe</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--NetIncomeLoss_pn3n3_c20230401__20230630__srt--StatementGeographicalAxis__srt--EuropeMember_zK3rniAVJOHl" style="border-bottom: Black 1pt solid; text-align: right" title="Net income attributable to Inter Parfums, Inc.">19,385</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--NetIncomeLoss_pn3n3_c20220401__20220630__srt--StatementGeographicalAxis__srt--EuropeMember_zl4Tvqa7Tnb4" style="border-bottom: Black 1pt solid; text-align: right" title="Net income attributable to Inter Parfums, Inc.">17,626</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--NetIncomeLoss_pn3n3_c20230101__20230630__srt--StatementGeographicalAxis__srt--EuropeMember_z7O8JoBb7Tb1" style="border-bottom: Black 1pt solid; text-align: right" title="Net income attributable to Inter Parfums, Inc.">63,110</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--NetIncomeLoss_pn3n3_c20220101__20220630__srt--StatementGeographicalAxis__srt--EuropeMember_z8OBtpAk857b" style="border-bottom: Black 1pt solid; text-align: right" title="Net income attributable to Inter Parfums, Inc.">46,411</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--NetIncomeLoss_pn3n3_c20230401__20230630_zzvqyUJzt2q8" style="border-bottom: Black 2.5pt double; text-align: right" title="Net income attributable to Inter Parfums, Inc.">34,952</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--NetIncomeLoss_pn3n3_c20220401__20220630_zqzXDYS35n1d" style="border-bottom: Black 2.5pt double; text-align: right" title="Net income attributable to Inter Parfums, Inc.">27,617</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--NetIncomeLoss_pn3n3_c20230101__20230630_z5XKhwyXYQ2c" style="border-bottom: Black 2.5pt double; text-align: right" title="Net income attributable to Inter Parfums, Inc.">89,020</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--NetIncomeLoss_pn3n3_c20220101__20220630_zPTKD1K9jPhd" style="border-bottom: Black 2.5pt double; text-align: right" title="Net income attributable to Inter Parfums, Inc.">62,916</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2" style="text-align: center">June 30,</td><td> </td><td> </td> <td colspan="2" style="text-align: center">December 31,</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2022</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Total Assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 63%; text-align: justify; padding-left: 10pt">United States</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--Assets_iI_pn3n3_c20230630__srt--StatementGeographicalAxis__country--US_zFNbkycfH8mf" style="width: 12%; text-align: right" title="Total Assets"><p style="margin: 0pt 0">313,261</p> </td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--Assets_iI_pn3n3_c20221231__srt--StatementGeographicalAxis__country--US_z0cgEYvBmlR" style="width: 12%; text-align: right" title="Total Assets">278,090</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 10pt">Europe</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--Assets_iI_pn3n3_c20230630__srt--StatementGeographicalAxis__srt--EuropeMember_zs9n66o4xl11" style="text-align: right" title="Total Assets">1,048,040</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--Assets_iI_pn3n3_c20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zGLDsM3lBLj" style="text-align: right" title="Total Assets">1,052,004</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 10pt">Eliminations</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--Assets_iI_pn3n3_c20230630__srt--StatementGeographicalAxis__custom--EliminationsMember_zcTF0BJordUc" style="border-bottom: Black 1pt solid; text-align: right" title="Total Assets">(9,637</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--Assets_iI_pn3n3_c20221231__srt--StatementGeographicalAxis__custom--EliminationsMember_zhOMrzymIJS" style="border-bottom: Black 1pt solid; text-align: right" title="Total Assets">(21,552</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--Assets_iI_pn3n3_c20230630_zYbBUr7htgP3" style="border-bottom: Black 2.5pt double; text-align: right" title="Assets">1,351,664</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--Assets_iI_pn3n3_c20221231_zcp9DBnNv3C6" style="border-bottom: Black 2.5pt double; text-align: right" title="Assets">1,308,542</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AB_zByG0lzY87q8" style="margin-top: 0; margin-bottom: 0"> </p> <p id="xdx_89E_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zxSLjvunMqB5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8B3_zchb0rfH7Zwj">Information on our operations by geographical areas is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="text-align: justify"></td><td> </td> <td colspan="6" style="text-align: center">Three months ended<br/> June 30,</td><td> </td><td> </td> <td colspan="6" style="text-align: center">Six months ended<br/> June 30,</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify">(In thousands)</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2022</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2022</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Net sales:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 33%; text-align: justify; padding-left: 10pt">United States</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20230401__20230630__srt--StatementGeographicalAxis__country--US_z6c2fSUpk303" style="width: 12%; text-align: right" title="Net sales">111,436</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20220401__20220630__srt--StatementGeographicalAxis__country--US_zoYinVpoQ1Dj" style="width: 12%; text-align: right" title="Net sales">78,444</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20230101__20230630__srt--StatementGeographicalAxis__country--US_z5VGPZjfyjPi" style="width: 12%; text-align: right" title="Net sales">192,890</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20220101__20220630__srt--StatementGeographicalAxis__country--US_zRkhKzwHrye" style="width: 12%; text-align: right" title="Net sales">146,946</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 10pt">Europe</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20230401__20230630__srt--StatementGeographicalAxis__srt--EuropeMember_znIUpdcn3Cl1" style="text-align: right" title="Net sales">197,808</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20220401__20220630__srt--StatementGeographicalAxis__srt--EuropeMember_zHw2ve4bTkg7" style="text-align: right" title="Net sales">166,287</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20230101__20230630__srt--StatementGeographicalAxis__srt--EuropeMember_zTc1MKEmesWa" style="text-align: right" title="Net sales">428,077</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20220101__20220630__srt--StatementGeographicalAxis__srt--EuropeMember_zmXmr898UPM6" style="text-align: right" title="Net sales">348,469</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 10pt">Eliminations</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20230401__20230630__srt--StatementGeographicalAxis__custom--EliminationsMember_zqkSTYtPhw08" style="border-bottom: Black 1pt solid; text-align: right" title="Net sales"><span style="-sec-ix-hidden: xdx2ixbrl1002">—</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20220401__20220630__srt--StatementGeographicalAxis__custom--EliminationsMember_zEe5I90o6p8d" style="border-bottom: Black 1pt solid; text-align: right" title="Net sales">(6</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20230101__20230630__srt--StatementGeographicalAxis__custom--EliminationsMember_zBsjeFPMO7e" style="border-bottom: Black 1pt solid; text-align: right" title="Net sales"><span style="-sec-ix-hidden: xdx2ixbrl1006">—</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20220101__20220630__srt--StatementGeographicalAxis__custom--EliminationsMember_zj4f0EqOaqTh" style="border-bottom: Black 1pt solid; text-align: right" title="Net sales">(12</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20230401__20230630_zFmbGuNtsJEe" style="border-bottom: Black 2.5pt double; text-align: right" title="Net sales">309,244</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20220401__20220630_zxecCUsTi2A9" style="border-bottom: Black 2.5pt double; text-align: right" title="Net sales">244,725</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20230101__20230630_zphNhI049RDk" style="border-bottom: Black 2.5pt double; text-align: right" title="Net sales">620,967</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_pn3n3_c20220101__20220630_zjTDyGloUXRb" style="border-bottom: Black 2.5pt double; text-align: right" title="Net sales">495,403</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Net income attributable to Inter Parfums, Inc.:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 10pt">United States</td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--NetIncomeLoss_pn3n3_c20230401__20230630__srt--StatementGeographicalAxis__country--US_zAnFYHJQQQOk" style="text-align: right" title="Net income attributable to Inter Parfums, Inc.">15,567</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--NetIncomeLoss_pn3n3_c20220401__20220630__srt--StatementGeographicalAxis__country--US_ztvIl6Vfojld" style="text-align: right" title="Net income attributable to Inter Parfums, Inc.">9,991</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--NetIncomeLoss_pn3n3_c20230101__20230630__srt--StatementGeographicalAxis__country--US_znZ8gaSsVRal" style="text-align: right" title="Net income attributable to Inter Parfums, Inc.">25,910</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--NetIncomeLoss_pn3n3_c20220101__20220630__srt--StatementGeographicalAxis__country--US_zy5GqPr7LHak" style="text-align: right" title="Net income attributable to Inter Parfums, Inc.">16,505</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 10pt">Europe</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--NetIncomeLoss_pn3n3_c20230401__20230630__srt--StatementGeographicalAxis__srt--EuropeMember_zK3rniAVJOHl" style="border-bottom: Black 1pt solid; text-align: right" title="Net income attributable to Inter Parfums, Inc.">19,385</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--NetIncomeLoss_pn3n3_c20220401__20220630__srt--StatementGeographicalAxis__srt--EuropeMember_zl4Tvqa7Tnb4" style="border-bottom: Black 1pt solid; text-align: right" title="Net income attributable to Inter Parfums, Inc.">17,626</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--NetIncomeLoss_pn3n3_c20230101__20230630__srt--StatementGeographicalAxis__srt--EuropeMember_z7O8JoBb7Tb1" style="border-bottom: Black 1pt solid; text-align: right" title="Net income attributable to Inter Parfums, Inc.">63,110</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--NetIncomeLoss_pn3n3_c20220101__20220630__srt--StatementGeographicalAxis__srt--EuropeMember_z8OBtpAk857b" style="border-bottom: Black 1pt solid; text-align: right" title="Net income attributable to Inter Parfums, Inc.">46,411</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--NetIncomeLoss_pn3n3_c20230401__20230630_zzvqyUJzt2q8" style="border-bottom: Black 2.5pt double; text-align: right" title="Net income attributable to Inter Parfums, Inc.">34,952</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--NetIncomeLoss_pn3n3_c20220401__20220630_zqzXDYS35n1d" style="border-bottom: Black 2.5pt double; text-align: right" title="Net income attributable to Inter Parfums, Inc.">27,617</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--NetIncomeLoss_pn3n3_c20230101__20230630_z5XKhwyXYQ2c" style="border-bottom: Black 2.5pt double; text-align: right" title="Net income attributable to Inter Parfums, Inc.">89,020</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--NetIncomeLoss_pn3n3_c20220101__20220630_zPTKD1K9jPhd" style="border-bottom: Black 2.5pt double; text-align: right" title="Net income attributable to Inter Parfums, Inc.">62,916</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2" style="text-align: center">June 30,</td><td> </td><td> </td> <td colspan="2" style="text-align: center">December 31,</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2022</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Total Assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 63%; text-align: justify; padding-left: 10pt">United States</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--Assets_iI_pn3n3_c20230630__srt--StatementGeographicalAxis__country--US_zFNbkycfH8mf" style="width: 12%; text-align: right" title="Total Assets"><p style="margin: 0pt 0">313,261</p> </td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--Assets_iI_pn3n3_c20221231__srt--StatementGeographicalAxis__country--US_z0cgEYvBmlR" style="width: 12%; text-align: right" title="Total Assets">278,090</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 10pt">Europe</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--Assets_iI_pn3n3_c20230630__srt--StatementGeographicalAxis__srt--EuropeMember_zs9n66o4xl11" style="text-align: right" title="Total Assets">1,048,040</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--Assets_iI_pn3n3_c20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zGLDsM3lBLj" style="text-align: right" title="Total Assets">1,052,004</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 10pt">Eliminations</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--Assets_iI_pn3n3_c20230630__srt--StatementGeographicalAxis__custom--EliminationsMember_zcTF0BJordUc" style="border-bottom: Black 1pt solid; text-align: right" title="Total Assets">(9,637</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--Assets_iI_pn3n3_c20221231__srt--StatementGeographicalAxis__custom--EliminationsMember_zhOMrzymIJS" style="border-bottom: Black 1pt solid; text-align: right" title="Total Assets">(21,552</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--Assets_iI_pn3n3_c20230630_zYbBUr7htgP3" style="border-bottom: Black 2.5pt double; text-align: right" title="Assets">1,351,664</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--Assets_iI_pn3n3_c20221231_zcp9DBnNv3C6" style="border-bottom: Black 2.5pt double; text-align: right" title="Assets">1,308,542</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 111436000 78444000 192890000 146946000 197808000 166287000 428077000 348469000 -6000 -12000 309244000 244725000 620967000 495403000 15567000 9991000 25910000 16505000 19385000 17626000 63110000 46411000 34952000 27617000 89020000 62916000 313261000 278090000 1048040000 1052004000 -9637000 -21552000 1351664000 1308542000 EXCEL 47 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 48 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 49 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 50 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.2 html 99 219 1 false 29 0 false 7 false false R1.htm 00000001 - Document - Cover Sheet http://interparfumsinc.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - CONSOLIDATED BALANCE SHEETS(Unaudited) Sheet http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited CONSOLIDATED BALANCE SHEETS(Unaudited) Statements 2 false false R3.htm 00000003 - Statement - CONSOLIDATED BALANCE SHEETS(Unaudited) (Parenthetical) Sheet http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunauditedParenthetical CONSOLIDATED BALANCE SHEETS(Unaudited) (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - CONSOLIDATED STATEMENTS OF INCOME (Unaudited) Sheet http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome CONSOLIDATED STATEMENTS OF INCOME (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) Sheet http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) Statements 5 false false R6.htm 00000006 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Unaudited) Sheet http://interparfumsinc.com/role/ConsolidatedStatementsOfChangesInEquity CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Unaudited) Statements 6 false false R7.htm 00000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS(Unaudited) Sheet http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited CONSOLIDATED STATEMENTS OF CASH FLOWS(Unaudited) Statements 7 false false R8.htm 00000008 - Disclosure - Significant Accounting Policies: Sheet http://interparfumsinc.com/role/SignificantAccountingPolicies Significant Accounting Policies: Notes 8 false false R9.htm 00000009 - Disclosure - Impact of COVID-19 Pandemic: Sheet http://interparfumsinc.com/role/ImpactOfCovid-19Pandemic Impact of COVID-19 Pandemic: Notes 9 false false R10.htm 00000010 - Disclosure - Recent Agreements: Sheet http://interparfumsinc.com/role/RecentAgreements Recent Agreements: Notes 10 false false R11.htm 00000011 - Disclosure - Recent Accounting Pronouncements: Sheet http://interparfumsinc.com/role/RecentAccountingPronouncements Recent Accounting Pronouncements: Notes 11 false false R12.htm 00000012 - Disclosure - Inventories: Sheet http://interparfumsinc.com/role/Inventories Inventories: Notes 12 false false R13.htm 00000013 - Disclosure - Fair Value Measurement: Sheet http://interparfumsinc.com/role/FairValueMeasurement Fair Value Measurement: Notes 13 false false R14.htm 00000014 - Disclosure - Derivative Financial Instruments: Sheet http://interparfumsinc.com/role/DerivativeFinancialInstruments Derivative Financial Instruments: Notes 14 false false R15.htm 00000015 - Disclosure - Leases: Sheet http://interparfumsinc.com/role/Leases Leases: Notes 15 false false R16.htm 00000016 - Disclosure - Share-Based Payments: Sheet http://interparfumsinc.com/role/Share-basedPayments Share-Based Payments: Notes 16 false false R17.htm 00000017 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders: Sheet http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholders Net Income Attributable to Inter Parfums, Inc. Common Shareholders: Notes 17 false false R18.htm 00000018 - Disclosure - Segment and Geographic Areas: Sheet http://interparfumsinc.com/role/SegmentAndGeographicAreas Segment and Geographic Areas: Notes 18 false false R19.htm 00000019 - Disclosure - Inventories: (Tables) Sheet http://interparfumsinc.com/role/InventoriesTables Inventories: (Tables) Tables http://interparfumsinc.com/role/Inventories 19 false false R20.htm 00000020 - Disclosure - Fair Value Measurement: (Tables) Sheet http://interparfumsinc.com/role/FairValueMeasurementTables Fair Value Measurement: (Tables) Tables http://interparfumsinc.com/role/FairValueMeasurement 20 false false R21.htm 00000021 - Disclosure - Share-Based Payments: (Tables) Sheet http://interparfumsinc.com/role/Share-basedPaymentsTables Share-Based Payments: (Tables) Tables http://interparfumsinc.com/role/Share-basedPayments 21 false false R22.htm 00000022 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders: (Tables) Sheet http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersTables Net Income Attributable to Inter Parfums, Inc. Common Shareholders: (Tables) Tables http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholders 22 false false R23.htm 00000023 - Disclosure - Segment and Geographic Areas: (Tables) Sheet http://interparfumsinc.com/role/SegmentAndGeographicAreasTables Segment and Geographic Areas: (Tables) Tables http://interparfumsinc.com/role/SegmentAndGeographicAreas 23 false false R24.htm 00000024 - Disclosure - Recent Agreements: (Details Narrative) Sheet http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative Recent Agreements: (Details Narrative) Details http://interparfumsinc.com/role/RecentAgreements 24 false false R25.htm 00000025 - Disclosure - Inventories consist of the following: (Details) Sheet http://interparfumsinc.com/role/InventoriesConsistOfFollowingDetails Inventories consist of the following: (Details) Details 25 false false R26.htm 00000026 - Disclosure - The following tables present our financial assets and liabilities that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy. The fair value hierarchy has three levels based on the reliability of the inputs use (Details) Sheet http://interparfumsinc.com/role/FollowingTablesPresentOurFinancialAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnRecurringBasisAndAreCategorizedUsingFairValueHierarchy.FairValueHierarchyHasThreeLevelsBasedOnReliabilityOfInputsUseDetails The following tables present our financial assets and liabilities that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy. The fair value hierarchy has three levels based on the reliability of the inputs use (Details) Details 26 false false R27.htm 00000027 - Disclosure - Derivative Financial Instruments: (Details Narrative) Sheet http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative Derivative Financial Instruments: (Details Narrative) Details http://interparfumsinc.com/role/DerivativeFinancialInstruments 27 false false R28.htm 00000028 - Disclosure - Leases: (Details Narrative) Sheet http://interparfumsinc.com/role/LeasesDetailsNarrative Leases: (Details Narrative) Details http://interparfumsinc.com/role/Leases 28 false false R29.htm 00000029 - Disclosure - The following table sets forth information with respect to nonvested options for the six months ended June 30, 2023: (Details) Sheet http://interparfumsinc.com/role/FollowingTableSetsForthInformationWithRespectToNonvestedOptionsForSixMonthsEndedJune302023Details The following table sets forth information with respect to nonvested options for the six months ended June 30, 2023: (Details) Details 29 false false R30.htm 00000030 - Disclosure - The following table summarizes stock option information as of June 30, 2023: (Details) Sheet http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionInformationAsOfJune302023Details The following table summarizes stock option information as of June 30, 2023: (Details) Details 30 false false R31.htm 00000031 - Disclosure - Cash proceeds, tax benefits and intrinsic value related to stock options exercised during the six months ended June 30, 2023 and 2022 were as follows: (Details) Sheet http://interparfumsinc.com/role/CashProceedsTaxBenefitsAndIntrinsicValueRelatedToStockOptionsExercisedDuringSixMonthsEndedJune302023And2022WereAsFollowsDetails Cash proceeds, tax benefits and intrinsic value related to stock options exercised during the six months ended June 30, 2023 and 2022 were as follows: (Details) Details 31 false false R32.htm 00000032 - Disclosure - Share-Based Payments: (Details Narrative) Sheet http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative Share-Based Payments: (Details Narrative) Details http://interparfumsinc.com/role/Share-basedPaymentsTables 32 false false R33.htm 00000033 - Disclosure - The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows: (Details) Sheet http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows: (Details) Details 33 false false R34.htm 00000034 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders: (Details Narrative) Sheet http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersDetailsNarrative Net Income Attributable to Inter Parfums, Inc. Common Shareholders: (Details Narrative) Details http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersTables 34 false false R35.htm 00000035 - Disclosure - Information on our operations by geographical areas is as follows: (Details) Sheet http://interparfumsinc.com/role/InformationOnOurOperationsByGeographicalAreasIsAsFollowsDetails Information on our operations by geographical areas is as follows: (Details) Details 35 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 20 fact(s) appearing in ix:hidden were eligible for transformation: dei:DocumentPeriodEndDate, dei:EntityAddressStateOrProvince, us-gaap:DebtInstrumentFaceAmount, us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments, us-gaap:LineOfCredit, us-gaap:LongTermDebtTerm, us-gaap:MaximumRemainingMaturityOfForeignCurrencyDerivatives1, us-gaap:NetIncomeLoss, us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1, us-gaap:PropertyPlantAndEquipmentUsefulLife, us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1, us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1, us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 - g083669_10q.htm 34, 35, 48, 49, 50, 51, 52, 67, 68, 69, 70, 71, 72, 75, 76, 77, 78, 79, 80, 81 g083669_10q.htm g083669_ex31-1.htm g083669_ex31-2.htm g083669_ex32-1.htm g083669_ex32-2.htm ipar-20230630.xsd ipar-20230630_cal.xml ipar-20230630_def.xml ipar-20230630_lab.xml ipar-20230630_pre.xml http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 true true JSON 53 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "g083669_10q.htm": { "axisCustom": 0, "axisStandard": 12, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 559, "http://xbrl.sec.gov/dei/2023": 29 }, "contextCount": 99, "dts": { "calculationLink": { "local": [ "ipar-20230630_cal.xml" ] }, "definitionLink": { "local": [ "ipar-20230630_def.xml" ] }, "inline": { "local": [ "g083669_10q.htm" ] }, "labelLink": { "local": [ "ipar-20230630_lab.xml" ] }, "presentationLink": { "local": [ "ipar-20230630_pre.xml" ] }, "schema": { "local": [ "ipar-20230630.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/currency/2023/currency-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] } }, "elementCount": 351, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2023": 47, "http://interparfumsinc.com/20230630": 1, "http://xbrl.sec.gov/dei/2023": 7, "total": 55 }, "keyCustom": 1, "keyStandard": 218, "memberCustom": 8, "memberStandard": 21, "nsprefix": "ipar", "nsuri": "http://interparfumsinc.com/20230630", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://interparfumsinc.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000010 - Disclosure - Recent Agreements:", "menuCat": "Notes", "order": "10", "role": "http://interparfumsinc.com/role/RecentAgreements", "shortName": "Recent Agreements:", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000011 - Disclosure - Recent Accounting Pronouncements:", "menuCat": "Notes", "order": "11", "role": "http://interparfumsinc.com/role/RecentAccountingPronouncements", "shortName": "Recent Accounting Pronouncements:", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000012 - Disclosure - Inventories:", "menuCat": "Notes", "order": "12", "role": "http://interparfumsinc.com/role/Inventories", "shortName": "Inventories:", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000013 - Disclosure - Fair Value Measurement:", "menuCat": "Notes", "order": "13", "role": "http://interparfumsinc.com/role/FairValueMeasurement", "shortName": "Fair Value Measurement:", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000014 - Disclosure - Derivative Financial Instruments:", "menuCat": "Notes", "order": "14", "role": "http://interparfumsinc.com/role/DerivativeFinancialInstruments", "shortName": "Derivative Financial Instruments:", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000015 - Disclosure - Leases:", "menuCat": "Notes", "order": "15", "role": "http://interparfumsinc.com/role/Leases", "shortName": "Leases:", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000016 - Disclosure - Share-Based Payments:", "menuCat": "Notes", "order": "16", "role": "http://interparfumsinc.com/role/Share-basedPayments", "shortName": "Share-Based Payments:", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000017 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders:", "menuCat": "Notes", "order": "17", "role": "http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholders", "shortName": "Net Income Attributable to Inter Parfums, Inc. Common Shareholders:", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000018 - Disclosure - Segment and Geographic Areas:", "menuCat": "Notes", "order": "18", "role": "http://interparfumsinc.com/role/SegmentAndGeographicAreas", "shortName": "Segment and Geographic Areas:", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000019 - Disclosure - Inventories: (Tables)", "menuCat": "Tables", "order": "19", "role": "http://interparfumsinc.com/role/InventoriesTables", "shortName": "Inventories: (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "AsOf2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000002 - Statement - CONSOLIDATED BALANCE SHEETS(Unaudited)", "menuCat": "Statements", "order": "2", "role": "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited", "shortName": "CONSOLIDATED BALANCE SHEETS(Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "AsOf2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000020 - Disclosure - Fair Value Measurement: (Tables)", "menuCat": "Tables", "order": "20", "role": "http://interparfumsinc.com/role/FairValueMeasurementTables", "shortName": "Fair Value Measurement: (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000021 - Disclosure - Share-Based Payments: (Tables)", "menuCat": "Tables", "order": "21", "role": "http://interparfumsinc.com/role/Share-basedPaymentsTables", "shortName": "Share-Based Payments: (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000022 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders: (Tables)", "menuCat": "Tables", "order": "22", "role": "http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersTables", "shortName": "Net Income Attributable to Inter Parfums, Inc. Common Shareholders: (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000023 - Disclosure - Segment and Geographic Areas: (Tables)", "menuCat": "Tables", "order": "23", "role": "http://interparfumsinc.com/role/SegmentAndGeographicAreasTables", "shortName": "Segment and Geographic Areas: (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:PaymentsToAcquireProductiveAssets", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000024 - Disclosure - Recent Agreements: (Details Narrative)", "menuCat": "Details", "order": "24", "role": "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative", "shortName": "Recent Agreements: (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:PaymentsToAcquireProductiveAssets", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "AsOf2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterials", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000025 - Disclosure - Inventories consist of the following: (Details)", "menuCat": "Details", "order": "25", "role": "http://interparfumsinc.com/role/InventoriesConsistOfFollowingDetails", "shortName": "Inventories consist of the following: (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "AsOf2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterials", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "AsOf2023-06-30_us-gaap_FairValueMeasurementsRecurringMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InvestmentsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000026 - Disclosure - The following tables present our financial assets and liabilities that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy. The fair value hierarchy has three levels based on the reliability of the inputs use (Details)", "menuCat": "Details", "order": "26", "role": "http://interparfumsinc.com/role/FollowingTablesPresentOurFinancialAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnRecurringBasisAndAreCategorizedUsingFairValueHierarchy.FairValueHierarchyHasThreeLevelsBasedOnReliabilityOfInputsUseDetails", "shortName": "The following tables present our financial assets and liabilities that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy. The fair value hierarchy has three levels based on the reliability of the inputs use (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "AsOf2023-06-30_us-gaap_FairValueMeasurementsRecurringMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InvestmentsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DerivativeNotionalAmount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000027 - Disclosure - Derivative Financial Instruments: (Details Narrative)", "menuCat": "Details", "order": "27", "role": "http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative", "shortName": "Derivative Financial Instruments: (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DerivativeNotionalAmount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "AsOf2023-06-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent", "reportCount": 1, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000028 - Disclosure - Leases: (Details Narrative)", "menuCat": "Details", "order": "28", "role": "http://interparfumsinc.com/role/LeasesDetailsNarrative", "shortName": "Leases: (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "From2023-04-012023-06-30", "decimals": "0", "lang": null, "name": "us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000029 - Disclosure - The following table sets forth information with respect to nonvested options for the six months ended June 30, 2023: (Details)", "menuCat": "Details", "order": "29", "role": "http://interparfumsinc.com/role/FollowingTableSetsForthInformationWithRespectToNonvestedOptionsForSixMonthsEndedJune302023Details", "shortName": "The following table sets forth information with respect to nonvested options for the six months ended June 30, 2023: (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "AsOf2023-06-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000003 - Statement - CONSOLIDATED BALANCE SHEETS(Unaudited) (Parenthetical)", "menuCat": "Statements", "order": "3", "role": "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunauditedParenthetical", "shortName": "CONSOLIDATED BALANCE SHEETS(Unaudited) (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "AsOf2023-06-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000030 - Disclosure - The following table summarizes stock option information as of June 30, 2023: (Details)", "menuCat": "Details", "order": "30", "role": "http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionInformationAsOfJune302023Details", "shortName": "The following table summarizes stock option information as of June 30, 2023: (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProceedsFromSaleAndCollectionOfReceivables", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000031 - Disclosure - Cash proceeds, tax benefits and intrinsic value related to stock options exercised during the six months ended June 30, 2023 and 2022 were as follows: (Details)", "menuCat": "Details", "order": "31", "role": "http://interparfumsinc.com/role/CashProceedsTaxBenefitsAndIntrinsicValueRelatedToStockOptionsExercisedDuringSixMonthsEndedJune302023And2022WereAsFollowsDetails", "shortName": "Cash proceeds, tax benefits and intrinsic value related to stock options exercised during the six months ended June 30, 2023 and 2022 were as follows: (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProceedsFromSaleAndCollectionOfReceivables", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "From2023-04-012023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000032 - Disclosure - Share-Based Payments: (Details Narrative)", "menuCat": "Details", "order": "32", "role": "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative", "shortName": "Share-Based Payments: (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "From2023-04-012023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "From2022-04-012022-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000033 - Disclosure - The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows: (Details)", "menuCat": "Details", "order": "33", "role": "http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails", "shortName": "The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows: (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "From2023-04-012023-06-30", "decimals": "INF", "lang": null, "name": "us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "span", "span", "span", "span", "p", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "From2023-04-012023-06-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000034 - Disclosure - Net Income Attributable to Inter Parfums, Inc. Common Shareholders: (Details Narrative)", "menuCat": "Details", "order": "34", "role": "http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersDetailsNarrative", "shortName": "Net Income Attributable to Inter Parfums, Inc. Common Shareholders: (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "span", "span", "p", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "From2023-04-012023-06-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "From2023-04-012023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000035 - Disclosure - Information on our operations by geographical areas is as follows: (Details)", "menuCat": "Details", "order": "35", "role": "http://interparfumsinc.com/role/InformationOnOurOperationsByGeographicalAreasIsAsFollowsDetails", "shortName": "Information on our operations by geographical areas is as follows: (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "From2023-04-012023-06-30_country_US", "decimals": "-3", "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "From2023-04-012023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000004 - Statement - CONSOLIDATED STATEMENTS OF INCOME (Unaudited)", "menuCat": "Statements", "order": "4", "role": "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome", "shortName": "CONSOLIDATED STATEMENTS OF INCOME (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "From2023-04-012023-06-30", "decimals": "-3", "lang": null, "name": "us-gaap:CostOfGoodsAndServicesSold", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "From2023-04-012023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000005 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited)", "menuCat": "Statements", "order": "5", "role": "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome", "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "From2023-04-012023-06-30", "decimals": "-3", "lang": null, "name": "us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "AsOf2021-12-31_us-gaap_CommonStockMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000006 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Unaudited)", "menuCat": "Statements", "order": "6", "role": "http://interparfumsinc.com/role/ConsolidatedStatementsOfChangesInEquity", "shortName": "CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "AsOf2021-12-31_us-gaap_CommonStockMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS(Unaudited)", "menuCat": "Statements", "order": "7", "role": "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited", "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS(Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": "-3", "lang": null, "name": "us-gaap:OtherDepreciationAndAmortization", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000008 - Disclosure - Significant Accounting Policies:", "menuCat": "Notes", "order": "8", "role": "http://interparfumsinc.com/role/SignificantAccountingPolicies", "shortName": "Significant Accounting Policies:", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:UnusualOrInfrequentItemsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000009 - Disclosure - Impact of COVID-19 Pandemic:", "menuCat": "Notes", "order": "9", "role": "http://interparfumsinc.com/role/ImpactOfCovid-19Pandemic", "shortName": "Impact of COVID-19 Pandemic:", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g083669_10q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:UnusualOrInfrequentItemsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 29, "tag": { "country_US": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UNITED STATES" } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2023", "presentation": [ "http://interparfumsinc.com/role/InformationOnOurOperationsByGeographicalAreasIsAsFollowsDetails" ], "xbrltype": "domainItemType" }, "currency_AllCurrenciesDomain": { "auth_ref": [], "localname": "AllCurrenciesDomain", "nsuri": "http://xbrl.sec.gov/currency/2023", "presentation": [ "http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "currency_EUR": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Euro Member Countries, Euro" } } }, "localname": "EUR", "nsuri": "http://xbrl.sec.gov/currency/2023", "presentation": [ "http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "currency_GBP": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "United Kingdom, Pounds" } } }, "localname": "GBP", "nsuri": "http://xbrl.sec.gov/currency/2023", "presentation": [ "http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r583" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r583" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2023", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r582" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r580", "r582", "r583" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r581" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r569" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r582" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r582" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r584" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r572" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r575" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r571" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r571" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r588" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r571" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r585" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r583" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r571" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r571" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r571" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r571" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r586" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r582" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r576" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r577" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r570" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r574" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r573" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r578" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r579" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r587" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://interparfumsinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "ipar_EliminationsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents eliminations member.", "label": "Eliminations [Member]" } } }, "localname": "EliminationsMember", "nsuri": "http://interparfumsinc.com/20230630", "presentation": [ "http://interparfumsinc.com/role/InformationOnOurOperationsByGeographicalAreasIsAsFollowsDetails" ], "xbrltype": "domainItemType" }, "ipar_EmployeesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents employees member.", "label": "Employees [Member]" } } }, "localname": "EmployeesMember", "nsuri": "http://interparfumsinc.com/20230630", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "ipar_InterparfumsSAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents interparfums SA member.", "label": "Interparfums SA [Member]" } } }, "localname": "InterparfumsSAMember", "nsuri": "http://interparfumsinc.com/20230630", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "domainItemType" }, "ipar_InterparfumsSASubsidiaryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents interparfums sa subsidiary member.", "label": "Interparfums SA Subsidiary [Member]" } } }, "localname": "InterparfumsSASubsidiaryMember", "nsuri": "http://interparfumsinc.com/20230630", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "ipar_LacosteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents lacoste member.", "label": "Lacoste [Member]" } } }, "localname": "LacosteMember", "nsuri": "http://interparfumsinc.com/20230630", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "domainItemType" }, "ipar_OfficersAndManagersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents officers and managers member.", "label": "Officers and Managers [Member]" } } }, "localname": "OfficersAndManagersMember", "nsuri": "http://interparfumsinc.com/20230630", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "ipar_RobertoCavalliMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents roberto cavalli member.", "label": "Roberto Cavalli [Member]" } } }, "localname": "RobertoCavalliMember", "nsuri": "http://interparfumsinc.com/20230630", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "domainItemType" }, "ipar_RochasFashionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents rochas fashion member.", "label": "Rochas Fashion [Member]" } } }, "localname": "RochasFashionMember", "nsuri": "http://interparfumsinc.com/20230630", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "domainItemType" }, "ipar_SupplementalDisclosureOfCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents supplemental disclosure of cash flow information abstract.", "label": "Supplemental disclosure of cash flow information:" } } }, "localname": "SupplementalDisclosureOfCashFlowInformationAbstract", "nsuri": "http://interparfumsinc.com/20230630", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited" ], "xbrltype": "stringItemType" }, "ipar_TransferOfSubsidiarySharesPurchasedToTreasuryShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents transfer of subsidiary shares purchased to treasury shares.", "label": "Transfer of subsidiary shares purchased" } } }, "localname": "TransferOfSubsidiarySharesPurchasedToTreasuryShares", "nsuri": "http://interparfumsinc.com/20230630", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "srt_ConsolidatedEntitiesAxis": { "auth_ref": [ "r178", "r318", "r319", "r322", "r323", "r386", "r527", "r607", "r610", "r611" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Axis]" } } }, "localname": "ConsolidatedEntitiesAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_ConsolidatedEntitiesDomain": { "auth_ref": [ "r178", "r318", "r319", "r322", "r323", "r386", "r527", "r607", "r610", "r611" ], "localname": "ConsolidatedEntitiesDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_CurrencyAxis": { "auth_ref": [ "r625" ], "lang": { "en-us": { "role": { "label": "Currency [Axis]" } } }, "localname": "CurrencyAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_EuropeMember": { "auth_ref": [ "r644", "r645", "r646", "r647" ], "lang": { "en-us": { "role": { "label": "Europe [Member]" } } }, "localname": "EuropeMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://interparfumsinc.com/role/InformationOnOurOperationsByGeographicalAreasIsAsFollowsDetails" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [ "r248", "r249", "r250", "r251", "r286", "r391", "r420", "r445", "r446", "r497", "r499", "r501", "r502", "r511", "r528", "r529", "r537", "r540", "r547", "r555", "r612", "r630", "r631", "r632", "r633", "r634", "r635" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative", "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r248", "r249", "r250", "r251", "r286", "r391", "r420", "r445", "r446", "r497", "r499", "r501", "r502", "r511", "r528", "r529", "r537", "r540", "r547", "r555", "r612", "r630", "r631", "r632", "r633", "r634", "r635" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative", "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_OwnershipAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Ownership [Axis]" } } }, "localname": "OwnershipAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_OwnershipDomain": { "auth_ref": [], "localname": "OwnershipDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r248", "r249", "r250", "r251", "r279", "r286", "r295", "r296", "r297", "r390", "r391", "r420", "r445", "r446", "r497", "r499", "r501", "r502", "r511", "r528", "r529", "r537", "r540", "r547", "r555", "r558", "r606", "r612", "r631", "r632", "r633", "r634", "r635" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative", "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r248", "r249", "r250", "r251", "r279", "r286", "r295", "r296", "r297", "r390", "r391", "r420", "r445", "r446", "r497", "r499", "r501", "r502", "r511", "r528", "r529", "r537", "r540", "r547", "r555", "r558", "r606", "r612", "r631", "r632", "r633", "r634", "r635" ], "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative", "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r235", "r236", "r438", "r441", "r443", "r498", "r500", "r503", "r512", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r531", "r541", "r558", "r613", "r637" ], "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://interparfumsinc.com/role/InformationOnOurOperationsByGeographicalAreasIsAsFollowsDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r235", "r236", "r438", "r441", "r443", "r498", "r500", "r503", "r512", "r516", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r531", "r541", "r558", "r613", "r637" ], "lang": { "en-us": { "role": { "label": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://interparfumsinc.com/role/InformationOnOurOperationsByGeographicalAreasIsAsFollowsDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r604", "r627" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingChangesAndErrorCorrectionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Changes and Error Corrections [Abstract]" } } }, "localname": "AccountingChangesAndErrorCorrectionsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r22", "r554" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts payable \u2013 trade" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r238", "r239" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts receivable, net" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r24" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued expenses" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r30", "r31", "r87", "r146", "r405", "r425", "r428" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.", "label": "Accumulated other comprehensive loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r1", "r13", "r31", "r328", "r331", "r384", "r421", "r422", "r594", "r595", "r596", "r600", "r601", "r602" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AcquisitionCosts": { "auth_ref": [ "r117", "r118" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The capitalized costs incurred during the period (excluded from amortization) to purchase, lease or otherwise acquire an unproved property, including costs of lease bonuses and options to purchase or lease properties, the portion of costs applicable to minerals when land including mineral rights is purchased in fee, brokers' fees, recording fees, legal costs, and other costs incurred in acquiring properties.", "label": "Acquisition costs, period cost" } } }, "localname": "AcquisitionCosts", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r79", "r554", "r640" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r300", "r301", "r302", "r434", "r600", "r601", "r602", "r621", "r642" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net income to net cash provided by (used in) operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited" ], "xbrltype": "stringItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r298", "r303" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Share-based payment arrangement, expense" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r206" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive potential common shares outstanding" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_AssetAtFairValueChangesInFairValueResultingFromChangesInAssumptions": { "auth_ref": [], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in fair value from changes in the assumptions or model used to calculate the fair value of a contract to service financial assets under which the benefits of servicing are expected to more than adequately compensate the servicer.", "label": "Change in fair value of derivatives" } } }, "localname": "AssetAtFairValueChangesInFairValueResultingFromChangesInAssumptions", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_Assets": { "auth_ref": [ "r119", "r143", "r177", "r215", "r224", "r229", "r241", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r318", "r322", "r351", "r402", "r465", "r554", "r568", "r608", "r609", "r628" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited", "http://interparfumsinc.com/role/InformationOnOurOperationsByGeographicalAreasIsAsFollowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r139", "r149", "r177", "r241", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r318", "r322", "r351", "r554", "r608", "r609", "r628" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsFairValueDisclosure": { "auth_ref": [ "r72" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Total asset" } } }, "localname": "AssetsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FollowingTablesPresentOurFinancialAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnRecurringBasisAndAreCategorizedUsingFairValueHierarchy.FairValueHierarchyHasThreeLevelsBasedOnReliabilityOfInputsUseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsFairValueDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets:" } } }, "localname": "AssetsFairValueDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FollowingTablesPresentOurFinancialAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnRecurringBasisAndAreCategorizedUsingFairValueHierarchy.FairValueHierarchyHasThreeLevelsBasedOnReliabilityOfInputsUseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BuildingMember": { "auth_ref": [ "r107" ], "lang": { "en-us": { "role": { "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.", "label": "Building [Member]" } } }, "localname": "BuildingMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r315", "r545", "r546" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree." } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r57", "r59", "r315", "r545", "r546" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity": { "auth_ref": [ "r58" ], "lang": { "en-us": { "role": { "documentation": "With respect to a business combination completed during the period, this element provides a description of the business, other than the name, which may include the industry, size, products and other important information.", "label": "Description of recent agreement" } } }, "localname": "BusinessAcquisitionDescriptionOfAcquiredEntity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionLineItems": { "auth_ref": [ "r315" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Acquisition [Line Items]" } } }, "localname": "BusinessAcquisitionLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination and Asset Acquisition [Abstract]" } } }, "localname": "BusinessCombinationAndAssetAcquisitionAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "auth_ref": [ "r112", "r316" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).", "label": "Recent Agreements:" } } }, "localname": "BusinessCombinationDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/RecentAgreements" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r39", "r141", "r532" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r39", "r102", "r174" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodEndLabel": "Cash and cash equivalents - end of period", "periodStartLabel": "Cash and cash equivalents - beginning of period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r0", "r102" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net decrease in cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of cash received from exercise of stock options and similar instruments granted under share-based payment arrangements and tax benefit from exercise of stock options.", "label": "Cash proceeds, tax benefits and intrinsic value related to stock options exercised during the six months ended June 30, 2023 and 2022 were as follows:" } } }, "localname": "CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockDividendsPerShareDeclared": { "auth_ref": [ "r109" ], "lang": { "en-us": { "role": { "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.", "label": "Dividends declared per share" } } }, "localname": "CommonStockDividendsPerShareDeclared", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r556", "r557", "r558", "r560", "r561", "r562", "r565", "r600", "r601", "r621", "r638", "r642" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r78" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common stock, par or stated value per share" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunauditedParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r78", "r453" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunauditedParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r14", "r78", "r453", "r471", "r642", "r643" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common stock, shares, outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunauditedParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r78", "r404", "r554" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock, $.001 par; authorized 100,000,000 shares; outstanding 31,975,670 and 31,967,300 shares at June 30, 2023 and December 31, 2022, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r32", "r157", "r159", "r166", "r398", "r416" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Comprehensive income attributable to Inter Parfums, Inc." } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Comprehensive income:" } } }, "localname": "ComprehensiveIncomeNetOfTaxAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "stringItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": { "auth_ref": [ "r7", "r62", "r65", "r157", "r159", "r165", "r397", "r415" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest", "totalLabel": "Comprehensive income (loss) attributable to the noncontrolling interests" } } }, "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Comprehensive income attributable to the noncontrolling interests:" } } }, "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "stringItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r65", "r113", "r157", "r159", "r164", "r396", "r414" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest", "totalLabel": "Comprehensive income (loss)" } } }, "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r92", "r392" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of sales" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r73", "r75", "r261", "r372", "r538", "r539" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt instrument, face amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateTerms": { "auth_ref": [ "r26" ], "lang": { "en-us": { "role": { "documentation": "Description of the interest rate as being fixed or variable, and, if variable, identification of the index or rate on which the interest rate is based and the number of points or percentage added to that index or rate to set the rate, and other pertinent information, such as frequency of rate resets.", "label": "Description of debt instrument interest rate terms" } } }, "localname": "DebtInstrumentInterestRateTerms", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredIncomeTaxAssetsNet": { "auth_ref": [ "r304", "r305" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.", "label": "Deferred tax assets" } } }, "localname": "DeferredIncomeTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "auth_ref": [ "r9", "r111", "r130", "r313", "r314", "r599" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred tax provision (benefit)" } } }, "localname": "DeferredIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxExpenseFromStockOptionsExercised": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax expense from write-off of the deferred tax asset related to deductible stock options at exercise.", "label": "Tax benefits" } } }, "localname": "DeferredTaxExpenseFromStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/CashProceedsTaxBenefitsAndIntrinsicValueRelatedToStockOptionsExercisedDuringSixMonthsEndedJune302023And2022WereAsFollowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssets": { "auth_ref": [ "r150", "r151", "r350", "r436", "r437", "r438", "r439", "r440", "r442", "r443", "r444", "r445", "r446", "r459", "r460", "r504", "r506", "r507", "r508", "r509", "r510", "r534", "r558", "r639" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Interest rate swaps" } } }, "localname": "DerivativeAssets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FollowingTablesPresentOurFinancialAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnRecurringBasisAndAreCategorizedUsingFairValueHierarchy.FairValueHierarchyHasThreeLevelsBasedOnReliabilityOfInputsUseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [ "r444", "r446", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r466", "r467", "r468", "r469", "r479", "r480", "r481", "r482", "r485", "r486", "r487", "r488", "r504", "r505", "r507", "r509", "r556", "r558" ], "lang": { "en-us": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset." } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative", "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeFixedInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fixed interest rate related to the interest rate derivative.", "label": "Fixed interest rate" } } }, "localname": "DerivativeFixedInterestRate", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r66", "r67", "r68", "r69", "r444", "r446", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r466", "r467", "r468", "r469", "r479", "r480", "r481", "r482", "r485", "r486", "r487", "r488", "r504", "r505", "r507", "r509", "r534", "r556", "r558" ], "lang": { "en-us": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument [Axis]" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative", "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "auth_ref": [ "r116", "r326", "r334" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.", "label": "Derivative Financial Instruments:" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/DerivativeFinancialInstruments" ], "xbrltype": "textBlockItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": { "auth_ref": [ "r15", "r66", "r68", "r69", "r70", "r71", "r325" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.", "label": "Derivative Instruments, Gain (Loss) [Table]" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossLineItems": { "auth_ref": [ "r325" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative Instruments, Gain (Loss) [Line Items]" } } }, "localname": "DerivativeInstrumentsGainLossLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeNotionalAmount": { "auth_ref": [ "r619", "r620" ], "lang": { "en-us": { "role": { "documentation": "Nominal or face amount used to calculate payment on derivative.", "label": "Loan amount" } } }, "localname": "DerivativeNotionalAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeSwaptionInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fixed interest rate that will be received or paid upon exercise of the interest rate swaption contract.", "label": "Derivative swap interest rate" } } }, "localname": "DerivativeSwaptionInterestRate", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DerivativeVariableInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Variable interest rate in effect as of the balance sheet date related to the interest rate derivative.", "label": "Variable interest rate" } } }, "localname": "DerivativeVariableInterestRate", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax": { "auth_ref": [ "r624" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of reclassification from other comprehensive income (loss) to earnings from the sale or complete or substantially complete liquidation of an investment in a foreign entity.", "label": "Transfer from other comprehensive income into earnings" } } }, "localname": "DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_DistributionMadeToLimitedPartnerUnitDistribution": { "auth_ref": [ "r109" ], "lang": { "en-us": { "role": { "documentation": "Number of units distributed for payment of a unit distribution to unit-holder of limited partnership (LP).", "label": "Number of share distributed" } } }, "localname": "DistributionMadeToLimitedPartnerUnitDistribution", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_DividendsCash": { "auth_ref": [ "r6", "r109" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of paid and unpaid cash dividends declared for classes of stock, for example, but not limited to, common and preferred.", "label": "Dividends, Cash", "negatedLabel": "Dividends" } } }, "localname": "DividendsCash", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings per share:", "verboseLabel": "Earnings Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r167", "r188", "r189", "r190", "r191", "r192", "r199", "r201", "r203", "r204", "r205", "r209", "r338", "r339", "r399", "r417", "r535" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Basic" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome", "http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareBasicAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net income attributable to Inter Parfums, Inc. common shareholders:" } } }, "localname": "EarningsPerShareBasicAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r167", "r188", "r189", "r190", "r191", "r192", "r201", "r203", "r204", "r205", "r209", "r338", "r339", "r399", "r417", "r535" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Diluted" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome", "http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r198", "r206", "r207", "r208" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Net Income Attributable to Inter Parfums, Inc. Common Shareholders:" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholders" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r362" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited": { "order": 4.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect of exchange rate changes on cash" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "auth_ref": [ "r299" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.", "label": "Unrecognized compensation cost" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense": { "auth_ref": [ "r56" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of plan compensation cost recognized during the period.", "label": "Recognized as compensation cost" } } }, "localname": "EmployeeStockOwnershipPlanESOPCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity:", "verboseLabel": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited" ], "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r14", "r135", "r160", "r161", "r162", "r179", "r180", "r181", "r185", "r193", "r195", "r210", "r242", "r245", "r276", "r300", "r301", "r302", "r307", "r308", "r327", "r328", "r329", "r330", "r331", "r333", "r337", "r364", "r365", "r366", "r367", "r368", "r370", "r384", "r421", "r422", "r423", "r434", "r492" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfChangesInEquity", "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_EscrowDeposit": { "auth_ref": [ "r76", "r517" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The designation of funds furnished by a borrower to a lender to assure future payments of the borrower's real estate taxes and insurance obligations with respect to a mortgaged property. Escrow deposits may be made for a variety of other purposes such as earnest money and contingent payments. This element excludes replacement reserves which are an escrow separately provided for within the US GAAP taxonomy.", "label": "Cash held in escrow is included in other assets" } } }, "localname": "EscrowDeposit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ExtraordinaryAndUnusualItemsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Unusual or Infrequent Items, or Both [Abstract]" } } }, "localname": "ExtraordinaryAndUnusualItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [ "r344", "r345", "r348" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FollowingTablesPresentOurFinancialAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnRecurringBasisAndAreCategorizedUsingFairValueHierarchy.FairValueHierarchyHasThreeLevelsBasedOnReliabilityOfInputsUseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r344", "r345", "r348" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FollowingTablesPresentOurFinancialAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnRecurringBasisAndAreCategorizedUsingFairValueHierarchy.FairValueHierarchyHasThreeLevelsBasedOnReliabilityOfInputsUseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r262", "r280", "r281", "r282", "r283", "r284", "r285", "r345", "r387", "r388", "r389", "r538", "r539", "r542", "r543", "r544" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FollowingTablesPresentOurFinancialAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnRecurringBasisAndAreCategorizedUsingFairValueHierarchy.FairValueHierarchyHasThreeLevelsBasedOnReliabilityOfInputsUseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r344", "r345", "r346", "r347", "r349" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement frequency.", "label": "Measurement Frequency [Axis]" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FollowingTablesPresentOurFinancialAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnRecurringBasisAndAreCategorizedUsingFairValueHierarchy.FairValueHierarchyHasThreeLevelsBasedOnReliabilityOfInputsUseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r343" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Measurement:" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FairValueMeasurement" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r262", "r280", "r285", "r345", "r387", "r542", "r543", "r544" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FollowingTablesPresentOurFinancialAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnRecurringBasisAndAreCategorizedUsingFairValueHierarchy.FairValueHierarchyHasThreeLevelsBasedOnReliabilityOfInputsUseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r262", "r280", "r285", "r345", "r388", "r538", "r539", "r542", "r543", "r544" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FollowingTablesPresentOurFinancialAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnRecurringBasisAndAreCategorizedUsingFairValueHierarchy.FairValueHierarchyHasThreeLevelsBasedOnReliabilityOfInputsUseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r262", "r280", "r281", "r282", "r283", "r284", "r285", "r345", "r389", "r538", "r539", "r542", "r543", "r544" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FollowingTablesPresentOurFinancialAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnRecurringBasisAndAreCategorizedUsingFairValueHierarchy.FairValueHierarchyHasThreeLevelsBasedOnReliabilityOfInputsUseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement frequency." } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FollowingTablesPresentOurFinancialAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnRecurringBasisAndAreCategorizedUsingFairValueHierarchy.FairValueHierarchyHasThreeLevelsBasedOnReliabilityOfInputsUseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r262", "r280", "r281", "r282", "r283", "r284", "r285", "r387", "r388", "r389", "r538", "r539", "r542", "r543", "r544" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FollowingTablesPresentOurFinancialAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnRecurringBasisAndAreCategorizedUsingFairValueHierarchy.FairValueHierarchyHasThreeLevelsBasedOnReliabilityOfInputsUseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsRecurringMember": { "auth_ref": [ "r343", "r349" ], "lang": { "en-us": { "role": { "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.", "label": "Fair Value, Recurring [Member]" } } }, "localname": "FairValueMeasurementsRecurringMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FollowingTablesPresentOurFinancialAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnRecurringBasisAndAreCategorizedUsingFairValueHierarchy.FairValueHierarchyHasThreeLevelsBasedOnReliabilityOfInputsUseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of liability contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward (delivery or nondelivery) contracts, and swaps entered into.", "label": "Forward exchange contracts" } } }, "localname": "ForeignCurrencyContractsLiabilityFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyFairValueHedgeAssetAtFairValue": { "auth_ref": [ "r67" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value as of the balance sheet date of all derivative assets designated as foreign currency fair value hedging instruments.", "label": "Foreign currency forward exchange contracts accounted for using hedge accounting" } } }, "localname": "ForeignCurrencyFairValueHedgeAssetAtFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FollowingTablesPresentOurFinancialAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnRecurringBasisAndAreCategorizedUsingFairValueHierarchy.FairValueHierarchyHasThreeLevelsBasedOnReliabilityOfInputsUseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyFairValueHedgeLiabilityAtFairValue": { "auth_ref": [ "r67" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value as of the balance sheet date of all derivative liabilities designated as foreign currency fair value hedging instruments.", "label": "Foreign currency forward exchange contracts not accounted for using hedge accounting" } } }, "localname": "ForeignCurrencyFairValueHedgeLiabilityAtFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FollowingTablesPresentOurFinancialAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnRecurringBasisAndAreCategorizedUsingFairValueHierarchy.FairValueHierarchyHasThreeLevelsBasedOnReliabilityOfInputsUseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": { "auth_ref": [ "r355", "r357", "r359", "r361", "r489" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction.", "label": "Gain (Loss), Foreign Currency Transaction, before Tax", "negatedLabel": "(Gain) loss on foreign currency" } } }, "localname": "ForeignCurrencyTransactionGainLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignExchangeContractMember": { "auth_ref": [ "r534", "r542", "r552" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.", "label": "Foreign Exchange Contract [Member]" } } }, "localname": "ForeignExchangeContractMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r91", "r177", "r215", "r223", "r228", "r231", "r241", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r351", "r536", "r608" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross margin" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r215", "r223", "r228", "r231", "r418", "r536" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome": { "order": 1.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.", "label": "Income before income taxes", "totalLabel": "Income before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome", "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r9", "r89", "r125", "r219", "r240", "r410" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).", "label": "Income (Loss) from Equity Method Investments", "negatedLabel": "Share of income of equity investment" } } }, "localname": "IncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r129", "r133", "r194", "r195", "r220", "r306", "r312", "r419" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome": { "order": 2.0, "parentTag": "us-gaap_ProfitLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income taxes" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaid": { "auth_ref": [ "r38", "r40" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.", "label": "Income Taxes Paid", "verboseLabel": "Income taxes" } } }, "localname": "IncomeTaxesPaid", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesReceivable": { "auth_ref": [ "r76", "r590" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited": { "order": 7.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.", "label": "Income taxes receivable" } } }, "localname": "IncomeTaxesReceivable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r8" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Accounts payable and accrued expenses" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r8" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedTaxesPayable": { "auth_ref": [ "r597" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period of all taxes owed but not paid, including income, property and other taxes.", "label": "Income taxes, net" } } }, "localname": "IncreaseDecreaseInAccruedTaxesPayable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r8" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventories" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": { "auth_ref": [ "r589", "r597" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligation for operating lease.", "label": "Operating lease liabilities" } } }, "localname": "IncreaseDecreaseInOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingAssets": { "auth_ref": [ "r8" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in operating assets classified as other.", "label": "Increase (Decrease) in Other Operating Assets", "negatedLabel": "Other assets" } } }, "localname": "IncreaseDecreaseInOtherOperatingAssets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r46", "r47" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Trademarks, licenses and other intangible assets, net" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r74", "r127", "r163", "r218", "r371", "r476", "r566", "r641" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r169", "r172", "r173" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestRateSwapMember": { "auth_ref": [ "r530", "r563", "r564" ], "lang": { "en-us": { "role": { "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.", "label": "Interest Rate Swap [Member]" } } }, "localname": "InterestRateSwapMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_InventoryDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Abstract]" } } }, "localname": "InventoryDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureTextBlock": { "auth_ref": [ "r247" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.", "label": "Inventories:" } } }, "localname": "InventoryDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/Inventories" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryFinishedGoods": { "auth_ref": [ "r591" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.", "label": "Finished goods" } } }, "localname": "InventoryFinishedGoods", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/InventoriesConsistOfFollowingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r147", "r533", "r554" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventories", "totalLabel": "Inventories" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited", "http://interparfumsinc.com/role/InventoriesConsistOfFollowingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryRawMaterials": { "auth_ref": [ "r592" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Raw materials and component parts" } } }, "localname": "InventoryRawMaterials", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/InventoriesConsistOfFollowingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeNet": { "auth_ref": [ "r95", "r97" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome": { "order": 3.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.", "label": "Investment Income, Net", "negatedLabel": "Interest and investment (income) loss" } } }, "localname": "InvestmentIncomeNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentsFairValueDisclosure": { "auth_ref": [ "r344" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.", "label": "Investments, Fair Value Disclosure", "verboseLabel": "Short-term investments" } } }, "localname": "InvestmentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FollowingTablesPresentOurFinancialAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnRecurringBasisAndAreCategorizedUsingFairValueHierarchy.FairValueHierarchyHasThreeLevelsBasedOnReliabilityOfInputsUseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LandMember": { "auth_ref": [ "r614" ], "lang": { "en-us": { "role": { "documentation": "Part of earth's surface not covered by water.", "label": "Land [Member]" } } }, "localname": "LandMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_LeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases [Abstract]" } } }, "localname": "LeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_LesseeOperatingLeasesTextBlock": { "auth_ref": [ "r375" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.", "label": "Leases:" } } }, "localname": "LesseeOperatingLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/Leases" ], "xbrltype": "textBlockItemType" }, "us-gaap_LiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities:" } } }, "localname": "LiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FollowingTablesPresentOurFinancialAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnRecurringBasisAndAreCategorizedUsingFairValueHierarchy.FairValueHierarchyHasThreeLevelsBasedOnReliabilityOfInputsUseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r83", "r122", "r408", "r554", "r598", "r605", "r623" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LIABILITIES AND EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r25", "r140", "r177", "r241", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r319", "r322", "r323", "r351", "r554", "r608", "r628", "r629" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesFairValueDisclosure": { "auth_ref": [ "r72" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial and nonfinancial obligations.", "label": "Total Liabilities" } } }, "localname": "LiabilitiesFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FollowingTablesPresentOurFinancialAssetsAndLiabilitiesThatAreMeasuredAtFairValueOnRecurringBasisAndAreCategorizedUsingFairValueHierarchy.FairValueHierarchyHasThreeLevelsBasedOnReliabilityOfInputsUseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCredit": { "auth_ref": [ "r20", "r120", "r636" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.", "label": "Long-term line of credit" } } }, "localname": "LineOfCredit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LoansPayableToBank": { "auth_ref": [ "r20", "r120", "r636" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of loans from a bank with maturities initially due after one year or beyond the normal operating cycle if longer.", "label": "Loans payable - banks" } } }, "localname": "LoansPayableToBank", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtCurrent": { "auth_ref": [ "r144" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation.", "label": "Current portion of long-term debt" } } }, "localname": "LongTermDebtCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtNoncurrent": { "auth_ref": [ "r145" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.", "label": "Long\u2013term debt, less current portion" } } }, "localname": "LongTermDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtTerm": { "auth_ref": [ "r622" ], "lang": { "en-us": { "role": { "documentation": "Period between issuance and maturity of long-term debt, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Long-term debt, term" } } }, "localname": "LongTermDebtTerm", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative", "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Maximum amount of time remaining before foreign currency exchange rate derivatives mature or expire, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Maturity of foreign currency" } } }, "localname": "MaximumRemainingMaturityOfForeignCurrencyDerivatives1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/DerivativeFinancialInstrumentsDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_MinorityInterest": { "auth_ref": [ "r29", "r121", "r177", "r241", "r252", "r254", "r255", "r256", "r259", "r260", "r351", "r407", "r455" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity.", "label": "Noncontrolling interest" } } }, "localname": "MinorityInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterestOwnershipPercentageByParent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage.", "label": "Ownership percentage" } } }, "localname": "MinorityInterestOwnershipPercentageByParent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r171" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash used in financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from financing activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r171" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash provided by (used in) investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from investing activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r102", "r103", "r104" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash provided by (used in) operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from operating activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r90", "r104", "r126", "r138", "r155", "r158", "r162", "r177", "r184", "r188", "r189", "r190", "r191", "r194", "r195", "r202", "r215", "r223", "r228", "r231", "r241", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r339", "r351", "r413", "r473", "r490", "r491", "r536", "r566", "r608" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net income attributable to Inter Parfums, Inc.", "totalLabel": "Net income attributable to Inter Parfums, Inc." } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome", "http://interparfumsinc.com/role/InformationOnOurOperationsByGeographicalAreasIsAsFollowsDetails", "http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "auth_ref": [ "r64", "r115", "r155", "r158", "r194", "r195", "r412", "r596" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "weight": 1.0 }, "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.", "label": "Less:\u00a0\u00a0Net income attributable to the noncontrolling interest", "verboseLabel": "Net income" } } }, "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome", "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "verboseLabel": "Net income attributable to Inter Parfums, Inc. common shareholders:" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasicAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": { "auth_ref": [ "r131", "r132", "r134", "r137", "r182", "r183", "r186", "r187", "r196", "r197", "r243", "r244", "r309", "r310", "r311", "r332", "r336", "r340", "r341", "r342", "r352", "r353", "r354", "r373", "r374", "r385", "r393", "r394", "r395", "r424", "r425", "r426", "r427", "r428" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.", "label": "Recent Accounting Pronouncements:" } } }, "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/RecentAccountingPronouncements" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance": { "auth_ref": [ "r11", "r49", "r114" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in noncontrolling interest from subsidiary issuance of equity interests to noncontrolling interest holders.", "label": "Purchase of subsidiary shares" } } }, "localname": "NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_NoncontrollingInterestMember": { "auth_ref": [ "r60", "r276", "r600", "r601", "r602", "r642" ], "lang": { "en-us": { "role": { "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.", "label": "Noncontrolling Interest [Member]" } } }, "localname": "NoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "domainItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r96" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "negatedTotalLabel": "Nonoperating Income (Expense)" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other expenses (income):" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r215", "r223", "r228", "r231", "r536" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Income from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseCost": { "auth_ref": [ "r379", "r553" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.", "label": "Noncash additions to operating lease assets" } } }, "localname": "OperatingLeaseCost", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/LeasesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseExpense": { "auth_ref": [ "r626" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating lease expense. Excludes sublease income.", "label": "Noncash lease expense" } } }, "localname": "OperatingLeaseExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r377" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Current portion of lease liabilities" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r377" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Lease liabilities, less current portion" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r378", "r380" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Operating lease, payments" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/LeasesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r376" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Right-of-use assets, net" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r383", "r553" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Operating lease, weighted average discount rate, percent" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/LeasesDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r382", "r553" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating lease, weighted average remaining lease term" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/LeasesDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_OtherAssetsCurrent": { "auth_ref": [ "r148", "r554" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited": { "order": 6.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current assets classified as other.", "label": "Other current assets" } } }, "localname": "OtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r142" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": { "auth_ref": [ "r3", "r87", "r356", "r358", "r363" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome": { "order": 3.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax", "negatedLabel": "Translation adjustments, net of tax" } } }, "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax": { "auth_ref": [ "r2", "r4", "r356", "r360", "r369" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of tax expense (benefit), before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Foreign currency translation adjustment, net of tax" } } }, "localname": "OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax": { "auth_ref": [ "r152", "r153", "r154", "r324" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of adjustments from accumulated other comprehensive income (AOCI) for gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.", "label": "Net derivative instrument gain (loss), net of tax", "negatedLabel": "Net derivative instrument loss, net of tax" } } }, "localname": "OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfChangesInEquity", "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "auth_ref": [ "r2" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome": { "order": 4.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Translation adjustments, net of tax" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other comprehensive income (loss):" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r7", "r12", "r113", "r156", "r159" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of other comprehensive income (loss) attributable to noncontrolling interests.", "label": "Net derivative instrument loss, net of tax" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherDepreciationAndAmortization": { "auth_ref": [ "r9", "r48", "r93" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other.", "label": "Depreciation and amortization" } } }, "localname": "OtherDepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r98" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome": { "order": 4.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income (Expense)", "negatedLabel": "Other income" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherReceivablesNetCurrent": { "auth_ref": [], "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.", "label": "Receivables, other" } } }, "localname": "OtherReceivablesNetCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRepurchaseOfEquity": { "auth_ref": [ "r36", "r430" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to reacquire common and preferred stock.", "label": "Payments for Repurchase of Equity", "negatedLabel": "Purchase of treasury stock" } } }, "localname": "PaymentsForRepurchaseOfEquity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDividendsCommonStock": { "auth_ref": [ "r36" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.", "label": "Payments of Ordinary Dividends, Common Stock", "negatedLabel": "Dividends paid" } } }, "localname": "PaymentsOfDividendsCommonStock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDividendsMinorityInterest": { "auth_ref": [ "r36" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.", "label": "Payments of Ordinary Dividends, Noncontrolling Interest", "negatedLabel": "Dividends paid to noncontrolling interest" } } }, "localname": "PaymentsOfDividendsMinorityInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireIntangibleAssets": { "auth_ref": [ "r101" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.", "label": "Payments to Acquire Intangible Assets", "negatedLabel": "Payment for intangible assets acquired" } } }, "localname": "PaymentsToAcquireIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireInvestments": { "auth_ref": [ "r100" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.", "label": "Payments to Acquire Investments", "negatedLabel": "Purchases of short-term investments" } } }, "localname": "PaymentsToAcquireInvestments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireProductiveAssets": { "auth_ref": [ "r128", "r616", "r617", "r618" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.", "label": "Purchase price, period cost" } } }, "localname": "PaymentsToAcquireProductiveAssets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r101" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Purchases of property, equipment and leasehold improvements" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToMinorityShareholders": { "auth_ref": [ "r35" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.", "label": "Payments to Noncontrolling Interests", "negatedLabel": "Purchase of subsidiary shares from noncontrolling interest" } } }, "localname": "PaymentsToMinorityShareholders", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r77", "r264" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred stock, par value (in dollars per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunauditedParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r77", "r453" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunauditedParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r77", "r264" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred stock, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunauditedParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r77", "r403", "r554" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred stock, $.001 par; authorized 1,000,000 shares; none issued" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted": { "auth_ref": [], "calculation": { "http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "The weighted average number of shares or units and dilutive common stock or unit equivalents outstanding in the calculation of proforma diluted earnings per share (earnings per unit), which is commonly presented in initial public offerings based on the terms of the offering.", "label": "Denominator for diluted earnings per share" } } }, "localname": "ProFormaWeightedAverageSharesOutstandingDiluted", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ProceedsFromConstructionLoansPayable": { "auth_ref": [ "r34" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from borrowings to finance the cost of construction.", "label": "Proceeds from loans payable, bank" } } }, "localname": "ProceedsFromConstructionLoansPayable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleAndCollectionOfReceivables": { "auth_ref": [ "r33" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the proceeds from sale and collection of receivables during the period.", "label": "Cash proceeds from stock options exercised" } } }, "localname": "ProceedsFromSaleAndCollectionOfReceivables", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/CashProceedsTaxBenefitsAndIntrinsicValueRelatedToStockOptionsExercisedDuringSixMonthsEndedJune302023And2022WereAsFollowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments": { "auth_ref": [ "r33" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the sale, maturity and collection of all investments such as debt, security and so forth during the period.", "label": "Proceeds from sale of short-term investments" } } }, "localname": "ProceedsFromSaleMaturityAndCollectionsOfInvestments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromStockOptionsExercised": { "auth_ref": [ "r5", "r18" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.", "label": "Proceeds from exercise of options" } } }, "localname": "ProceedsFromStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r138", "r155", "r158", "r170", "r177", "r184", "r194", "r195", "r215", "r223", "r228", "r231", "r241", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r317", "r320", "r321", "r339", "r351", "r400", "r411", "r433", "r473", "r490", "r491", "r536", "r550", "r551", "r567", "r596", "r608" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 }, "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net income", "totalLabel": "Net income" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited", "http://interparfumsinc.com/role/ConsolidatedStatementsOfChangesInEquity", "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome", "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r10", "r401", "r409", "r554" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, equipment and leasehold improvements, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r107" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Depreciated over a range" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_ProvisionForDoubtfulAccounts": { "auth_ref": [ "r168", "r246" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.", "label": "Provision for doubtful accounts" } } }, "localname": "ProvisionForDoubtfulAccounts", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent": { "auth_ref": [ "r19", "r31" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome": { "order": 3.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.", "label": "Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent", "negatedLabel": "Transfer from OCI into earnings" } } }, "localname": "ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfLongTermDebt": { "auth_ref": [ "r37", "r430" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.", "label": "Repayments of Long-Term Debt", "negatedLabel": "Repayment of long-term debt" } } }, "localname": "RepaymentsOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r80", "r109", "r406", "r424", "r428", "r431", "r454", "r554" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated undistributed earnings (deficit).", "label": "Retained earnings" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r135", "r179", "r180", "r181", "r185", "r193", "r195", "r242", "r245", "r300", "r301", "r302", "r307", "r308", "r327", "r329", "r330", "r333", "r337", "r421", "r423", "r434", "r642" ], "lang": { "en-us": { "role": { "documentation": "Accumulated undistributed earnings (deficit).", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": { "auth_ref": [ "r216", "r217", "r222", "r226", "r227", "r233", "r235", "r237", "r277", "r278", "r392" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.", "label": "Net sales" } } }, "localname": "RevenueFromContractWithCustomerIncludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome", "http://interparfumsinc.com/role/InformationOnOurOperationsByGeographicalAreasIsAsFollowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Revenues from External Customers and Long-Lived Assets [Line Items]" } } }, "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/InformationOnOurOperationsByGeographicalAreasIsAsFollowsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "auth_ref": [ "r381", "r553" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.", "label": "Operating leases, rent expense, net" } } }, "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/LeasesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "auth_ref": [ "r57", "r59", "r315" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.", "label": "Schedule of Business Acquisitions, by Acquisition [Table]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/RecentAgreementsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r603" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows:" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/NetIncomeAttributableToInterParfumsInc.CommonShareholdersTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "auth_ref": [ "r344", "r345" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "The following tables present our financial assets and liabilities that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy. The fair value hierarchy has three levels based on the reliability of the inputs used to determine fair value." } } }, "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FairValueMeasurementTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r21", "r84", "r85", "r86" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Inventories consist of the following:" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/InventoriesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock": { "auth_ref": [ "r54" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the changes in outstanding nonvested shares.", "label": "The following table sets forth information with respect to nonvested options for the six months ended June 30, 2023:" } } }, "localname": "ScheduleOfNonvestedShareActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": { "auth_ref": [ "r44", "r88" ], "lang": { "en-us": { "role": { "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.", "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]" } } }, "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/InformationOnOurOperationsByGeographicalAreasIsAsFollowsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r41", "r42", "r43", "r45" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Information on our operations by geographical areas is as follows:" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/SegmentAndGeographicAreasTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r16", "r17", "r53" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "The following table summarizes stock option information as of June 30, 2023:" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of subsidiary's sales of previously unissued stock made to investors outside the consolidated group. This includes stock issued in a business combination in exchange for shares of an acquired entity.", "label": "Schedule of Subsidiary or Equity Method Investee [Table]" } } }, "localname": "ScheduleOfSubsidiaryOrEquityMethodInvesteeTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r211", "r212", "r213", "r214", "r215", "r221", "r225", "r229", "r230", "r231", "r232", "r233", "r234", "r237" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment and Geographic Areas:" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/SegmentAndGeographicAreas" ], "xbrltype": "textBlockItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r94" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, general and administrative expenses" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r8" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Noncash stock compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [ "r548" ], "lang": { "en-us": { "role": { "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Options vesting period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "auth_ref": [ "r549" ], "lang": { "en-us": { "role": { "documentation": "Number of shares authorized for issuance under share-based payment arrangement.", "label": "Aggregate shares to offices and managers" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "auth_ref": [ "r52" ], "lang": { "en-us": { "role": { "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.", "label": "Options available for future grants" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionInformationAsOfJune302023Details" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r289" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Options exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionInformationAsOfJune302023Details" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r289" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Weighted average exercise price options exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionInformationAsOfJune302023Details" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": { "auth_ref": [ "r294" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.", "label": "Intrinsic value of stock options exercised" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/CashProceedsTaxBenefitsAndIntrinsicValueRelatedToStockOptionsExercisedDuringSixMonthsEndedJune302023And2022WereAsFollowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r292" ], "lang": { "en-us": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period", "negatedLabel": "Options forfeited" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionInformationAsOfJune302023Details" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": { "auth_ref": [ "r615" ], "lang": { "en-us": { "role": { "documentation": "Net number of share options (or share units) granted during the period.", "label": "Options granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [ "r290" ], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Nonvested options granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSetsForthInformationWithRespectToNonvestedOptionsForSixMonthsEndedJune302023Details" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r293" ], "lang": { "en-us": { "role": { "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.", "label": "Weighted average grant date fair value, nonvested options granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSetsForthInformationWithRespectToNonvestedOptionsForSixMonthsEndedJune302023Details" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "auth_ref": [ "r52" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.", "label": "Aggregate intrinsic value of options outstanding and options outstanding" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r287", "r288" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Options shares under option - end of year", "periodStartLabel": "Options shares under option - beginning of year" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionInformationAsOfJune302023Details" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r287", "r288" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Weighted average exercise price shares under option - end of year", "periodStartLabel": "Weighted average exercise price shares under option - beginning of year" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionInformationAsOfJune302023Details" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r291" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Weighted average exercise price options exercised" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionInformationAsOfJune302023Details" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r292" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.", "label": "Weighted average exercise price options forfeited" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionInformationAsOfJune302023Details" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "auth_ref": [ "r52" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.", "label": "Aggregate intrinsic value of options outstanding and options exercisable" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r52" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Weighted average remaining contractual life of options exercisable (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of non-vested options outstanding.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares", "periodEndLabel": "Nonvested options end of period", "periodStartLabel": "Nonvested options beginning of period" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSetsForthInformationWithRespectToNonvestedOptionsForSixMonthsEndedJune302023Details" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of non-vested options forfeited.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares", "negatedLabel": "Nonvested options vested or forfeited" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSetsForthInformationWithRespectToNonvestedOptionsForSixMonthsEndedJune302023Details" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average grant-date fair value of non-vested options forfeited.", "label": "Weighted average grant date fair value, nonvested options vested or forfeited" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSetsForthInformationWithRespectToNonvestedOptionsForSixMonthsEndedJune302023Details" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average grant-date fair value of non-vested options outstanding.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price", "periodEndLabel": "Weighted average grant date fair value, nonvested options end of period", "periodStartLabel": "Weighted average grant date fair value, beginning of year" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSetsForthInformationWithRespectToNonvestedOptionsForSixMonthsEndedJune302023Details" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r110" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Weighted average remaining contractual life of options outstanding (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": { "auth_ref": [ "r294" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.", "label": "Fair value of shares vested" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShortTermInvestments": { "auth_ref": [ "r123", "r124", "r593" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.", "label": "Short-term investments" } } }, "localname": "ShortTermInvestments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r105", "r175" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies:" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/SignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r14", "r28", "r135", "r160", "r161", "r162", "r179", "r180", "r181", "r185", "r193", "r195", "r210", "r242", "r245", "r276", "r300", "r301", "r302", "r307", "r308", "r327", "r328", "r329", "r330", "r331", "r333", "r337", "r364", "r365", "r366", "r367", "r368", "r370", "r384", "r421", "r422", "r423", "r434", "r492" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfChangesInEquity", "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [ "r179", "r180", "r181", "r210", "r392", "r429", "r435", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r466", "r467", "r468", "r469", "r470", "r472", "r474", "r475", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r492", "r559" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r179", "r180", "r181", "r210", "r392", "r429", "r435", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r466", "r467", "r468", "r469", "r470", "r472", "r474", "r475", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r492", "r559" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r14", "r77", "r78", "r109", "r291" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period", "negatedLabel": "Options exercised" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/FollowingTableSummarizesStockOptionInformationAsOfJune302023Details" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockSplits": { "auth_ref": [ "r14", "r77", "r78", "r109" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of a stock split.", "label": "Adjusted for stock splits" } } }, "localname": "StockIssuedDuringPeriodSharesStockSplits", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "auth_ref": [ "r55", "r77", "r78", "r109" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Share-based compensation" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r14", "r28", "r109" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Shares issued upon exercise of stock options" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockOptionMember": { "auth_ref": [ "r558" ], "lang": { "en-us": { "role": { "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option).", "label": "Equity Option [Member]" } } }, "localname": "StockOptionMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_StockRepurchasedDuringPeriodShares": { "auth_ref": [ "r14", "r77", "r78", "r109", "r430", "r492", "r513" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Shares repurchased" } } }, "localname": "StockRepurchasedDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRepurchasedDuringPeriodValue": { "auth_ref": [ "r14", "r77", "r78", "r109", "r434", "r492", "r513", "r567" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Shares repurchase value", "negatedLabel": "Shares repurchased" } } }, "localname": "StockRepurchasedDuringPeriodValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfChangesInEquity", "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r78", "r81", "r82", "r106", "r455", "r471", "r493", "r494", "r554", "r568", "r598", "r605", "r623", "r642" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.", "label": "Equity, Attributable to Parent", "totalLabel": "Total Inter Parfums, Inc. shareholders\u2019 equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inter Parfums, Inc. shareholders\u2019 equity:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r60", "r61", "r63", "r135", "r136", "r161", "r179", "r180", "r181", "r185", "r193", "r242", "r245", "r276", "r300", "r301", "r302", "r307", "r308", "r327", "r328", "r329", "r330", "r331", "r333", "r337", "r364", "r365", "r370", "r384", "r422", "r423", "r432", "r455", "r471", "r493", "r494", "r514", "r567", "r598", "r605", "r623", "r642" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.", "label": "Equity, Including Portion Attributable to Noncontrolling Interest", "periodEndLabel": "Ending Balance", "periodStartLabel": "Beginning Balance", "totalLabel": "Total equity" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited", "http://interparfumsinc.com/role/ConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r108", "r176", "r263", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r335", "r495", "r496", "r515" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for equity.", "label": "Share-Based Payments:" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/Share-basedPayments" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Subsidiary or Equity Method Investee [Line Items]" } } }, "localname": "SubsidiaryOrEquityMethodInvesteeLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash paid for:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfCashFlowsunaudited" ], "xbrltype": "stringItemType" }, "us-gaap_TaxesPayableCurrent": { "auth_ref": [ "r23" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Income taxes payable" } } }, "localname": "TaxesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_TreasuryStockCommonMember": { "auth_ref": [ "r50" ], "lang": { "en-us": { "role": { "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury.", "label": "Treasury Stock, Common [Member]" } } }, "localname": "TreasuryStockCommonMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfChangesInEquity", "http://interparfumsinc.com/role/Share-basedPaymentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockCommonShares": { "auth_ref": [ "r50" ], "lang": { "en-us": { "role": { "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury.", "label": "Treasury stock, shares" } } }, "localname": "TreasuryStockCommonShares", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunauditedParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockValue": { "auth_ref": [ "r27", "r50", "r51" ], "calculation": { "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited": { "order": 6.0, "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.", "label": "Treasury Stock, Value", "negatedLabel": "Treasury stock, at cost, 9,949,865 and 9,864,805 shares at June 30, 2023 and December 31, 2022, respectively" } } }, "localname": "TreasuryStockValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedBalanceSheetsunaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnusualOrInfrequentItemsDisclosureTextBlock": { "auth_ref": [ "r99" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for an event or transaction that is unusual in nature or infrequent in occurrence, or both.", "label": "Impact of COVID-19 Pandemic:" } } }, "localname": "UnusualOrInfrequentItemsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ImpactOfCovid-19Pandemic" ], "xbrltype": "textBlockItemType" }, "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": { "auth_ref": [ "r603" ], "calculation": { "http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails": { "order": 2.0, "parentTag": "us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.", "label": "Stock options" } } }, "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r200", "r205" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "verboseLabel": "Diluted" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted average number of shares outstanding:", "verboseLabel": "Denominator:" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome", "http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r199", "r205" ], "calculation": { "http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails": { "order": 1.0, "parentTag": "us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted average shares", "verboseLabel": "Basic" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ConsolidatedStatementsOfIncome", "http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Numerator:" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://interparfumsinc.com/role/ReconciliationBetweenNumeratorsAndDenominatorsOfBasicAndDilutedEpsComputationsIsAsFollowsDetails" ], "xbrltype": "stringItemType" } }, "unitCount": 7 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r105": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org//235/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r108": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org//505/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r112": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "https://asc.fasb.org//805/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-23", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r116": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "815", "URI": "https://asc.fasb.org//815/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-10(c)(3)(ii)(A))", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147479664/932-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-10(c)(7)(ii))", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147479664/932-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(22))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(4))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(5))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(13)(f))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(d)(1)", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481925/310-20-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(d)(2)", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481925/310-20-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r134": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "250", "URI": "https://asc.fasb.org//250/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "105", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(dd)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(22))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(23))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(5))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(4)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482739/220-10-55-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r198": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "https://asc.fasb.org//260/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r211": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "https://asc.fasb.org//280/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-26", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-34", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481664/323-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "https://asc.fasb.org//330/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29,30)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.31)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a-c)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "4E", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-5C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(i)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(iii)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(iv)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(i)(1)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(i)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(1)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(c)(2)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(c)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481839/830-10-45-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481839/830-10-45-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147482014/830-20-35-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147482014/830-20-35-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481956/830-20-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481956/830-20-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481926/830-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-21", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(3)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r375": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org//842-20/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(2)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "848", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481435/852-10-45-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(f)(1)", "Topic": "926", "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(f)(2)", "Topic": "926", "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(f)(3)", "Topic": "926", "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(24))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(25))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-12", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(21))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(22))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(24))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(10))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(16))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(17))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(20))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(21))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iii)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iv)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(b)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(b)(2)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(c)(2)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(2)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(4)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(e)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(f)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(16)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(17))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(19))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(2)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(2)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(8))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-05(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-05(4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(9))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(1)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481549/505-30-45-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13A(Column E))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13B(Column E))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13C(Column H))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(d)", "Topic": "954", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "12A", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(b)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "55", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480489/718-40-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13C(Column A)(Footnote 1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13C(Column B)(Footnote 1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r569": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r570": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r571": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r572": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r573": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r574": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r575": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r576": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r577": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r578": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r579": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r580": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r581": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r582": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r583": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r584": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r585": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r586": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r587": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r588": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "405", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147481071/942-405-45-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-16", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r614": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r615": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r616": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "50", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147480060/805-50-25-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r617": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "30", "SubTopic": "50", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147480027/805-50-30-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r618": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "30", "SubTopic": "50", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147480027/805-50-30-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r619": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-21", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r620": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r621": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r622": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r623": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r624": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r625": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147479424/830-30-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r626": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r627": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r628": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r629": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4I", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r630": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r631": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r632": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r633": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r634": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r635": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r636": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r637": { "Name": "Accounting Standards Codification", "Paragraph": "2B", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r638": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r639": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(3)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r640": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(18))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r641": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(i)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r642": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r643": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r644": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r645": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r646": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r647": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-20", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "182", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480401/815-10-55-182", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "25", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480238/815-25-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.10)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(12))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.3)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(a),(b))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r99": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "220", "URI": "https://asc.fasb.org//220-20/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" } }, "version": "2.2" } ZIP 54 0001753926-23-001015-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001753926-23-001015-xbrl.zip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�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end